<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Gym Trix</title>
	<atom:link href="https://gymtrix.net/feed/" rel="self" type="application/rss+xml" />
	<link>https://gymtrix.net/</link>
	<description></description>
	<lastBuildDate>Fri, 05 Jun 2026 04:45:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://gymtrix.net/wp-content/uploads/2022/08/cropped-LOGO2-scaled-2-32x32.jpg</url>
	<title>Gym Trix</title>
	<link>https://gymtrix.net/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Dianabol vs SARMs: Classic Bulking Steroid vs Modern Research Alternatives</title>
		<link>https://gymtrix.net/dianabol-vs-sarms/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Fri, 05 Jun 2026 04:45:32 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3131</guid>

					<description><![CDATA[<p>The comparison between Dianabol and SARMs is not really a comparison between two similar tools. It is a comparison between two entirely different relationships with risk one known, one largely unknown and two entirely different philosophies about what performance enhancement should look like. Dianabol (Methandienone) is the most widely used oral anabolic steroid in the...</p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-sarms/">Dianabol vs SARMs: Classic Bulking Steroid vs Modern Research Alternatives</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The comparison between Dianabol and SARMs is not really a comparison between two similar tools. It is a comparison between two entirely different relationships with risk one known, one largely unknown and two entirely different philosophies about what performance enhancement should look like.</p>



<p class="wp-block-paragraph">Dianabol (Methandienone) is the most widely used oral anabolic steroid in the history of bodybuilding. It has been in use since the 1950s. Its pharmacology is understood in detail. Its side effect profile is documented across decades of real-world use and clinical observation. </p>



<p class="wp-block-paragraph">Its results are predictable, its mechanisms are well-characterized, and the protocols for managing its risks aromatase inhibitors for estrogen, TUDCA for liver support, SERMs for PCT have been refined across generations of users. When you run Dianabol, you know what you are dealing with.</p>



<p class="wp-block-paragraph">Selective androgen receptor modulators Ostarine (MK-2866), RAD-140 (Testolone), and LGD-4033 (Ligandrol) being the most commonly discussed are marketed as a modern, more targeted alternative to traditional anabolic steroids. </p>



<p class="wp-block-paragraph">The concept is pharmacologically legitimate: compounds designed to bind androgen receptors with tissue selectivity, producing anabolic effects in muscle and bone while minimizing the androgenic activity in other tissues that drives traditional steroid side effects. </p>



<p class="wp-block-paragraph">In concept, this is a valuable goal. In practice, the research is largely preclinical or early-phase human data, the compounds available through bodybuilding channels are unregulated research chemicals subject to significant contamination and mislabeling, and the long-term safety data that would allow confident risk assessment simply does not exist.</p>



<p class="wp-block-paragraph">That asymmetry known risk versus uncertain risk is the real substance of this comparison.</p>



<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/04/dmwl8v7l8g4-1024x683.jpg" alt="man exercising in dip station" class="wp-image-3013" srcset="https://gymtrix.net/wp-content/uploads/2026/04/dmwl8v7l8g4-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/04/dmwl8v7l8g4-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/04/dmwl8v7l8g4-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/04/dmwl8v7l8g4-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/04/dmwl8v7l8g4.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Proven Potency vs Selective Uncertainty</strong></h2>



<p class="wp-block-paragraph">Dianabol&#8217;s mechanism is straightforward and well-understood. <a href="https://pubchem.ncbi.nlm.nih.gov/compound/Methandrostenolone">Methandienone aromatizes to estradiol</a>, and this estrogenic conversion drives glycogen supercompensation the intramuscular loading of glycogen and water that creates the dramatic volumization and rapid size accumulation the compound is famous for. </p>



<p class="wp-block-paragraph">Protein synthesis increases significantly, nitrogen retention improves, and the combination of genuine lean tissue accumulation and estrogenic fullness produces the 15 to 25 pounds of mass gain in four to six weeks that has defined the Dianabol bulking experience for sixty years. The mechanisms are known. The management protocols work. The risk profile is characterized.</p>



<p class="wp-block-paragraph">SARMs operate on the tissue selectivity principle <a href="https://www.ncbi.nlm.nih.gov/books/NBK532357/">binding androgen receptors</a> in muscle and bone with the intention of producing anabolic effects while minimizing androgenic activity in the liver, prostate, skin, and other tissues where traditional steroid activity drives side effects. </p>



<p class="wp-block-paragraph">The selectivity is real but partial none of the commonly used SARMs achieve complete tissue selectivity, and all of them produce meaningful HPTA suppression at effective doses. Their anabolic output is genuine but substantially lower than Dianabol&#8217;s in most users&#8217; experience. </p>



<p class="wp-block-paragraph">The compounds available outside pharmaceutical channels carry the contamination risk that independent laboratory testing has consistently documented products containing different compounds than labeled, products with no active ingredient, and products containing undisclosed anabolic steroids.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Dianabol for Bulking and Strength</strong></h2>



<h3 class="wp-block-heading"><strong>Rapid Size and Power</strong></h3>



<p class="wp-block-paragraph">The speed at which Dianabol produces results is its defining quality and the primary reason it has remained the reference point for oral mass building for over half a century. Within the first week, muscle fullness increases visibly. By week two, strength on major compound lifts has typically increased by 15 to 30 pounds. </p>



<p class="wp-block-paragraph">By week four, the scale reflects 15 to 25 pounds of accumulated mass a rate of change that no SARM or natural supplement approaches in the same timeframe. For athletes in a dedicated mass phase where rapid progress is the explicit goal, this speed has genuine training value beyond aesthetics: earlier strength increases support heavier training earlier in the cycle, which drives the hypertrophy that accumulates across the full cycle duration.</p>



<h3 class="wp-block-heading"><strong>Proven Track Record</strong></h3>



<p class="wp-block-paragraph">The clinical and real-world documentation on Dianabol spans seven decades of human use. Its pharmacology is covered in the published scientific literature. Its side effects are characterized, dose-dependent, and well understood. </p>



<p class="wp-block-paragraph">Its interactions with management compounds aromatase inhibitors, liver support agents, SERMs for PCT are validated through widespread use rather than theoretical projection. When a user encounters a side effect on Dianabol, there is a well-established intervention. </p>



<p class="wp-block-paragraph">When a user needs to know what bloodwork parameters to monitor, the answer is clear. This predictability is itself a meaningful safety advantage over compounds whose profiles are still being characterized.</p>



<h3 class="wp-block-heading"><strong>Effective Kickstart Role</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s most logically sound use case is as a kickstart to a testosterone-based bulking cycle filling the first four to six weeks while longer-acting injectables build to stable blood concentrations. </p>



<p class="wp-block-paragraph">The immediate anabolic activity of Dianabol means the cycle produces results from day one rather than from week four, which maintains training momentum and psychological engagement across the full cycle duration. </p>



<p class="wp-block-paragraph">This sequential structure Dianabol for early weeks, testosterone carrying the cycle beyond week six is the most tested and most consistent oral-plus-injectable architecture in the history of performance-enhancing bodybuilding.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of SARMs for Lean Gains</strong></h2>



<h3 class="wp-block-heading"><strong>Tissue-Selective Anabolic Action</strong></h3>



<p class="wp-block-paragraph">The tissue selectivity that defines SARMs produces genuinely different anabolic profiles depending on the compound. Ostarine at 15 to 25mg per day produces modest lean mass preservation and mild anabolic activity appropriate for recomposition or cutting contexts where preserving existing muscle is the priority rather than building new mass. </p>



<p class="wp-block-paragraph">LGD-4033 at 5 to 10mg per day produces more pronounced lean mass accumulation, closer to the lower end of mild injectable steroid outcomes, with moderate suppression. RAD-140 at 10 to 20mg per day delivers the most potent anabolic stimulus of the three, with a strength and lean mass output that approaches mild anabolic steroid results at the cost of correspondingly more significant suppression and androgenic activity.</p>



<p class="wp-block-paragraph">The selectivity advantage means these compounds do not cause the estrogenic water retention that makes Dianabol&#8217;s mass look wet and full gains on SARMs are drier and leaner, which may be a meaningful advantage for users whose goal is body recomposition rather than maximum scale weight.</p>



<h3 class="wp-block-heading"><strong>Less Water Retention</strong></h3>



<p class="wp-block-paragraph">The absence of aromatization across all three major SARMs means the water retention that significantly contributes to Dianabol&#8217;s mass numbers is simply not present. What SARMs produce is lean tissue not glycogen supercompensation, not estrogenic volumization. </p>



<p class="wp-block-paragraph">The scale moves more slowly, but the physique at the end of an Ostarine or RAD-140 cycle looks leaner at a comparable body weight than the same physique would on Dianabol, because what was added is genuine muscle rather than muscle plus water.</p>



<h3 class="wp-block-heading"><strong>Perceived Safety Profile</strong></h3>



<p class="wp-block-paragraph">The perception that SARMs are safer than traditional anabolic steroids is pervasive in online performance-enhancement communities and reflects a real but partial truth. They do not cause hepatotoxicity through C17-alpha alkylation. </p>



<p class="wp-block-paragraph">They do not aromatize. They produce partial rather than complete HPTA suppression at standard doses. These are genuine advantages in specific categories. </p>



<p class="wp-block-paragraph">What the perception misses is the contamination risk of black-market research chemicals, the incomplete long-term safety data, and the fact that several SARMs have demonstrated liver enzyme elevation in clinical observation that approaches what standard-dose oral anabolic steroids produce.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>CrazyBulk SARMs Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Exo+2:wght@600;700;800&#038;family=Inter:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #e0e4e8;
    padding: 28px 16px;
    font-family: 'Inter', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 8px;
    overflow: hidden;
    box-shadow: 0 8px 40px rgba(0,0,0,0.4);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.5);
  }

  /* ── BANNER ── */
  .banner {
    width: 100%;
    background: #080d14;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Top neon bar */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }
  @keyframes barShift {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG texture layers */
  .bg-fx {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background:
      radial-gradient(ellipse 60% 80% at 90% 50%, rgba(0,80,255,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 40% 60% at 15% 50%, rgba(0,200,120,0.07) 0%, transparent 60%),
      repeating-linear-gradient(-52deg, transparent, transparent 16px, rgba(255,255,255,0.014) 16px, rgba(255,255,255,0.014) 17px);
  }

  /* Blue diagonal slash */
  .slash {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background: linear-gradient(108deg,
      transparent 0%,
      transparent 42%,
      rgba(0,100,255,0.09) 42%,
      rgba(0,200,200,0.06) 100%
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    gap: 12px;
    padding: 18px 22px 14px 18px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0;
    width: 118px;
    display: flex;
    align-items: center;
    justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 110px;
    height: auto;
    display: block;
    border-radius: 6px;
    filter:
      drop-shadow(0 0 16px rgba(0,150,255,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
    transform: scale(1.04);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: scale(1.1);
    filter:
      drop-shadow(0 0 22px rgba(0,180,255,0.75))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
  }
  .img-badge {
    position: absolute;
    top: -5px;
    right: -4px;
    background: linear-gradient(135deg, #0055ff, #00c6ff);
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 8px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 7px;
    border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,100,255,0.55);
    white-space: nowrap;
    z-index: 3;
  }

  /* TEXT */
  .text-col {
    flex: 1;
    min-width: 0;
  }
  .eyebrow {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 700;
    letter-spacing: 3px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.9;
    letter-spacing: 1.5px;
    color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,150,255,0.35);
  }
  .headline em {
    color: #00c6ff;
    font-style: normal;
  }
  .sub {
    font-size: 11px;
    color: rgba(255,255,255,0.55);
    line-height: 1.5;
    margin-bottom: 10px;
    max-width: 320px;
  }

  /* Product tags */
  .tags {
    display: flex;
    flex-wrap: wrap;
    gap: 5px;
  }
  .tag {
    display: inline-flex;
    align-items: center;
    gap: 4px;
    background: rgba(0,150,255,0.1);
    border: 1px solid rgba(0,180,255,0.28);
    color: #55ccff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 8px;
    border-radius: 2px;
  }
  .tag::before { content: '▸'; font-size: 8px; }

  /* CTA COLUMN */
  .cta-col {
    flex-shrink: 0;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 9px;
    min-width: 145px;
    padding-left: 6px;
  }

  /* Price */
  .price-wrap { text-align: center; }
  .p-from {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 600;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.3);
    margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px;
    color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 46px;
    line-height: 1;
    color: #fff;
    letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Exo 2', sans-serif;
    font-size: 9.5px;
    font-weight: 800;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: #00ff9d;
    margin-top: 1px;
  }

  /* Button */
  .cta-btn {
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #0044dd 0%, #00aaff 50%, #00ddff 100%);
    background-size: 200% 100%;
    background-position: 0% 50%;
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 12.5px;
    letter-spacing: 1.8px;
    text-transform: uppercase;
    padding: 13px 14px;
    border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,100,255,0.5);
    transition: background-position 0.4s, box-shadow 0.2s, transform 0.2s;
    white-space: nowrap;
    position: relative;
    overflow: hidden;
  }
  .cta-btn::after {
    content: '';
    position: absolute;
    top: 0; left: -100%;
    width: 50%;
    height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,140,255,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow {
    font-size: 14px;
    transition: transform 0.2s;
  }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px;
    color: rgba(255,255,255,0.25);
    text-align: center;
    letter-spacing: 0.8px;
    text-transform: uppercase;
  }

  /* DIVIDER between text and cta */
  .v-divider {
    width: 1px;
    align-self: stretch;
    margin: 10px 0;
    background: linear-gradient(to bottom, transparent, rgba(0,180,255,0.3), transparent);
    flex-shrink: 0;
  }

  /* ── PRODUCT STRIP ── */
  .product-strip {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 0;
    background: rgba(0,100,255,0.08);
    border-top: 1px solid rgba(0,180,255,0.15);
    overflow: hidden;
  }
  .ps-item {
    flex: 1;
    text-align: center;
    padding: 7px 6px;
    border-right: 1px solid rgba(0,180,255,0.12);
    transition: background 0.2s;
  }
  .ps-item:last-child { border-right: none; }
  .banner-link:hover .ps-item { background: rgba(0,120,255,0.1); }
  .ps-name {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 800;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .ps-desc {
    font-size: 8px;
    color: rgba(255,255,255,0.35);
    letter-spacing: 0.5px;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
  }

  /* ── BOTTOM STRIP ── */
  .bottom-strip {
    position: relative;
    z-index: 2;
    background: rgba(0,0,0,0.25);
    border-top: 1px solid rgba(255,255,255,0.05);
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 16px;
    padding: 6px 16px;
    flex-wrap: wrap;
  }
  .bs-item {
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.4px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.32);
    display: flex;
    align-items: center;
    gap: 5px;
  }
  .bs-dot {
    width: 3px; height: 3px;
    border-radius: 50%;
    background: #00c6ff;
    opacity: 0.5;
  }

  /* Bottom bar */
  .bottom-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 90px; }
    .product-col img { width: 80px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 38px; }
    .cta-col { min-width: 120px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .ps-desc { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .cta-col { min-width: 108px; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/49747C/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal SARMs</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Legal SARMs Alternatives — OSTA 2866, LIGAN 4033, TESTOL 140, IBUTA 677">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal &amp; Safe Alternatives</div>
          <div class="headline">
            <em>SARMs</em> Range<br>
            Gym Beast Mode
          </div>
          <p class="sub">Torch fat, skyrocket testosterone &amp; build serious muscle — 100% natural, zero side effects, no prescription needed.</p>
          <div class="tags">
            <span class="tag">Muscle Growth</span>
            <span class="tag">Fat Burning</span>
            <span class="tag">Boost T-Levels</span>
            <span class="tag">60-Day Guarantee</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-from">Singles from</div>
            <div class="p-was">Was $84.99</div>
            <div class="p-now">$69.99</div>
            <div class="p-save">Save $15 · Stacks from $249</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Product name strip -->
      <div class="product-strip">
        <div class="ps-item">
          <div class="ps-name">OSTA 2866</div>
          <div class="ps-desc">Muscle Growth</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">LIGAN 4033</div>
          <div class="ps-desc">Energy &amp; Pumps</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">TESTOL 140</div>
          <div class="ps-desc">Boosts Testosterone</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">IBUTA 677</div>
          <div class="ps-desc">HGH &amp; Strength</div>
        </div>
      </div>

      <!-- Social proof strip -->
      <div class="bottom-strip">
        <div class="bs-item"><span class="bs-dot"></span>509,389 Bottles Sold</div>
        <div class="bs-item"><span class="bs-dot"></span>100% Natural Ingredients</div>
        <div class="bs-item"><span class="bs-dot"></span>Legal In All Countries</div>
        <div class="bs-item"><span class="bs-dot"></span>Free Shipping $100+</div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects: Known Profile vs Variable Uncertainty</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s side effects divide into hepatic and estrogenic categories, both well-characterized and manageable with established protocols. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">C17-alpha alkylation</a> produces ALT and AST elevation that is dose-dependent and requires TUDCA at 1 to 1.5g per day and enforcement of the four to six-week cycle length ceiling. </p>



<p class="wp-block-paragraph">Estrogenic effects gynecomastia risk, water retention, and blood pressure elevation from fluid accumulation respond effectively to aromatase inhibitors calibrated to bloodwork. HDL suppression and LDL elevation require lipid monitoring. HPTA suppression is complete and requires structured PCT. </p>



<p class="wp-block-paragraph">Every element of this profile is documented, dose-dependent, and responds to established intervention.</p>



<h3 class="wp-block-heading"><strong>SARMs Side Effects</strong></h3>



<p class="wp-block-paragraph">The SARM side effect picture is complicated by the regulatory and quality control gap between pharmaceutical compounds and research chemicals. Testosterone suppression of 30 to 70 percent depending on compound, dose, and duration is the most consistent documented effect, and the assumption that all SARMs cycles recover without PCT is a generalization that does not hold for RAD-140 or LGD-4033 at effective doses. </p>



<p class="wp-block-paragraph">Liver enzyme elevation has been documented in clinical observation for both Ostarine and LGD-4033 at levels that approach or occasionally match moderate-dose oral anabolic steroids challenging the categorical claim that SARMs are liver-safe.</p>



<p class="wp-block-paragraph">The contamination issue is the most practically significant concern for black-market SARMs users. Independent laboratory testing has consistently found commercial SARM products containing incorrect compounds, incorrect doses, and undisclosed anabolic steroid content. </p>



<p class="wp-block-paragraph"><a href="https://www.fda.gov/consumers/consumer-updates/fda-in-brief-fda-warns-against-using-sarms-body-building-products">The FDA has issued explicit warnings</a> about SARMs marketed for bodybuilding, specifically citing undisclosed ingredients and safety concerns. A user who believes they are running a research-grade SARM may be running an unidentified oral steroid or nothing at all neither outcome is predictable without third-party testing of every product batch.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Dianabol</th><th>SARMs (Ostarine / LGD-4033 / RAD-140)</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>High — C17-alpha alkylation</td><td>Low to Moderate — enzyme elevation documented</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>Significant — aromatization</td><td>None — do not aromatize</td></tr><tr><td><strong>Water Retention</strong></td><td>Significant</td><td>Low to Moderate</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Complete shutdown</td><td>30–70% testosterone reduction</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Significant</td><td>Mild to Moderate</td></tr><tr><td><strong>Purity Assurance</strong></td><td>Pharmaceutical grade</td><td>Black market — contamination documented</td></tr><tr><td><strong>Long-Term Safety Data</strong></td><td>Decades of human use</td><td>Largely preclinical or early-phase</td></tr><tr><td><strong>PCT Requirement</strong></td><td>Mandatory — full SERM protocol</td><td>Varies — RAD-140 and LGD-4033 warrant PCT</td></tr><tr><td><strong>Gyno Risk</strong></td><td>Estrogenic — AI required</td><td>Not estrogenic — AI not relevant</td></tr><tr><td><strong>Female Appropriate</strong></td><td>No at standard doses</td><td>Ostarine only at very conservative doses</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Structure and Use Cases</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol for Aggressive Bulking</strong></h3>



<p class="wp-block-paragraph">Dianabol at 20 to 50mg per day split across two daily doses given its 3 to 6-hour half-life across four to six weeks represents the standard protocol for a dedicated mass phase kickstart or standalone oral blast. </p>



<p class="wp-block-paragraph">Atop a testosterone base of 400 to 500mg per week, it produces the most rapid and dramatic mass accumulation available from any oral anabolic compound. For users prioritizing scale weight, early cycle strength, and the full, rounded aesthetic of a classic wet bulk, Dianabol is the appropriate and most proven choice.</p>



<p class="wp-block-paragraph">The four to six-week ceiling is non-negotiable from a hepatic burden perspective extending beyond this window increases liver enzyme elevation without proportional additional benefit, and the cycle length discipline that characterizes responsible Dianabol use is the primary variable separating manageable liver impact from potentially significant hepatic damage.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h3 class="wp-block-heading"><strong>SARMs for Lean Recomposition and Cutting</strong></h3>



<p class="wp-block-paragraph">SARMs fit most logically into contexts where lean mass preservation or modest lean mass accumulation is the goal caloric deficits, recomposition phases, or bridging periods between harder cycles. Ostarine at 15 to 25mg per day across eight to twelve weeks provides genuine anabolic support for lean mass preservation in a cut. </p>



<p class="wp-block-paragraph">LGD-4033 at 5 to 10mg per day across eight weeks produces modest but dry lean mass accumulation appropriate for a controlled off-season lean building phase. RAD-140 at 10 to 20mg per day provides the most anabolic output in the category but requires PCT consideration given its more significant suppression profile.</p>



<p class="wp-block-paragraph">In no scenario does any SARM approach Dianabol&#8217;s mass accumulation speed or magnitude. The tradeoff is that SARMs produce drier, more definition-friendly results without the estrogenic water and the active estrogen management that Dianabol demands.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>CrazyBulk SARMs Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Exo+2:wght@600;700;800&#038;family=Inter:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #e0e4e8;
    padding: 28px 16px;
    font-family: 'Inter', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 8px;
    overflow: hidden;
    box-shadow: 0 8px 40px rgba(0,0,0,0.4);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.5);
  }

  /* ── BANNER ── */
  .banner {
    width: 100%;
    background: #080d14;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Top neon bar */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }
  @keyframes barShift {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG texture layers */
  .bg-fx {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background:
      radial-gradient(ellipse 60% 80% at 90% 50%, rgba(0,80,255,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 40% 60% at 15% 50%, rgba(0,200,120,0.07) 0%, transparent 60%),
      repeating-linear-gradient(-52deg, transparent, transparent 16px, rgba(255,255,255,0.014) 16px, rgba(255,255,255,0.014) 17px);
  }

  /* Blue diagonal slash */
  .slash {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background: linear-gradient(108deg,
      transparent 0%,
      transparent 42%,
      rgba(0,100,255,0.09) 42%,
      rgba(0,200,200,0.06) 100%
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    gap: 12px;
    padding: 18px 22px 14px 18px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0;
    width: 118px;
    display: flex;
    align-items: center;
    justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 110px;
    height: auto;
    display: block;
    border-radius: 6px;
    filter:
      drop-shadow(0 0 16px rgba(0,150,255,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
    transform: scale(1.04);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: scale(1.1);
    filter:
      drop-shadow(0 0 22px rgba(0,180,255,0.75))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
  }
  .img-badge {
    position: absolute;
    top: -5px;
    right: -4px;
    background: linear-gradient(135deg, #0055ff, #00c6ff);
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 8px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 7px;
    border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,100,255,0.55);
    white-space: nowrap;
    z-index: 3;
  }

  /* TEXT */
  .text-col {
    flex: 1;
    min-width: 0;
  }
  .eyebrow {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 700;
    letter-spacing: 3px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.9;
    letter-spacing: 1.5px;
    color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,150,255,0.35);
  }
  .headline em {
    color: #00c6ff;
    font-style: normal;
  }
  .sub {
    font-size: 11px;
    color: rgba(255,255,255,0.55);
    line-height: 1.5;
    margin-bottom: 10px;
    max-width: 320px;
  }

  /* Product tags */
  .tags {
    display: flex;
    flex-wrap: wrap;
    gap: 5px;
  }
  .tag {
    display: inline-flex;
    align-items: center;
    gap: 4px;
    background: rgba(0,150,255,0.1);
    border: 1px solid rgba(0,180,255,0.28);
    color: #55ccff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 8px;
    border-radius: 2px;
  }
  .tag::before { content: '▸'; font-size: 8px; }

  /* CTA COLUMN */
  .cta-col {
    flex-shrink: 0;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 9px;
    min-width: 145px;
    padding-left: 6px;
  }

  /* Price */
  .price-wrap { text-align: center; }
  .p-from {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 600;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.3);
    margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px;
    color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 46px;
    line-height: 1;
    color: #fff;
    letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Exo 2', sans-serif;
    font-size: 9.5px;
    font-weight: 800;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: #00ff9d;
    margin-top: 1px;
  }

  /* Button */
  .cta-btn {
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #0044dd 0%, #00aaff 50%, #00ddff 100%);
    background-size: 200% 100%;
    background-position: 0% 50%;
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 12.5px;
    letter-spacing: 1.8px;
    text-transform: uppercase;
    padding: 13px 14px;
    border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,100,255,0.5);
    transition: background-position 0.4s, box-shadow 0.2s, transform 0.2s;
    white-space: nowrap;
    position: relative;
    overflow: hidden;
  }
  .cta-btn::after {
    content: '';
    position: absolute;
    top: 0; left: -100%;
    width: 50%;
    height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,140,255,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow {
    font-size: 14px;
    transition: transform 0.2s;
  }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px;
    color: rgba(255,255,255,0.25);
    text-align: center;
    letter-spacing: 0.8px;
    text-transform: uppercase;
  }

  /* DIVIDER between text and cta */
  .v-divider {
    width: 1px;
    align-self: stretch;
    margin: 10px 0;
    background: linear-gradient(to bottom, transparent, rgba(0,180,255,0.3), transparent);
    flex-shrink: 0;
  }

  /* ── PRODUCT STRIP ── */
  .product-strip {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 0;
    background: rgba(0,100,255,0.08);
    border-top: 1px solid rgba(0,180,255,0.15);
    overflow: hidden;
  }
  .ps-item {
    flex: 1;
    text-align: center;
    padding: 7px 6px;
    border-right: 1px solid rgba(0,180,255,0.12);
    transition: background 0.2s;
  }
  .ps-item:last-child { border-right: none; }
  .banner-link:hover .ps-item { background: rgba(0,120,255,0.1); }
  .ps-name {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 800;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .ps-desc {
    font-size: 8px;
    color: rgba(255,255,255,0.35);
    letter-spacing: 0.5px;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
  }

  /* ── BOTTOM STRIP ── */
  .bottom-strip {
    position: relative;
    z-index: 2;
    background: rgba(0,0,0,0.25);
    border-top: 1px solid rgba(255,255,255,0.05);
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 16px;
    padding: 6px 16px;
    flex-wrap: wrap;
  }
  .bs-item {
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.4px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.32);
    display: flex;
    align-items: center;
    gap: 5px;
  }
  .bs-dot {
    width: 3px; height: 3px;
    border-radius: 50%;
    background: #00c6ff;
    opacity: 0.5;
  }

  /* Bottom bar */
  .bottom-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 90px; }
    .product-col img { width: 80px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 38px; }
    .cta-col { min-width: 120px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .ps-desc { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .cta-col { min-width: 108px; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/49747C/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal SARMs</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Legal SARMs Alternatives — OSTA 2866, LIGAN 4033, TESTOL 140, IBUTA 677">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal &amp; Safe Alternatives</div>
          <div class="headline">
            <em>SARMs</em> Range<br>
            Gym Beast Mode
          </div>
          <p class="sub">Torch fat, skyrocket testosterone &amp; build serious muscle — 100% natural, zero side effects, no prescription needed.</p>
          <div class="tags">
            <span class="tag">Muscle Growth</span>
            <span class="tag">Fat Burning</span>
            <span class="tag">Boost T-Levels</span>
            <span class="tag">60-Day Guarantee</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-from">Singles from</div>
            <div class="p-was">Was $84.99</div>
            <div class="p-now">$69.99</div>
            <div class="p-save">Save $15 · Stacks from $249</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Product name strip -->
      <div class="product-strip">
        <div class="ps-item">
          <div class="ps-name">OSTA 2866</div>
          <div class="ps-desc">Muscle Growth</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">LIGAN 4033</div>
          <div class="ps-desc">Energy &amp; Pumps</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">TESTOL 140</div>
          <div class="ps-desc">Boosts Testosterone</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">IBUTA 677</div>
          <div class="ps-desc">HGH &amp; Strength</div>
        </div>
      </div>

      <!-- Social proof strip -->
      <div class="bottom-strip">
        <div class="bs-item"><span class="bs-dot"></span>509,389 Bottles Sold</div>
        <div class="bs-item"><span class="bs-dot"></span>100% Natural Ingredients</div>
        <div class="bs-item"><span class="bs-dot"></span>Legal In All Countries</div>
        <div class="bs-item"><span class="bs-dot"></span>Free Shipping $100+</div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Factor</th><th>Dianabol</th><th>SARMs (Ostarine / LGD-4033 / RAD-140)</th></tr></thead><tbody><tr><td><strong>Effective Dose</strong></td><td>20–50mg/day</td><td>10–25mg/day compound-dependent</td></tr><tr><td><strong>Cycle Length</strong></td><td>4–6 weeks maximum</td><td>8–12 weeks</td></tr><tr><td><strong>Mass Gain Speed</strong></td><td>Fast — 15–25lbs in 4–6 weeks</td><td>Moderate — 4–10lbs in 8–12 weeks</td></tr><tr><td><strong>Mass Type</strong></td><td>Wet — glycogen and water component</td><td>Dry — lean tissue primarily</td></tr><tr><td><strong>Strength Onset</strong></td><td>Explosive — week 1 to 2</td><td>Steady — progressive across cycle</td></tr><tr><td><strong>Liver Risk</strong></td><td>High — alkylation documented</td><td>Low to Moderate — enzyme data emerging</td></tr><tr><td><strong>Purity Reliability</strong></td><td>Pharmaceutical standard</td><td>Variable — black market contamination risk</td></tr><tr><td><strong>Estrogenic Management</strong></td><td>AI required</td><td>Not required</td></tr><tr><td><strong>PCT Requirement</strong></td><td>Mandatory — full protocol</td><td>Compound and dose dependent</td></tr><tr><td><strong>Long-Term Data</strong></td><td>60+ years human use</td><td>Limited — primarily preclinical</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>PCT and Recovery</strong></h2>



<p class="wp-block-paragraph">Dianabol requires structured PCT without exception. Complete HPTA suppression at standard doses means endogenous testosterone production will not restart meaningfully without pharmacological intervention. For Dianabol-only cycles without a testosterone base not the recommended structure but occasionally used PCT begins immediately after the last dose given the compound&#8217;s short clearance time. </p>



<p class="wp-block-paragraph">Nolvadex at 40mg daily for two weeks followed by 20mg daily for two more weeks, with optional Clomid at 50mg daily for the first two weeks for users wanting a more aggressive restart, is the standard protocol.</p>



<p class="wp-block-paragraph">For Dianabol cycles with a testosterone base, PCT timing is governed by the testosterone ester&#8217;s clearance typically beginning 10 to 14 days after the last Testosterone Enanthate injection, with an HCG bridge during the clearance window to maintain testicular responsiveness before SERMs take over.</p>



<p class="wp-block-paragraph">SARMs PCT requirements are genuinely variable. Ostarine at conservative doses frequently recovers naturally without pharmaceutical intervention in otherwise healthy users though bloodwork confirming testosterone normalization at four weeks post-cycle is the only reliable verification rather than subjective assessment. </p>



<p class="wp-block-paragraph">RAD-140 and LGD-4033 at standard effective doses produce enough suppression that a light Nolvadex taper at 20mg per day for three to four weeks is advisable. The mistake that causes prolonged post-cycle low-testosterone states is assuming natural recovery will occur based on community consensus rather than confirming it with bloodwork.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg" alt="topless man in black shorts holding orange bar" class="wp-image-3005" srcset="https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Who Should Choose Which Compound</strong></h2>



<p class="wp-block-paragraph">Dianabol is the appropriate choice for experienced users who want the most proven, fastest mass accumulation available from an oral anabolic steroid, who understand and can actively manage estrogenic and hepatic side effects, and whose training goal is genuine bulk maximum scale weight, maximum early strength, and the training environment that rapid mass accumulation creates. </p>



<p class="wp-block-paragraph">Its risk profile is known, its management protocols work, and its results are consistent. None of these qualities apply to the same degree to any SARM currently available.</p>



<p class="wp-block-paragraph">SARMs fit best as a starting point for users new to performance enhancement who want to understand their individual response to anabolic compounds before progressing to traditional steroids, as a bridging tool between harder cycles to maintain gains during recovery without reimposing full hepatic and hormonal burden, or as the primary tool for athletes whose goals are lean recomposition rather than maximum mass and whose risk tolerance favors the more modest but cleaner gains SARMs produce.</p>



<p class="wp-block-paragraph">The critical reality check for both is this: neither is risk-free, and Dianabol&#8217;s risk profile is far better understood than most SARMs. The person who runs Dianabol with bloodwork, TUDCA, an AI, and a proper PCT is managing a known risk with established tools. </p>



<p class="wp-block-paragraph">The person who runs a black-market SARM without third-party purity testing does not know with certainty what they are running or what it is doing and that uncertainty is itself a meaningful and underappreciated risk that no side effect comparison table fully captures.</p>



<p class="wp-block-paragraph">Bloodwork before, during, and after any cycle involving either compound. Purity testing for any black-market research chemical. PCT completed in full and confirmed by post-PCT bloodwork. These are not optional they are the minimum responsible framework for any performance enhancement decision at this level of pharmacological engagement.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-sarms/">Dianabol vs SARMs: Classic Bulking Steroid vs Modern Research Alternatives</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dianabol vs Turinabol: Wet Mass vs Dry Quality Gains Comparison</title>
		<link>https://gymtrix.net/dianabol-vs-turinabol/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Mon, 25 May 2026 01:04:02 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3091</guid>

					<description><![CDATA[<p>The comparison between Dianabol and Turinabol is one of those matchups that cuts straight to the heart of what bodybuilders actually want from a cycle and forces an honest answer. Both are C17-alpha alkylated oral anabolic steroids. Both derive from the same structural lineage. Both have been in use in competitive bodybuilding for decades. And...</p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-turinabol/">Dianabol vs Turinabol: Wet Mass vs Dry Quality Gains Comparison</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The comparison between Dianabol and Turinabol is one of those matchups that cuts straight to the heart of what bodybuilders actually want from a cycle and forces an honest answer. Both are C17-alpha alkylated oral anabolic steroids. Both derive from the same structural lineage. </p>



<p class="wp-block-paragraph">Both have been in use in competitive bodybuilding for decades. And yet in practice, they deliver experiences so different that choosing between them without understanding that difference leads to cycles that underperform against expectations, produce unwanted side effects, or simply produce the wrong kind of result for the goal at hand.</p>



<p class="wp-block-paragraph">Dianabol (Methandienone) is the mass compound. It is the compound that built the physiques of the golden era, that remains the most widely used oral anabolic steroid in the world, and that delivers the rapid, dramatic, full-bodied size accumulation that defines what most people picture when they imagine a classic bulking cycle. It is powerful, it is fast, and it comes with the estrogenic and hepatic cost that power and speed at this level inevitably carry.</p>



<p class="wp-block-paragraph">Turinabol (Chlorodehydromethyltestosterone) is something more considered. Developed in East Germany and used systematically in their state-sponsored athletic program, it was designed specifically to produce performance enhancement with lower detectability and a cleaner physiological profile than Dianabol. </p>



<p class="wp-block-paragraph">The result is a compound that produces slower, drier, more controlled gains leaner muscle tissue accumulation without the estrogenic water retention that defines Dianabol&#8217;s mass-building character at the cost of significantly less dramatic short-term results.</p>



<p class="wp-block-paragraph">The decision between them is a decision about what kind of cycle you actually want to run, not just what sounds more impressive.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/7kepupb8vnk-1024x683.jpg" alt="topless man in black shorts carrying black dumbbell" class="wp-image-2997" srcset="https://gymtrix.net/wp-content/uploads/2026/03/7kepupb8vnk-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/7kepupb8vnk-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/7kepupb8vnk-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/7kepupb8vnk-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/7kepupb8vnk.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Fast Wet Mass vs Steady Dry Quality</strong></h2>



<p class="wp-block-paragraph">Dianabol&#8217;s mass-building mechanism centers on its aromatization to estradiol. This estrogenic conversion drives glycogen supercompensation the intramuscular loading of glycogen and water that creates the rapid volumization and fullness that Methandienone has been famous for since its introduction in the 1950s. </p>



<p class="wp-block-paragraph">The 15 to 25 pounds gained in a four to six-week Dianabol cycle reflect a combination of genuine lean tissue, elevated intramuscular glycogen, and the subcutaneous and intracellular water that estrogenic activity drives. The lean tissue component is real and keepable. The glycogen and water are transient but create the training conditions full muscles, superior pump, faster recovery that make the lean tissue accumulation possible.</p>



<p class="wp-block-paragraph">Turinabol does not aromatize. Chlorodehydromethyltestosterone is structurally a combination of Dianabol and Clostebol the addition of a 4-chloro group to Dianabol&#8217;s structure eliminates its ability to convert to estrogen while maintaining anabolic activity. </p>



<p class="wp-block-paragraph">The result is a compound that produces steady lean mass accumulation without the estrogenic water retention that both inflates and obscures Dianabol&#8217;s results. Gains on Turinabol are slower, typically 6 to 10 pounds of genuine lean tissue across a six to eight-week cycle, but they are dry, defined, and retained at a high percentage post-cycle precisely because there is no transient water component in what was built.</p>



<p class="wp-block-paragraph">Neither compound is superior in the abstract. They are optimized for different goals, and the clarity of that distinction is what makes this comparison useful.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Dianabol for Muscle Gains</strong></h2>



<h3 class="wp-block-heading"><strong>Rapid Size and Strength</strong></h3>



<p class="wp-block-paragraph">The speed at which Dianabol produces measurable results is unmatched among oral anabolic steroids. Within the first week of a cycle at standard doses, users report visible changes in muscle fullness and size. By week two, strength on major compound lifts has typically increased by 15 to 30 pounds. </p>



<p class="wp-block-paragraph">By week four, the scale reflects 15 to 25 pounds of accumulated mass. This rate of change both visual and performance-based is the primary reason Dianabol has retained its position as the most widely used oral anabolic despite being one of the oldest compounds in the class. Nothing else oral produces results this quickly at doses this manageable.</p>



<p class="wp-block-paragraph">The strength increases specifically reflect a combination of the anabolic drive of Methandienone&#8217;s androgen receptor activity, the performance enhancement of glycogen-saturated muscle tissue, and the psychological effect of the dramatic physical changes that motivate heavier training. Each factor reinforces the others in a way that makes a Dianabol cycle feel uniquely productive from the very beginning.</p>



<h3 class="wp-block-heading"><strong>Dramatic Muscle Fullness and Bulk</strong></h3>



<p class="wp-block-paragraph">The estrogenic volumization that Dianabol drives produces a visual and physical fullness that is qualitatively different from what non-aromatizing compounds deliver. Muscles appear rounder, larger, and more three-dimensional not from actual structural changes but from the glycogen and water filling that Dianabol&#8217;s estrogenic activity drives. </p>



<p class="wp-block-paragraph">For athletes in a mass phase where maximum size is the priority, this fullness is not a liability it is the visual confirmation that the compound is working and the caloric surplus is being directed into the muscle tissue where training demands it.</p>



<p class="wp-block-paragraph">This full, bulky aesthetic is the defining characteristic of a classic wet bulk, and for users who want that specific look and feel during a mass phase, Dianabol delivers it more completely than any other oral compound.</p>



<h3 class="wp-block-heading"><strong>Effective Kickstart Compound</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s rapid onset makes it the most logical kickstart for testosterone-based bulking cycles. As Testosterone Enanthate or Testosterone Cypionate builds slowly toward stable blood concentrations across the first three to four weeks of a cycle, Dianabol fills the performance and anabolic gap immediately providing size, strength, and training quality from day one rather than from week four. </p>



<p class="wp-block-paragraph">By the time Dianabol is discontinued at weeks four to six, the testosterone is fully active and continues driving the cycle without the oral&#8217;s hepatic burden. This sequential structure is the most validated cycle architecture in bodybuilding, and Dianabol&#8217;s pharmacological character is precisely what makes it the ideal compound for the kickstart role.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Turinabol for Lean Gains</strong></h2>



<h3 class="wp-block-heading"><strong>Dry Quality Muscle Accumulation</strong></h3>



<p class="wp-block-paragraph">Turinabol&#8217;s gains are not dramatic in the way Dianabol&#8217;s are, and setting expectations appropriately is the starting point for any honest discussion of the compound. Six to ten pounds of lean mass across a six to eight-week cycle is the realistic outcome not 20 pounds, not the kind of scale change that prompts immediate comment from training partners. </p>



<p class="wp-block-paragraph">What those gains represent, however, is a quality of muscle tissue that Dianabol cannot match: dry, hard, structurally genuine lean mass without a water or glycogen component. The physique at the end of a Turinabol cycle looks leaner and more defined at the same body weight than the same physique would on Dianabol, because what was added is visible rather than obscured by estrogenic water.</p>



<p class="wp-block-paragraph">This quality-over-quantity character makes Turinabol particularly suited to athletes who are building toward a physique goal rather than chasing scale weight competitive physique athletes in an off-season that prioritizes lean mass accumulation, or anyone for whom appearing lean and defined is more important than appearing maximally large.</p>



<h3 class="wp-block-heading"><strong>Steady Strength Progression</strong></h3>



<p class="wp-block-paragraph">The strength gains Turinabol produces are real but linear rather than explosive. Week-over-week improvements in training performance accumulate gradually across the cycle duration the experience is less the dramatic early surge of Dianabol and more a consistent, reliable upward trend in workout quality and capacity. </p>



<p class="wp-block-paragraph">For athletes whose training is built around progressive overload rather than peak performance output, this steady progression supports training structure in a way that a compound with dramatic early peaks and subsequent plateaus does not. Turinabol&#8217;s strength contribution is sustainable across the full cycle length in a way that mirrors its mass accumulation character.</p>



<h3 class="wp-block-heading"><strong>Harder, More Defined Physique Quality</strong></h3>



<p class="wp-block-paragraph">Without estrogenic water retention, without the subcutaneous and intracellular fluid that Dianabol&#8217;s aromatization drives, the physique on Turinabol reflects its actual body composition rather than an estrogenically inflated version of it. Muscle separation is more visible, vascularity is more pronounced, and the hardness of the physique reads as genuinely lean rather than full. </p>



<p class="wp-block-paragraph">For athletes preparing for a physique competition or a photo session, this quality is significantly more useful than the wet, rounded fullness of a Dianabol cycle and it is the primary reason Turinabol was the compound of choice for athletes in sports where maintaining weight class while maximizing performance was the objective.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="683" height="1024" src="http://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-683x1024.jpg" alt="grayscale photo of man working out" class="wp-image-2988" srcset="https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-683x1024.jpg 683w, https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-200x300.jpg 200w, https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-768x1152.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu.jpg 800w" sizes="(max-width: 683px) 100vw, 683px" /></figure>



<h2 class="wp-block-heading"><strong>Side Effects: Understanding What Each Compound Costs</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s side effects divide into two categories: estrogenic and hepatic. The estrogenic consequences gynecomastia risk, water retention, and blood pressure elevation from the fluid load arise from aromatization and are managed with an aromatase inhibitor calibrated to bloodwork rather than a fixed dose. </p>



<p class="wp-block-paragraph">The hepatic consequences significant <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">ALT and AST elevation from C17-alpha alkylation</a> require TUDCA at 1 to 1.5g per day and enforcement of the four to six-week cycle length ceiling. HPTA suppression is complete at standard doses and requires structured PCT. Androgenic effects acne, mood elevation, oily skin are present but moderate given Methandienone&#8217;s relatively balanced anabolic-to-androgenic profile.</p>



<p class="wp-block-paragraph">The cholesterol disruption from Dianabol is meaningful: HDL suppression and LDL elevation create an atherogenic lipid profile during the cycle that requires monitoring and lipid recovery support post-cycle through fish oil supplementation and dietary management.</p>



<h3 class="wp-block-heading"><strong>Turinabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Turinabol&#8217;s side effects are primarily hepatic and androgenic rather than estrogenic. Without aromatization, there is no gynecomastia risk from estrogen, no estrogenic water retention, and no fluid-driven blood pressure elevation a genuine advantage over Dianabol in these specific categories. </p>



<p class="wp-block-paragraph">However, the C17-alpha alkylation that Turinabol shares with Dianabol produces its own liver enzyme elevation, and while the magnitude is generally considered lower than Dianabol&#8217;s at comparable doses, it is not negligible. TUDCA at 500 to 1g per day and the six to eight-week cycle length limit are appropriate harm reduction approaches.</p>



<p class="wp-block-paragraph">Cholesterol disruption is potentially more severe with Turinabol than its relatively mild reputation suggests HDL suppression at standard doses can be significant, and lipid monitoring throughout the cycle is appropriate. HPTA suppression occurs and requires PCT. </p>



<p class="wp-block-paragraph">Androgenic effects acne, hair loss in predisposed individuals are present, though Turinabol&#8217;s androgenic rating is lower than Dianabol&#8217;s, which generally translates to milder androgenic side effects.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Dianabol</th><th>Turinabol</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>High — significant ALT/AST elevation</td><td>Moderate — present but lower magnitude</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>Significant — aromatization driven</td><td>None — does not aromatize</td></tr><tr><td><strong>Gyno Risk</strong></td><td>Present — AI required</td><td>Not from estrogen — no AI needed</td></tr><tr><td><strong>Water Retention</strong></td><td>Significant</td><td>Low — dry gains</td></tr><tr><td><strong>Blood Pressure</strong></td><td>Elevated from fluid load</td><td>Mild — no fluid contribution</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Significant</td><td>Significant — often underestimated</td></tr><tr><td><strong>Androgenic Effects</strong></td><td>Moderate — acne, oily skin</td><td>Mild to Moderate</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Complete</td><td>Complete</td></tr><tr><td><strong>Female Appropriate</strong></td><td>No</td><td>No at standard bodybuilding doses</td></tr><tr><td><strong>Liver Support Required</strong></td><td>TUDCA 1–1.5g/day</td><td>TUDCA 500mg–1g/day</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Structure and Use Case</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol for Bulking Cycles</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s optimal use case is a four to six-week kickstart or standalone oral blast within a mass-focused training phase. At 20 to 50mg per day split across two daily doses given its 3 to 6-hour half-life it provides the rapid glycogen-driven size and explosive early strength that makes a bulking cycle productive from week one. </p>



<p class="wp-block-paragraph">Atop a testosterone base of 400 to 500mg per week, it represents the most validated oral-plus-injectable bulking architecture available. For users prioritizing scale weight, training performance in the early cycle weeks, and the full, rounded mass aesthetic that estrogenic volumization produces, Dianabol is the appropriate choice.</p>



<h3 class="wp-block-heading"><strong>Turinabol for Lean Recomposition Cycles</strong></h3>



<p class="wp-block-paragraph">Turinabol&#8217;s optimal use case is a controlled six to eight-week lean mass accumulation phase either alongside a low-to-moderate testosterone base or as a standalone compound for users whose goals and experience level align with the more conservative approach. </p>



<p class="wp-block-paragraph">At 20 to 50mg per day with a single daily dose appropriate given its longer half-life, it produces steady lean mass improvement that compounds visually over the cycle duration. For athletes prioritizing physique quality over scale weight those who want to add visible, dry muscle without the water-inflated appearance that Dianabol produces Turinabol delivers what the goal requires. </p>



<p class="wp-block-paragraph">It also suits athletes in weight-class sports where gaining water weight counterproductively inflates scale weight without improving the performance metrics that matter.</p>



<h3 class="wp-block-heading"><strong>Matching Compound to Goal</strong></h3>



<p class="wp-block-paragraph">The practical selection between them reduces to a single honest question: do you want rapid dramatic size that includes a water component and requires active estrogen management, or do you want slower lean gains that reflect genuine tissue accumulation without the transient water that will clear post-cycle? </p>



<p class="wp-block-paragraph">Both are valid goals. Neither compound is better in the abstract each is better for the specific outcome it is pharmacologically designed to produce.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/dbveoau3ics-1024x683.jpg" alt="topless man in black shorts" class="wp-image-2996" srcset="https://gymtrix.net/wp-content/uploads/2026/03/dbveoau3ics-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/dbveoau3ics-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/dbveoau3ics-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/dbveoau3ics-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/dbveoau3ics.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Factor</th><th>Dianabol</th><th>Turinabol</th></tr></thead><tbody><tr><td><strong>Effective Dose Range</strong></td><td>20–50mg/day (split dosing)</td><td>20–50mg/day (single or split)</td></tr><tr><td><strong>Cycle Length</strong></td><td>4–6 weeks</td><td>6–8 weeks</td></tr><tr><td><strong>Mass Accumulation</strong></td><td>15–25lbs in 4–6 weeks</td><td>6–10lbs in 6–8 weeks</td></tr><tr><td><strong>Mass Type</strong></td><td>Wet — glycogen and water component</td><td>Dry — lean tissue primarily</td></tr><tr><td><strong>Strength Onset</strong></td><td>Explosive — weeks 1 to 2</td><td>Steady — progressive across full cycle</td></tr><tr><td><strong>Water Retention</strong></td><td>High</td><td>Low</td></tr><tr><td><strong>Estrogenic Management</strong></td><td>AI required — Anastrozole or Aromasin</td><td>Not required</td></tr><tr><td><strong>Physique Look</strong></td><td>Full, round, bulky</td><td>Harder, drier, more defined</td></tr><tr><td><strong>Post-Cycle Retention</strong></td><td>40–60% after water clears</td><td>75–85% genuine lean tissue</td></tr><tr><td><strong>Liver Support</strong></td><td>TUDCA 1–1.5g/day</td><td>TUDCA 500mg–1g/day</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>PCT and Recovery</strong></h2>



<p class="wp-block-paragraph">Both compounds produce complete <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404628/">HPTA suppression</a> requiring structured post-cycle therapy. The recovery protocol for both follows the same SERM-based framework, with timing governed by cycle length and whether a testosterone base was included.</p>



<p class="wp-block-paragraph">For oral-only cycles of either compound, PCT begins within days of the last dose the short half-lives of both Dianabol and Turinabol mean clearance is rapid and there is no extended waiting period before SERMs can be effective. </p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">Nolvadex at 40mg daily for two weeks followed by 20mg daily for two more weeks is the standard protocol for moderate-duration cycles. Clomid at 50mg daily alongside Nolvadex in the first two weeks provides additional LH and FSH stimulation for users who want a more aggressive restart.</p>



<p class="wp-block-paragraph">For cycles that include a testosterone base the appropriate structure for either compound in a serious cycle PCT timing is governed by the testosterone ester&#8217;s clearance window. TUDCA continuing at a reduced dose post-cycle supports liver enzyme normalization. Fish oil at 3g per day throughout PCT supports the lipid recovery that both compounds&#8217; cholesterol disruption requires.</p>



<p class="wp-block-paragraph">Bloodwork at four to six weeks post-PCT confirming testosterone, LH, FSH, and lipid normalization is the reliable endpoint for a complete recovery rather than subjective assessment of how the user feels.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Final Verdict: Two Tools, One Decision</strong></h2>



<p class="wp-block-paragraph">The verdict of this comparison is not that one compound is better it is that they are better for different things, and knowing which one you need requires an honest assessment of what you actually want your cycle to accomplish.</p>



<p class="wp-block-paragraph">Dianabol wins on speed, dramatic visual impact, and the full, powerful mass aesthetic of a classic wet bulk. If you want the scale to move quickly, your training performance to surge in the first two weeks, and your physique to look maximally large during the cycle, Dianabol delivers all of this reliably. </p>



<p class="wp-block-paragraph">Accept the estrogen management requirement, enforce the cycle length limit, and run the liver support and the results are everything the compound&#8217;s reputation promises.</p>



<p class="wp-block-paragraph">Turinabol wins on quality, definition, and the durability of what it builds. If you want lean mass that looks like lean mass rather than a combination of muscle and water, that retains at a high percentage post-cycle, and that produces a harder and more defined physique rather than a fuller and rounder one, Turinabol is the more appropriate tool. </p>



<p class="wp-block-paragraph">Accept the slower timeline, manage the cholesterol disruption that its relatively mild reputation can obscure, and run the full cycle length it requires to express its results properly.</p>



<p class="wp-block-paragraph">Both compounds demand the same commitment: pre-cycle bloodwork, appropriate liver support, complete PCT, and post-PCT bloodwork confirming recovery. The compound that earns your respect is the one you will use intelligently. The one you dismiss as manageable without monitoring is the one that creates problems you did not anticipate.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-turinabol/">Dianabol vs Turinabol: Wet Mass vs Dry Quality Gains Comparison</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dianabol vs Superdrol: Oral Mass King vs Extreme Power Explosive</title>
		<link>https://gymtrix.net/dianabol-vs-superdrol/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Thu, 14 May 2026 23:45:48 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3088</guid>

					<description><![CDATA[<p>When the conversation turns to oral anabolic steroids for mass and strength, two compounds consistently generate the most intense debate among experienced users: Dianabol and Superdrol. Not because they are interchangeable they are not but because they represent the two dominant philosophies of what a powerful oral mass builder should do. One floods the body...</p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-superdrol/">Dianabol vs Superdrol: Oral Mass King vs Extreme Power Explosive</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">When the conversation turns to oral anabolic steroids for mass and strength, two compounds consistently generate the most intense debate among experienced users: Dianabol and Superdrol. Not because they are interchangeable they are not but because they represent the two dominant philosophies of what a powerful oral mass builder should do. </p>



<p class="wp-block-paragraph">One floods the body with estrogenic fullness, classic wet bulk, and the kind of rapid size that has defined mass-phase bodybuilding for over half a century. The other delivers brutal dry density and strength gains that are among the most dramatic any oral compound produces, at the cost of the most demanding hepatotoxic burden in the class.</p>



<p class="wp-block-paragraph">Dianabol (Methandienone) is the benchmark. It has been the reference point for oral mass building since the early days of competitive bodybuilding, and its combination of rapid glycogen-driven size, explosive early strength, and a relatively manageable side effect profile relative being the operative word has made it the most widely used oral anabolic steroid in history. </p>



<p class="wp-block-paragraph">Superdrol (Methyldrostanolone) is something different in almost every respect. Developed in the early 2000s and briefly sold as a legal supplement before being scheduled, it produces dry, dense mass gains with strength increases that frequently exceed what Dianabol delivers alongside liver toxicity and cholesterol disruption so severe that the effective cycle window is measured in weeks rather than months.</p>



<p class="wp-block-paragraph">The decision between them is not about which is stronger in the abstract. It is about what your training phase requires, what your experience level warrants, and what risk profile you are genuinely equipped to manage.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/9dzwzqwzmde-1024x683.jpg" alt="topless man in black shorts sitting on black and silver barbell" class="wp-image-3006" srcset="https://gymtrix.net/wp-content/uploads/2026/03/9dzwzqwzmde-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/9dzwzqwzmde-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/9dzwzqwzmde-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/9dzwzqwzmde-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/9dzwzqwzmde.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Wet Classic Mass vs Dry Brutal Power</strong></h2>



<p class="wp-block-paragraph">Dianabol&#8217;s mechanism is estrogenic at its core. Methandienone aromatizes to estradiol, and this estrogen conversion drives the glycogen supercompensation intramuscular loading of glycogen and water that creates the rapid volumization and fullness the compound is famous for. </p>



<p class="wp-block-paragraph">The 15 to 25 pounds gained in a four to six-week Dianabol cycle reflect a combination of genuine lean tissue, significantly elevated intramuscular glycogen, and the water retention that estrogenic activity drives. The lean tissue component is real and durable. The water and glycogen are transient but contribute meaningfully to training performance during the cycle.</p>



<p class="wp-block-paragraph">Superdrol (Methyldrostanolone) is structurally a <a href="https://pubchem.ncbi.nlm.nih.gov/compound/Superdrol">17-alpha methylated derivative of Drostanolone</a> which is Masteron making it a DHT-derived compound rather than a testosterone-derived one. It does not aromatize. It produces no estrogenic water retention, no glycogen supercompensation through estrogenic mechanisms, and no estrogen-driven joint lubrication. </p>



<p class="wp-block-paragraph">What it produces instead is extraordinarily dense, dry mass accumulation driven by potent androgen receptor activation, combined with strength increases that are among the most dramatic any oral steroid delivers per milligram of active compound. </p>



<p class="wp-block-paragraph">The C17-alpha methylation that enables its oral bioavailability is also responsible for hepatotoxicity so severe that two to four weeks is the maximum safe cycle window not a conservative recommendation, but the pharmacological reality of what Superdrol does to liver enzyme levels.</p>



<p class="wp-block-paragraph">These are not two versions of the same experience. They are genuinely different tools that happen to share the general category of oral mass-building anabolic steroids.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Dianabol for Mass</strong></h2>



<h3 class="wp-block-heading">Classic Wet Muscle Fullness</h3>



<p class="wp-block-paragraph">The visual and physical experience of a Dianabol bulk is immediately recognizable to anyone who has run the compound or trained alongside someone who has. The glycogen supercompensation and estrogenic water retention that Methandienone drives creates a dramatic fullness and roundness to muscle tissue the classic &#8220;blown up&#8221; appearance of a heavy mass phase that develops visibly within the first week of use. </p>



<p class="wp-block-paragraph">The 15 to 25 pounds of scale weight gained across four to six weeks represents the most rapid mass accumulation available from any oral anabolic, and while the breakdown includes a meaningful water component, the anabolic conditions created by this fullness better training performance, faster recovery, superior pump during sessions support genuine lean tissue accumulation throughout.</p>



<p class="wp-block-paragraph">For athletes eating in a significant caloric surplus and training with maximal volume, Dianabol&#8217;s estrogenic fullness is not a liability it is a performance advantage that makes the training that drives mass building more productive.</p>



<h3 class="wp-block-heading"><strong>Explosive Strength and Pump</strong></h3>



<p class="wp-block-paragraph">Strength increases within the first one to two weeks of Dianabol use are one of its most practically important qualities. Bench press, squat, and deadlift numbers move quickly and reliably 15 to 30-pound increases in major compound lifts within the first two weeks are consistent across user reports. </p>



<p class="wp-block-paragraph">The pump during training is equally pronounced: glycogen-saturated muscle tissue combined with enhanced nitric oxide activity creates the full, engorged training sensation that competitive bodybuilders have associated with productive mass-phase training for decades.</p>



<h3 class="wp-block-heading"><strong>Beginner Accessibility</strong></h3>



<p class="wp-block-paragraph">Among the most powerful oral mass-building compounds, Dianabol is genuinely the most accessible for less experienced users. </p>



<p class="wp-block-paragraph">Its side effect profile estrogenic and hepatic is well-characterized, predictable, and manageable with standard protocols: an aromatase inhibitor controls estrogen, TUDCA supports the liver, and the four to six-week cycle limit contains the hepatic burden within a window that most healthy users can manage without permanent damage. </p>



<p class="wp-block-paragraph">This relative manageability compared to Superdrol makes it the appropriate first experience with a powerful oral mass builder.</p>



<h3 class="wp-block-heading"><strong>Effective Kickstart Compound</strong></h3>



<p class="wp-block-paragraph">The most common and most logically sound use of Dianabol is as a kickstart to a testosterone-based bulking cycle filling the first four to six weeks while long-ester injectables build to stable blood concentrations. </p>



<p class="wp-block-paragraph">The rapid early size and strength it provides creates immediate training quality and momentum that makes the first month of a 12 to 16-week cycle as productive as the final months, rather than waiting for injectable testosterone to fully express before significant results begin.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Superdrol for Mass and Strength</strong></h2>



<h3 class="wp-block-heading"><strong>Extreme Dry Dense Gains</strong></h3>



<p class="wp-block-paragraph">Superdrol&#8217;s mass accumulation is qualitatively distinct from Dianabol&#8217;s. Without aromatization, without glycogen supercompensation through estrogenic mechanisms, the 20 or more pounds of mass that Superdrol can produce in four to six weeks when nutrition and training support it is dense, hard, and dry in a way that Dianabol&#8217;s wet mass is not. </p>



<p class="wp-block-paragraph">Muscle tissue does not look inflated with water. It looks denser, harder, and more developed. The conditioning quality of Superdrol-built mass more closely resembles what an injectable like Trenbolone produces than what any other oral compound delivers. </p>



<p class="wp-block-paragraph">For experienced athletes who want mass gains that do not come with the water-obscured softness that estrogenic compounds inevitably produce, Superdrol&#8217;s dry character is its most valued quality.</p>



<h3 class="wp-block-heading"><strong>Off-the-Charts Strength</strong></h3>



<p class="wp-block-paragraph">The strength output Superdrol produces is frequently described by experienced users as exceeding anything Dianabol delivers not by a small margin, but by a meaningful one. The CNS stimulation that Methyldrostanolone&#8217;s potent androgenic activity drives, combined with the direct androgen receptor activation in muscle tissue, creates strength increases that are among the most dramatic any oral compound produces. </p>



<p class="wp-block-paragraph">Personal records fall regularly and sometimes dramatically in weeks 2 and 3 of a Superdrol cycle. For powerlifters or strength athletes using a brief oral blast specifically to drive through a strength plateau, Superdrol&#8217;s power output per milligram is in a different tier from Dianabol&#8217;s.</p>



<h3 class="wp-block-heading"><strong>Minimal Estrogenic Burden</strong></h3>



<p class="wp-block-paragraph">The absence of aromatization means Superdrol does not produce the gynecomastia risk, water retention, or blood pressure elevation from fluid loading that Dianabol&#8217;s estrogenic activity creates. </p>



<p class="wp-block-paragraph">For users who find estrogenic side effects particularly problematic those with high aromatase activity, those who are estrogen-sensitive, or those who simply do not want the bloated appearance that wet mass creates Superdrol&#8217;s dry character eliminates an entire category of side effects that Dianabol users must actively manage. </p>



<p class="wp-block-paragraph">The tradeoff is that Superdrol&#8217;s androgenic side effects and hepatotoxicity are considerably more severe, but for the specific user profile that finds estrogenic management burdensome, this tradeoff may be acceptable.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="819" src="http://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg" alt="man in black shorts and black tank top doing push up" class="wp-image-2993" srcset="https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-300x240.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-768x614.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu.jpg 1500w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Side Effects: A Comparison That Favors Neither</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">hepatotoxicity from C17-alpha alkylation</a> is significant ALT and AST elevation is dose-dependent, reliable, and requires TUDCA at 1 to 1.5g per day and enforcement of the four to six-week cycle length ceiling. This is genuinely demanding but has been managed safely by experienced users for decades through appropriate liver support and cycle duration discipline.</p>



<p class="wp-block-paragraph">Estrogenic side effects gynecomastia, significant water retention, and blood pressure elevation from fluid accumulation arise from aromatization and respond effectively to aromatase inhibitors. </p>



<p class="wp-block-paragraph">Anastrozole or Aromasin, calibrated to bloodwork rather than a fixed dose, keeps estradiol in a range where estrogenic sides are controlled without being completely suppressed to the point where joint lubrication and mood are impaired. HPTA suppression is complete and requires structured PCT.</p>



<h3 class="wp-block-heading"><strong>Superdrol Side Effects</strong></h3>



<p class="wp-block-paragraph">Superdrol&#8217;s hepatotoxicity is categorically more severe than Dianabol&#8217;s not somewhat more demanding, but substantially more so. ALT and AST elevation at standard Superdrol doses (10 to 20mg per day) reaches levels that make two to four weeks the maximum defensible cycle window, and aggressive liver support TUDCA at 1.5g per day plus NAC at 2.4g per day is the minimum appropriate protocol. Liver enzyme panels before and during the cycle are not optional at this level of hepatic stress.</p>



<p class="wp-block-paragraph">Cholesterol disruption is equally severe. HDL suppression is dramatic values can fall to levels that represent genuine cardiovascular risk in the short term and LDL rises correspondingly. For users with pre-existing lipid issues or cardiovascular risk factors, Superdrol&#8217;s cholesterol impact is a serious contraindication rather than a manageable side effect. </p>



<p class="wp-block-paragraph">Joint dryness is present and can be significant, driven by the absence of estrogenic joint lubrication and the potent DHT-derived androgenic activity on connective tissue. Aggression, acne, and androgenic alopecia in predisposed individuals complete the androgenic side effect profile.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Dianabol</th><th>Superdrol</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Very High — C17-alpha oral</td><td>Extreme — most severe among common orals</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>Significant — heavy aromatization</td><td>Minimal — does not aromatize</td></tr><tr><td><strong>Gyno Management</strong></td><td>Aromatase inhibitor required</td><td>Not required for estrogenic gyno</td></tr><tr><td><strong>Water Retention</strong></td><td>Significant</td><td>Minimal — dry mass</td></tr><tr><td><strong>Blood Pressure</strong></td><td>Elevated from fluid load</td><td>Moderate — no fluid contribution</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Significant</td><td>Extreme — severe cardiovascular concern</td></tr><tr><td><strong>Joint Impact</strong></td><td>Neutral — estrogen provides lubrication</td><td>Dry — connective tissue stress</td></tr><tr><td><strong>Aggression</strong></td><td>Moderate</td><td>Significant — potent androgenic drive</td></tr><tr><td><strong>Maximum Safe Cycle</strong></td><td>4–6 weeks</td><td>2–4 weeks absolute maximum</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Complete</td><td>Complete — severe</td></tr><tr><td>Female Appropriate</td><td>No</td><td>Absolutely not</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycling Protocols: Realistic Use Patterns</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Cycles</strong></h3>



<p class="wp-block-paragraph">The standard Dianabol protocol is 20 to 40mg per day split into two daily doses given its 3 to 6-hour half-life across four to six weeks as a kickstart to a testosterone-based cycle. At 20mg per day, the results are real but modest appropriate for a first experience or for users who prioritize minimizing side effects. </p>



<p class="wp-block-paragraph">At 40mg per day, the mass and strength output is fully expressed and represents the dose most associated with the classic Dianabol kickstart experience. TUDCA at 1g per day covers the hepatic support requirement at this dose range. Anastrozole at 0.5mg every other day manages aromatization.</p>



<h3 class="wp-block-heading"><strong>Superdrol Cycles</strong></h3>



<p class="wp-block-paragraph">Superdrol at 10 to 20mg per day is effective but the window is narrow two to four weeks is the ceiling that hepatic enzyme data supports, and most experienced users find that four weeks requires aggressive monitoring with bloodwork at the midpoint to confirm liver values have not risen to the point where continuation is inadvisable. </p>



<p class="wp-block-paragraph">At 10mg per day, Superdrol is already producing significant anabolic and hepatotoxic effects. At 20mg per day, the strength and mass output is maximized alongside the most severe liver stress. Starting at 10mg for the first week to assess individual response before potentially increasing is the appropriate approach for a first Superdrol cycle.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Dosages and Cycle Protocols Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Dianabol</th><th>Superdrol</th></tr></thead><tbody><tr><td><strong>Effective Dose Range</strong></td><td>20–50mg/day</td><td>10–20mg/day</td></tr><tr><td><strong>Cycle Length</strong></td><td>4–6 weeks</td><td>2–4 weeks maximum</td></tr><tr><td><strong>Mass Accumulation</strong></td><td>15–25lbs (wet)</td><td>20+lbs (dry/dense)</td></tr><tr><td><strong>Strength Output</strong></td><td>Excellent — rapid peak</td><td>Elite — exceeds Dianabol per mg</td></tr><tr><td><strong>Liver Support Required</strong></td><td>TUDCA 1–1.5g/day</td><td>TUDCA 1.5g/day + NAC 2.4g/day</td></tr><tr><td><strong>Bloodwork Monitoring</strong></td><td>Pre and post-cycle</td><td>Pre, mid, and post-cycle mandatory</td></tr><tr><td><strong>Estrogenic Management</strong></td><td>AI required</td><td>Not required</td></tr><tr><td><strong>Cycle Role</strong></td><td>Kickstart or standalone oral blast</td><td>Short power phase — standalone or stacked</td></tr><tr><td><strong>Beginner Appropriate</strong></td><td>Yes with monitoring</td><td>No — advanced users only</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Dianabol and Superdrol Together</strong></h2>



<p class="wp-block-paragraph">The appeal of combining Dianabol and Superdrol is understandable from a pharmacological standpoint Dianabol&#8217;s wet fullness and Superdrol&#8217;s dry density would theoretically produce both maximum size and maximum hardness simultaneously. In practice, the combination is one of the most hepatotoxically demanding stacks possible in oral anabolic use, and the risks are proportionally severe.</p>



<p class="wp-block-paragraph">Both compounds are C17-alpha alkylated orals. Running them simultaneously does not double the anabolic benefit the mechanisms overlap significantly through androgen receptor activation. What doubles is the liver stress, producing ALT and AST elevation that can move from elevated into clinically dangerous within days. </p>



<p class="wp-block-paragraph">Cholesterol disruption compounds similarly the HDL suppression of both compounds simultaneously creates cardiovascular risk that far exceeds either individually. Extreme HPTA suppression is guaranteed.</p>



<p class="wp-block-paragraph">For the small population of advanced users who approach this combination with appropriate preparation, the maximum defensible framework looks like this: two to three weeks total duration with no extension regardless of how good the results look, TUDCA at 1.5g per day plus NAC at 2.4g per day from day one, liver enzyme testing before and at the seven to ten day mark as a mandatory continuation criterion, fish oil at 4g per day throughout, no other hepatotoxic compounds in the stack, and a full PCT protocol planned and in hand before the first dose. </p>



<p class="wp-block-paragraph">This is not a recommended approach. It is the most harm-reduction-conscious framework for an approach that carries meaningful risk regardless of how it is managed.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>PCT and Recovery</strong></h2>



<p class="wp-block-paragraph">The HPTA suppression that both compounds produce is complete, and PCT is mandatory regardless of cycle length. The mistaken belief that a short Superdrol cycle is too brief to suppress testosterone meaningfully is one of the most common errors users make two weeks of Superdrol produces complete suppression that does not resolve without intervention.</p>



<p class="wp-block-paragraph">For a Dianabol-only or Superdrol-only cycle without a testosterone base, PCT begins immediately after the last dose the short half-lives of both compounds mean clearance is rapid and there is no waiting period. Nolvadex at 40mg daily for two weeks followed by 20mg daily for two more weeks is the standard protocol for moderate-duration cycles of either compound. Users who ran higher doses or longer durations should consider adding Clomid at 50mg daily for the first two weeks of the taper.</p>



<p class="wp-block-paragraph">For cycles that include a testosterone base which is the appropriate structure for either compound in a serious mass phase PCT timing is governed by the testosterone ester&#8217;s clearance window, with the HCG bridge in the days before SERMs begin.</p>



<p class="wp-block-paragraph">Liver enzyme monitoring does not end at the last dose. ALT and AST should be checked two to four weeks post-cycle to confirm normalization is progressing particularly after Superdrol cycles where the hepatic burden can sustain elevated values for weeks after discontinuation. Fish oil at 4g per day throughout PCT supports lipid recovery alongside whatever the cycle&#8217;s cholesterol disruption produced.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Who Each Compound Is Best Suited For</strong></h2>



<p class="wp-block-paragraph">Dianabol is the appropriate choice for any user who has not previously run a powerful oral mass builder, for anyone who prioritizes manageable side effects alongside significant results, and for anyone for whom estrogenic water retention and the classic wet bulk aesthetic is an acceptable or even desirable part of the mass-building experience. </p>



<p class="wp-block-paragraph">At doses of 20 to 40mg per day with appropriate support, it delivers what decades of use have established it for rapid, meaningful mass and strength gains within a risk profile that experienced monitoring can manage.</p>



<p class="wp-block-paragraph">Superdrol belongs in the toolkit of experienced anabolic steroid users who have already established their individual response to demanding compounds, who have current bloodwork confirming that liver and lipid parameters are at baseline, and who specifically want the dry, dense mass quality and elite strength output that Dianabol does not deliver at the same level. </p>



<p class="wp-block-paragraph">The two to four-week cycle ceiling is not negotiable it is the point at which the hepatotoxic burden exceeds what ongoing use can justify regardless of how productive the cycle feels.</p>



<p class="wp-block-paragraph">Neither compound belongs in the hands of someone who is not prepared to monitor bloodwork, enforce cycle length discipline regardless of how good the results look, and run a complete PCT. The liver damage that oral anabolic steroids at this potency level produce without appropriate management is not always symptomatic until it is clinically significant and by then, the window for harm reduction has passed.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-superdrol/">Dianabol vs Superdrol: Oral Mass King vs Extreme Power Explosive</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dianabol vs Deca Durabolin: Rapid Wet Mass vs Joint-Safe Bulk</title>
		<link>https://gymtrix.net/dianabol-vs-deca-durabolin/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Mon, 11 May 2026 03:42:54 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3085</guid>

					<description><![CDATA[<p>The classic bulking cycle has been a fixture of competitive bodybuilding since the sport&#8217;s earliest pharmacological era, and at the center of that tradition sit two compounds that have shaped what mass building means at the enhanced level: Dianabol and Deca Durabolin. They have been run together in the same cycles since before most people...</p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-deca-durabolin/">Dianabol vs Deca Durabolin: Rapid Wet Mass vs Joint-Safe Bulk</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The classic bulking cycle has been a fixture of competitive bodybuilding since the sport&#8217;s earliest pharmacological era, and at the center of that tradition sit two compounds that have shaped what mass building means at the enhanced level: Dianabol and Deca Durabolin. They have been run together in the same cycles since before most people reading this were born. </p>



<p class="wp-block-paragraph">They appear in the training histories of generations of competitive bodybuilders. And the reason they keep appearing is not nostalgia it is because the combination works in a way that reflects genuine pharmacological logic.</p>



<p class="wp-block-paragraph">Dianabol (Methandienone) solves the problem that every bulking cycle faces in its earliest weeks: injectable testosterone takes time to reach stable blood concentrations, and the first three to four weeks of a long cycle are underserved without an oral kickstart. </p>



<p class="wp-block-paragraph">Dianabol fills that gap with explosive glycogen-driven size and immediate strength that makes the cycle productive from day one. Deca Durabolin (Nandrolone Decanoate) solves a different problem how to build dense, durable mass across a full 12 to 16-week cycle with therapeutic joint support that allows the heavy compound training that mass building demands, without the water retention and estrogenic burden of more aggressive aromatizing compounds.</p>



<p class="wp-block-paragraph">Together, they address different phases and different physiological needs within the same cycle. Understanding why their mechanisms complement rather than duplicate each other is what makes this particular pairing so enduring.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg" alt="topless man in black shorts holding orange bar" class="wp-image-3005" srcset="https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Explosive Glycogen Loading vs Sustained Structural Mass</strong></h2>



<p class="wp-block-paragraph">Dianabol&#8217;s mass-building mechanism is fundamentally estrogenic. Methandienone aromatizes to estradiol, and estrogen-driven glycogen supercompensation the intramuscular loading of glycogen and water that creates the dramatic volumization Dianabol is famous for accounts for a significant portion of the rapid scale weight gain the compound produces. </p>



<p class="wp-block-paragraph">The anabolic component elevated protein synthesis and nitrogen retention contributes genuine lean tissue alongside this glycogen and water component. The result is rapid, visually dramatic size accumulation that creates the conditions for productive heavy training from the beginning of the cycle.</p>



<p class="wp-block-paragraph">Deca Durabolin&#8217;s mechanism is structurally distinct. As a <a href="https://www.ncbi.nlm.nih.gov/books/NBK526128/">19-nor testosterone derivative</a> modified by removal of the carbon atom at the 19th position Nandrolone interacts with androgen receptors and aromatizes to a lesser degree than testosterone, producing mild rather than heavy estrogenic activity. More significantly, it drives collagen synthesis and synovial fluid production in a way that no other common anabolic compound replicates. </p>



<p class="wp-block-paragraph">The mass it builds across 12 to 16 weeks is dense, structurally sound, and durable accumulated slowly but retained at a high percentage post-cycle because it represents genuine connective-tissue-supported muscle rather than glycogen and water that clear when the compound is discontinued.</p>



<p class="wp-block-paragraph">The practical implication of these different mechanisms is that they are additive rather than redundant in a combined cycle. Dianabol provides the early momentum. Deca Durabolin provides the long-term foundation. Neither replaces the other&#8217;s contribution.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Dianabol for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Explosive Early Gains</strong></h3>



<p class="wp-block-paragraph">The 20 to 25 pounds of scale weight that a standard four-week Dianabol kickstart produces represents the fastest mass accumulation available from any oral anabolic steroid. The intracellular glycogen loading and estrogenic volumization that drive this number create the full, round, pumped aesthetic that defines classic wet bulking not the lean, dry look of a Trenbolone or Masteron cycle, but the massive, powerful appearance that heavy eating and heavy training at enhanced anabolic levels produces. </p>



<p class="wp-block-paragraph">Within this total, genuine lean tissue accumulation perhaps 6 to 10 pounds in a well-run cycle with appropriate nutrition and training provides the durable result that remains after the water clears post-cycle.</p>



<p class="wp-block-paragraph">The rapid size accumulation also has practical training benefits beyond aesthetics: glycogen-saturated muscles perform better, recover faster between sets, and support the volume of heavy compound training that drives the hypertrophy the cycle is designed to produce.</p>



<h3 class="wp-block-heading"><strong>Kickstart Power Surge</strong></h3>



<p class="wp-block-paragraph">The strength increases Dianabol delivers in the first one to two weeks are the defining practical quality that makes it the most widely used kickstart oral in bulking cycle history. As Testosterone Enanthate and Deca Durabolin build slowly toward stable blood concentrations across the first three to four weeks of the cycle, Dianabol is immediately active producing bench press, squat, and deadlift increases of 15 to 30 pounds within the first week or two. </p>



<p class="wp-block-paragraph">This strength platform allows maximal training overload from day one, which generates the progressive overload stimulus that drives genuine hypertrophy throughout the injectables&#8217; active period.</p>



<h3 class="wp-block-heading"><strong>Pump-Driven Training Intensity</strong></h3>



<p class="wp-block-paragraph">The glycogen-supercompensated, estrogenically-volumized training pump that Dianabol produces during sessions is the physical expression of everything the compound is doing hormonally. </p>



<p class="wp-block-paragraph">Enhanced nitric oxide activity combined with intramuscularly loaded glycogen creates the skin-tight, vascular fullness that makes training feel maximally productive every rep feels more effective, every set produces visible muscular engorgement that reinforces intensity. </p>



<p class="wp-block-paragraph">At standard doses this quality enhances training rather than limiting it, and the psychological effect of feeling and looking dramatically bigger during a Dianabol cycle is a genuine performance variable that supports sustained training quality across the full oral phase.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Deca Durabolin for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Thick Sustainable Hypertrophy</strong></h3>



<p class="wp-block-paragraph">Nandrolone Decanoate&#8217;s hypertrophic output is qualitatively different from what Dianabol produces. Where Dianabol&#8217;s mass comes rapidly and includes a significant transient component, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303131/">Deca&#8217;s collagen synthesis enhancement</a> builds muscle that is structurally reinforced tendons and connective tissue strengthen alongside the contractile muscle tissue, contributing to the durability and keepability that Deca-built mass is known for. </p>



<p class="wp-block-paragraph">Nitrogen retention is markedly elevated, IGF-1 levels increase, and the intramuscular anabolic environment that promotes genuine hypertrophy is maintained across the full 12 to 16-week cycle rather than peaking early and plateauing. </p>



<p class="wp-block-paragraph">The 15 to 20 pounds of quality mass that a well-run Deca cycle produces is predominantly lean tissue at a retention rate of 75 to 85 percent post-cycle a reflection of the structural rather than transient nature of what was built.</p>



<h3 class="wp-block-heading"><strong>Joint Lubrication Therapy</strong></h3>



<p class="wp-block-paragraph">This is the property that makes Deca Durabolin irreplaceable for athletes with heavy training histories. The synovial fluid production increase that Nandrolone drives filling joint capsules with the lubricating fluid that cushions heavy compound lifts reduces or eliminates the chronic joint pain that years of squatting, pressing, and pulling accumulates. </p>



<p class="wp-block-paragraph">Athletes who could not previously train at full intensity on certain movements due to shoulder, knee, or hip pain frequently find that low-dose Deca at 200 to 300mg per week restores full pain-free function within weeks of cycle initiation. </p>



<p class="wp-block-paragraph">This therapeutic quality persists throughout the cycle duration and allows the training volume and intensity that mass building demands making it not just a pharmacological benefit but a practical training enabler.</p>



<h3 class="wp-block-heading"><strong>Steady Strength Progression</strong></h3>



<p class="wp-block-paragraph">Deca Durabolin&#8217;s strength gains are linear and sustained rather than front-loaded and plateauing. The decanoate ester&#8217;s 15-day half-life produces a gradual rise to stable blood concentrations typically reaching full expression around weeks 4 to 6 after which strength continues building progressively across the remainder of the cycle. </p>



<p class="wp-block-paragraph">This pattern is the direct opposite of Dianabol&#8217;s rapid-peak-and-plateau strength profile, which means a combined Dianabol-Deca-Testosterone cycle produces early strength momentum from Dianabol, then sustained progressive strength improvement from Deca and testosterone across the remaining weeks delivering the full-cycle strength development that neither compound alone achieves as completely.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Deca-Max Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(0,100,200,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(0,140,255,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #060810;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — steel blue/cyan */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #080a14 0%, #080a14 36%,
      #001428 36%, #001e3a 54%,
      #060810 54%, #060810 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(0,100,220,0.16) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(0,60,140,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(0,100,220,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(0,120,255,0.62))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(0,160,255,0.80))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #003399, #0066dd);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,80,200,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.3) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #0088ff; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,100,220,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #3399ff; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,80,180,0.10);
    border: 1px solid rgba(0,120,230,0.28);
    color: #66bbff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #0088ff; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,120,220,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #66bbff; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(0,100,220,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(100,180,255,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #002299 0%, #0055cc 45%, #0088ff 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(0,80,200,0.52), 0 0 0 1px rgba(0,130,255,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,120,255,0.7), 0 0 0 1px rgba(0,160,255,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(0,60,150,0.08);
    border-top: 1px solid rgba(0,100,200,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,80,180,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,80,170,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #0088ff; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/SMZ9S/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Deca</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Deca-Max — Legal Deca Steroid Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Deca Steroid Alternative</div>
          <div class="headline">
            <small>Mega Strength, Endurance &amp; Gains</small>
            <em>Deca-Max</em>
          </div>
          <p class="sub"><strong>Advanced anabolic formula</strong> — maximises nitrogen retention &amp; red blood cells for <strong>huge muscle gains</strong>. Even soothes joint pain. Bulk or cut.</p>
          <div class="tags">
            <span class="tag">Huge Muscle</span>
            <span class="tag">Extreme Strength</span>
            <span class="tag">Joint Relief</span>
            <span class="tag">Fast Recovery</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 47 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Huge Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9b4.png" alt="🦴" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Joint Relief</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects: Different Mechanisms, Different Management</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s hepatotoxicity from its C17-alpha alkylated oral structure is the primary concern during the kickstart phase. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">Liver enzyme elevation</a> ALT and AST is dose-dependent and reliable, requiring TUDCA at 1.5g per day throughout and enforcement of the four to six-week cycle length ceiling. </p>



<p class="wp-block-paragraph">Estrogenic side effects gynecomastia risk, significant water retention, and blood pressure elevation from the fluid load arise from aromatization and respond effectively to aromatase inhibitors. </p>



<p class="wp-block-paragraph">Anastrozole at 0.5mg every other day, started before the first Dianabol dose, manages estradiol throughout the combined cycle. HPTA suppression is complete and part of the recovery burden addressed by PCT.</p>



<h3 class="wp-block-heading"><strong>Deca Durabolin Side Effects</strong></h3>



<p class="wp-block-paragraph">Deca Durabolin&#8217;s most clinically significant side effect is prolactin elevation driven by its progestogenic receptor activity. This mechanism distinct from the estrogenic pathway creates the erectile dysfunction and libido suppression known as Deca Dick when prolactin rises unchecked. </p>



<p class="wp-block-paragraph">Cabergoline at 0.25mg twice weekly is the appropriate preventive management tool, and it must begin with the first Deca injection rather than waiting for symptoms to develop. Aromatase inhibitors address estrogen. Cabergoline addresses prolactin. </p>



<p class="wp-block-paragraph">These are different systems requiring different interventions, and confusing them is how users end up with prolactin-driven sexual dysfunction that an AI cannot resolve.</p>



<p class="wp-block-paragraph">HPTA suppression with Deca is severe and prolonged the decanoate ester&#8217;s 15-day half-life means active suppression continues for weeks after the last injection, and complete hormonal clearance can take 12 to 18 months at standard bodybuilding doses. </p>



<p class="wp-block-paragraph">PCT timing must account for this clearance window rather than beginning immediately after the last injection, which is why the HCG bridge period is particularly important in Deca-containing cycles.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Dianabol</th><th>Deca Durabolin</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Very High — oral alkylation</td><td>None — injectable</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>Significant — heavy aromatization</td><td>Mild — aromatizes less than testosterone</td></tr><tr><td><strong>Prolactin Risk</strong></td><td>None</td><td>Significant — Cabergoline mandatory</td></tr><tr><td><strong>Gyno Management</strong></td><td>Aromatase inhibitor</td><td>Cabergoline for prolactin-driven gyno</td></tr><tr><td><strong>Water Retention</strong></td><td>Significant</td><td>Moderate</td></tr><tr><td><strong>Blood Pressure</strong></td><td>Elevated — fluid load</td><td>Moderate elevation</td></tr><tr><td><strong>Joint Impact</strong></td><td>Neutral</td><td>Therapeutic — synovial fluid increase</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Complete</td><td>Severe — very long clearance time</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Significant</td><td>Moderate</td></tr><tr><td><strong>PCT Complexity</strong></td><td>Standard</td><td>Extended — HCG bridge mandatory</td></tr><tr><td><strong>Female Appropriate</strong></td><td>No</td><td>No</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Protocols: The Classic Mass Architecture</strong></h2>



<p class="wp-block-paragraph">The Dianabol-Deca-Testosterone combination is the most classic three-compound bulking stack in bodybuilding history, and its longevity reflects genuine pharmacological logic rather than convention. Testosterone provides the hormonal base Deca cannot be run without it, and neither should Dianabol in a cycle intended to build substantial mass. </p>



<p class="wp-block-paragraph">Deca provides the sustainable mass foundation and joint support across the full cycle. Dianabol provides the early momentum that makes the cycle productive before the injectables reach full effect.</p>



<p class="wp-block-paragraph">The absolute requirement is that Deca Durabolin is never run without a testosterone base. Running Nandrolone without exogenous testosterone creates the low-androgen, high-prolactin environment that produces sexual dysfunction, libido crash, and wellbeing deterioration that the Deca Dick reputation reflects. </p>



<p class="wp-block-paragraph">Testosterone at any meaningful dose prevents this by maintaining the androgenic environment that Deca&#8217;s HPTA suppression would otherwise eliminate.</p>



<h3 class="wp-block-heading"><strong>Classic Mass Stack</strong></h3>



<p class="wp-block-paragraph">Testosterone Enanthate at 500mg per week across weeks 1 through 12, Deca Durabolin at 400mg per week across weeks 1 through 12, and Dianabol at 40mg per day split across two daily doses in weeks 1 through 6. </p>



<p class="wp-block-paragraph">Anastrozole at 0.5mg every other day manages the combined estrogenic load of testosterone and Dianabol throughout. Cabergoline at 0.25mg twice weekly manages Deca&#8217;s prolactin elevation from week 1 through early PCT. TUDCA at 1.5g per day covers the Dianabol phase.</p>



<h3 class="wp-block-heading"><strong>Joint-Safe Bulk Variation</strong></h3>



<p class="wp-block-paragraph">For athletes whose primary concern is joint health alongside mass building particularly those with pre-existing shoulder, knee, or hip issues a slightly moderated approach: Testosterone Enanthate at 500mg per week, Deca Durabolin at 300mg per week where the joint-therapeutic benefit is maximized while water retention is moderated, and Dianabol at 30mg per day in weeks 1 through 4. </p>



<p class="wp-block-paragraph">This structure delivers full joint support across the cycle with slightly reduced estrogenic burden from both the lower Deca dose and the shorter Dianabol window.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Dianabol</th><th>Deca Durabolin</th></tr></thead><tbody><tr><td><strong>Dose Range</strong></td><td>30–50mg/day oral (4–6 weeks)</td><td>300–600mg/week injectable (10–16 weeks)</td></tr><tr><td><strong>Mass Accumulation Speed</strong></td><td>Explosive — 20–25lbs in 4 weeks</td><td>Steady — 15–20lbs across full cycle</td></tr><tr><td><strong>Mass Quality</strong></td><td>Wet — glycogen and water component</td><td>Dense — collagen-supported lean tissue</td></tr><tr><td><strong>Post-Cycle Retention</strong></td><td>40–60% after water clears</td><td>75–85% genuine lean tissue</td></tr><tr><td><strong>Strength Pattern</strong></td><td>Rapid peak — weeks 1 to 2</td><td>Progressive — weeks 4 through 16</td></tr><tr><td><strong>Joint Impact</strong></td><td>Neutral</td><td>Therapeutic — synovial support</td></tr><tr><td><strong>Liver Risk</strong></td><td>Very High — oral alkylation</td><td>None — injectable</td></tr><tr><td><strong>Prolactin Management</strong></td><td>Not required</td><td>Cabergoline 0.25mg twice weekly</td></tr><tr><td><strong>Onset of Full Effect</strong></td><td>Days 1 to 3</td><td>Weeks 4 to 6</td></tr><tr><td><strong>PCT Length</strong></td><td>Standard — governed by testosterone ester</td><td>Extended — HCG bridge + 6-week SERM taper</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Support and Post-Cycle Therapy</strong></h2>



<h3 class="wp-block-heading"><strong>On-Cycle Support</strong></h3>



<p class="wp-block-paragraph">TUDCA at 1.5g per day from week 1 through the end of the Dianabol phase is the hepatic support standard for Methandienone at standard doses reflecting its more significant liver burden compared to milder oral anabolics. </p>



<p class="wp-block-paragraph">Anastrozole at 0.5mg every other day manages the combined aromatization of Dianabol and the testosterone base throughout the full cycle, with dose recalibration after Dianabol is discontinued as the combined estrogenic load decreases. </p>



<p class="wp-block-paragraph">Cabergoline at 0.25mg twice weekly runs from week 1 through the Deca clearance window post-cycle, ensuring prolactin remains controlled throughout. Fish oil at 4g per day supports the lipid parameters all three compounds affect.</p>



<h3 class="wp-block-heading"><strong>PCT Protocol</strong></h3>



<p class="wp-block-paragraph">The PCT following this cycle is more complex than a testosterone-only cycle because Deca&#8217;s 15-day half-life means it continues suppressing the HPTA for weeks after the last injection. Beginning SERMs before Nandrolone has cleared adequately produces an incomplete restart because the suppressive signal is still present. The HCG bridge during the clearance window maintains testicular function and responsiveness before the SERM phase begins.</p>



<p class="wp-block-paragraph"><strong>Days 1 to 14 — HCG Bridge</strong> Begin 3 to 4 weeks after the last Deca Durabolin injection — when Nandrolone blood concentrations have fallen sufficiently. HCG at 1,000iu every other day. Cabergoline continuing at 0.25mg twice weekly for prolactin normalization. TUDCA at 1g per day for ongoing hepatic recovery.</p>



<p class="wp-block-paragraph"><strong>Weeks 3 to 8 — SERM Taper</strong> Clomid at 100mg daily in week 3, dropping to 50mg daily in weeks 4 and 5, then 25mg daily in weeks 6 and 7. Nolvadex at 40mg daily in weeks 3 and 4, dropping to 20mg daily in weeks 5 through 7. Fish oil at 4g per day continuing. Zinc at 50mg per day throughout PCT.</p>



<p class="wp-block-paragraph">Bloodwork at six to eight weeks post-PCT total testosterone, free testosterone, LH, FSH, prolactin, and a full liver enzyme and lipid panel confirms whether the HPTA has restarted adequately, prolactin has normalized, and hepatic values are returning toward baseline.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-1024x683.jpg" alt="man doing gymnastic" class="wp-image-3001" srcset="https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>PCT and Support Protocol Reference Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Phase</th><th>Protocol</th><th>Duration</th><th>Purpose</th></tr></thead><tbody><tr><td><strong>On-Cycle — Dianabol Phase</strong></td><td>TUDCA 1.5g/day</td><td>Weeks 1–6</td><td>Hepatoprotection</td></tr><tr><td><strong>On-Cycle — Full Cycle</strong></td><td>Anastrozole 0.5mg EOD</td><td>Weeks 1–12</td><td>Aromatization control</td></tr><tr><td><strong>On-Cycle — Deca Phase</strong></td><td>Cabergoline 0.25mg 2x/week</td><td>Week 1 through early PCT</td><td>Prolactin management</td></tr><tr><td><strong>Lipid Support</strong></td><td>Fish Oil 4g/day</td><td>Full cycle + PCT</td><td>Cardiovascular protection</td></tr><tr><td><strong>HCG Bridge</strong></td><td>HCG 1,000iu EOD</td><td>14 days post-Deca clearance</td><td>Testicular responsiveness</td></tr><tr><td><strong>PCT Weeks 1–2</strong></td><td>Clomid 100mg + Nolvadex 40mg daily</td><td>Weeks 3–4</td><td>Aggressive HPTA restart</td></tr><tr><td><strong>PCT Weeks 3–4</strong></td><td>Clomid 50mg + Nolvadex 20mg daily</td><td>Weeks 5–6</td><td>Sustained recovery</td></tr><tr><td><strong>PCT Weeks 5–6</strong></td><td>Clomid 25mg + Nolvadex 20mg daily</td><td>Weeks 7–8</td><td>Final normalization</td></tr><tr><td><strong>Bloodwork Confirmation</strong></td><td>Full hormone + prolactin + liver + lipid panel</td><td>6–8 weeks post-PCT</td><td>Recovery verification</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Legal Status of Dianabol and Deca Durabolin</strong></h2>



<p class="wp-block-paragraph">Both Dianabol and Deca Durabolin are Schedule III controlled substances under the United States Controlled Substances Act, subject to identical DEA enforcement frameworks. Dianabol has no FDA-approved medical indication and is available exclusively through channels outside the legal pharmaceutical supply in the United States. </p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">Deca Durabolin has legitimate medical applications treatment of anemia and osteoporosis for which it is occasionally prescribed in some clinical contexts, though its use for bodybuilding purposes falls outside any valid prescription framework and constitutes a federal offense.</p>



<p class="wp-block-paragraph">Both compounds are prohibited by the World Anti-Doping Agency across all competitive sport categories. Nandrolone metabolites remain detectable in urine testing for an exceptionally long period up to 18 months at standard bodybuilding doses using modern detection methods making Deca Durabolin a particularly significant anti-doping risk for any athlete competing in tested sport regardless of how the cycle is timed relative to competition.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Deca-Max Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(0,100,200,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(0,140,255,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #060810;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — steel blue/cyan */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #080a14 0%, #080a14 36%,
      #001428 36%, #001e3a 54%,
      #060810 54%, #060810 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(0,100,220,0.16) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(0,60,140,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(0,100,220,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(0,120,255,0.62))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(0,160,255,0.80))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #003399, #0066dd);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,80,200,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.3) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #0088ff; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,100,220,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #3399ff; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,80,180,0.10);
    border: 1px solid rgba(0,120,230,0.28);
    color: #66bbff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #0088ff; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,120,220,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #66bbff; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(0,100,220,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(100,180,255,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #002299 0%, #0055cc 45%, #0088ff 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(0,80,200,0.52), 0 0 0 1px rgba(0,130,255,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,120,255,0.7), 0 0 0 1px rgba(0,160,255,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(0,60,150,0.08);
    border-top: 1px solid rgba(0,100,200,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,80,180,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,80,170,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #0088ff; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/SMZ9S/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Deca</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Deca-Max — Legal Deca Steroid Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Deca Steroid Alternative</div>
          <div class="headline">
            <small>Mega Strength, Endurance &amp; Gains</small>
            <em>Deca-Max</em>
          </div>
          <p class="sub"><strong>Advanced anabolic formula</strong> — maximises nitrogen retention &amp; red blood cells for <strong>huge muscle gains</strong>. Even soothes joint pain. Bulk or cut.</p>
          <div class="tags">
            <span class="tag">Huge Muscle</span>
            <span class="tag">Extreme Strength</span>
            <span class="tag">Joint Relief</span>
            <span class="tag">Fast Recovery</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 47 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Huge Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9b4.png" alt="🦴" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Joint Relief</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Conclusion: The Most Proven Bulking Combination in Bodybuilding History</strong></h2>



<p class="wp-block-paragraph">The Dianabol-Deca-Testosterone stack is not the most sophisticated cycle design available. It does not produce the conditioning of a Trenbolone-based cycle or the extreme strength of an Anadrol protocol. </p>



<p class="wp-block-paragraph">What it produces, consistently and reliably, is the combination of rapid early mass momentum and sustainable long-term hypertrophy with therapeutic joint support that makes heavy compound training productive across a full 12 to 16-week mass phase. That combination is why this stack has appeared in competitive bodybuilding for over 50 years.</p>



<p class="wp-block-paragraph">Dianabol wins on speed nothing else oral produces size and strength in the first four weeks at the same rate. Deca Durabolin wins on sustainability and structural quality the dense, collagen-supported mass it builds across a full cycle retains at a higher percentage and holds up to heavier training without the joint deterioration that aggressive bulking cycles without Nandrolone can produce.</p>



<p class="wp-block-paragraph">The practical rules are non-negotiable: never run Deca without a testosterone base. Never run Dianabol beyond six weeks. Manage prolactin with Cabergoline from the first Deca injection. Plan PCT timing around Deca&#8217;s clearance window, not the last injection date. </p>



<p class="wp-block-paragraph">And let bloodwork prolactin, liver enzymes, lipids, and post-PCT hormonal recovery govern every cycle decision rather than how the physique looks in the mirror at week eight.</p>



<p class="wp-block-paragraph">The mirror lies. Bloodwork does not.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-deca-durabolin/">Dianabol vs Deca Durabolin: Rapid Wet Mass vs Joint-Safe Bulk</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dianabol vs Trenbolone: Wet Mass Explosion vs Dry Power Beast</title>
		<link>https://gymtrix.net/dianabol-vs-trenbolone/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Mon, 11 May 2026 03:26:06 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3083</guid>

					<description><![CDATA[<p>Two compounds. Two completely different definitions of what anabolic steroids are supposed to accomplish. Dianabol floods the body with size, fullness, and early strength momentum in a way that nothing else in the oral steroid class can match. Trenbolone strips fat while forging the kind of dense, dry, three-dimensional musculature that makes a physique look...</p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-trenbolone/">Dianabol vs Trenbolone: Wet Mass Explosion vs Dry Power Beast</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Two compounds. Two completely different definitions of what anabolic steroids are supposed to accomplish. Dianabol floods the body with size, fullness, and early strength momentum in a way that nothing else in the oral steroid class can match. Trenbolone strips fat while forging the kind of dense, dry, three-dimensional musculature that makes a physique look genuinely elite not just big, but conditioned, detailed, and visually dominant in a way that wet mass never achieves.</p>



<p class="wp-block-paragraph">The comparison between Dianabol (Methandienone) and Trenbolone is not a choice between two mass-building compounds. It is a choice between two entirely different cycle objectives, two entirely different side effect management challenges, and two entirely different levels of pharmacological demand on the body. </p>



<p class="wp-block-paragraph">Dianabol is powerful and manageable for experienced users who understand estrogenic side effects and hepatotoxicity. Trenbolone is in a different category of intensity a 19-nor derivative with androgen receptor binding affinity approximately five times that of testosterone, a prolactin-elevating progestogenic mechanism, and a psychological and physiological side effect burden that makes it one of the most demanding compounds in common use.</p>



<p class="wp-block-paragraph">Neither should be in a cycle without a testosterone base. Neither belongs in the hands of someone who has not already established their individual response to less demanding compounds. But used correctly, in the cycles they are designed for, they represent the two most effective tools available for their specific applications rapid mass accumulation and elite conditioning, respectively.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="819" src="http://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg" alt="man in black shorts and black tank top doing push up" class="wp-image-2993" srcset="https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-300x240.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-768x614.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu.jpg 1500w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Glycogen Flooding vs Nutrient Partitioning</strong></h2>



<p class="wp-block-paragraph">Dianabol&#8217;s mass-building mechanism is estrogenic at its core. Methandienone aromatizes to estradiol, and this estrogenic activity drives glycogen supercompensation the intramuscular loading of glycogen and water that creates the dramatic fullness, rapid size, and cellular volumization that define a Dianabol bulk. </p>



<p class="wp-block-paragraph">The compound produces 20 to 30 pounds of scale weight in four weeks through this mechanism, and while a significant portion of that is transient water and glycogen, the lean tissue component accumulated through elevated protein synthesis and nitrogen retention is genuine and durable.</p>



<p class="wp-block-paragraph">Trenbolone operates on a fundamentally different principle. As a <a href="https://www.ncbi.nlm.nih.gov/books/NBK526128/">19-nor testosterone derivative</a> with approximately five times the androgen receptor binding affinity of testosterone, it does not aromatize there is no estrogen conversion, no water retention, and no glycogen supercompensation. </p>



<p class="wp-block-paragraph">Instead, it produces what experienced users describe as direct nutrient partitioning: calories and protein are preferentially directed toward muscle tissue at the expense of fat storage, creating lean mass accumulation alongside simultaneous fat loss that no other commonly available anabolic compound reliably achieves. </p>



<p class="wp-block-paragraph">The 10 to 20 pounds gained on a Trenbolone cycle are almost entirely lean tissue not inflated by water, not temporarily boosted by glycogen which is why the keepable gains percentage on Trenbolone dramatically exceeds what Dianabol produces.</p>



<p class="wp-block-paragraph">The side effect profiles are as different as the mechanisms. Dianabol&#8217;s costs are estrogenic and hepatic manageable with aromatase inhibitors and liver support. Trenbolone&#8217;s costs are prolactin-driven, neurological, and cardiovascular requiring a different management toolkit entirely.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Dianabol for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Explosive Rapid Mass</strong></h3>



<p class="wp-block-paragraph">No oral compound produces size at the speed Dianabol does. The glycogen supercompensation mechanism that Methandienone&#8217;s aromatization drives creates a visually dramatic transformation within the first two weeks muscles appear fuller, harder in a volumized sense, and larger than they were before the first tablet. </p>



<p class="wp-block-paragraph">The 20 to 30-pound scale gains across four weeks represent the most rapid mass accumulation available from any oral anabolic steroid, and while the breakdown of that number includes a significant water and glycogen component, the anabolic conditions that rapid fullness creates better training performance, faster recovery, superior pump support genuine lean tissue accumulation that persists after the cycle ends.</p>



<p class="wp-block-paragraph">For the purpose of a bulking cycle&#8217;s early weeks before long-acting injectable testosterone reaches stable blood concentrations Dianabol&#8217;s rapid effect fills the gap with immediate, measurable results that maintain training quality and psychological momentum from day one.</p>



<h3 class="wp-block-heading"><strong>Kickstart Strength Surge</strong></h3>



<p class="wp-block-paragraph">The strength increases Dianabol delivers in weeks 1 and 2 of a cycle are one of its most practically important qualities. Where Testosterone Enanthate requires 3 to 4 weeks to reach stable blood levels and full anabolic expression, Dianabol is fully active within days. </p>



<p class="wp-block-paragraph">Bench press, squat, and deadlift numbers typically move 15 to 30 pounds across the first two weeks of a Dianabol kickstart not through neural adaptation but through genuine anabolic and glycogen-driven performance enhancement. This strength platform allows maximal training overload from the beginning of the cycle rather than waiting for the injectables to take over.</p>



<h3 class="wp-block-heading"><strong>Pump-Driven Training Aggression</strong></h3>



<p class="wp-block-paragraph">The vascular pump Dianabol produces during training is the direct physical expression of its glycogen supercompensation and estrogenic volumization. Enhanced nitric oxide activity combined with glycogen-saturated intramuscular tissue creates training sessions where every set feels maximal, recovery between sets is faster, and the physical feedback of the pump reinforces training intensity. </p>



<p class="wp-block-paragraph">At standard doses this pump enhances quality without becoming limiting a meaningful distinction from Anadrol, where the pump at higher doses can genuinely impair range of motion.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Trenbolone for Recomposition</strong></h2>



<h3 class="wp-block-heading"><strong>Dry Dense Quality Gains</strong></h3>



<p class="wp-block-paragraph">Trenbolone&#8217;s lean mass gains 10 to 20 pounds across a cycle with 80 to 90 percent keepable post-cycle represent a fundamentally different quality of result from Dianabol&#8217;s wet mass accumulation. Without aromatization or subcutaneous water retention, the muscle built on Trenbolone is visible in a way that estrogenically-driven gains are not. </p>



<p class="wp-block-paragraph">Striations develop. Muscle density and hardness increase progressively across the cycle. The three-dimensional, grainy quality that competitive bodybuilders describe as the Trenbolone look is the visual expression of lean tissue accumulation without the estrogenic water obscuring it. In a recomposition context where simultaneous fat loss and muscle gain is the goal this dry, dense quality is irreplaceable.</p>



<h3 class="wp-block-heading"><strong>Fat Incineration and Vascularity</strong></h3>



<p class="wp-block-paragraph">Trenbolone&#8217;s direct nutrient partitioning effect preferentially directing caloric intake toward muscle tissue produces fat loss even in conditions of caloric maintenance or modest surplus. Combined with the thermal effect of high androgenic activity and the absence of any water retention, body fat percentage drops measurably across a Trenbolone cycle in a way that is qualitatively different from what other anabolic steroids produce. </p>



<p class="wp-block-paragraph">This is why Trenbolone-using bodybuilders can simultaneously gain lean mass and lose body fat, appearing both larger and more defined at the end of a cycle than at the beginning an outcome that most compounds cannot produce without the user accepting either fat gain during a bulk or muscle loss during a cut.</p>



<h3 class="wp-block-heading"><strong>Neurological Power Dominance</strong></h3>



<p class="wp-block-paragraph">The strength and training intensity that Trenbolone&#8217;s high-affinity androgen receptor binding produces is in a category above what Dianabol delivers. Not more of the same qualitatively different. </p>



<p class="wp-block-paragraph">The neurological stimulation of training on Trenbolone, the aggression and focus that its potent androgenic drive creates, and the sustained strength progression across the full cycle length produce training outputs that experienced users consistently describe as unlike any other compound. </p>



<p class="wp-block-paragraph">This quality is also the origin of the psychological side effects the same androgenic intensity that creates elite training drive does not always stay contained to the gym.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1024x683.jpg" alt="a group of men standing next to each other on a stage" class="wp-image-3014" srcset="https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Side Effects: Two Different Management Challenges</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">hepatotoxicity from C17-alpha alkylation</a> is significant but characterized ALT and AST elevation is dose-dependent, reliably managed with TUDCA at 1.5g per day, and constrained to the 4 to 6-week oral window. </p>



<p class="wp-block-paragraph">The estrogenic side effects gynecomastia risk, water retention, blood pressure elevation arise from genuine aromatization and respond effectively to aromatase inhibitors. Anastrozole at 0.5mg every other day started before the first dose prevents gyno rather than reacting to it after onset. HPTA suppression is complete and requires structured PCT.</p>



<h3 class="wp-block-heading"><strong>Trenbolone Side Effects</strong></h3>



<p class="wp-block-paragraph">Trenbolone&#8217;s side effect profile is categorically more demanding across multiple systems simultaneously. Tren cough an acute bronchospasm that occurs immediately after injection in some users is a distinctive and sometimes alarming experience that reflects the compound entering the bloodstream and stimulating an acute inflammatory response. </p>



<p class="wp-block-paragraph">Night sweats are nearly universal at meaningful doses, severe enough to disrupt sleep architecture. Insomnia, anxiety, and the mood volatility known as Tren rage are dose-dependent neurological effects that require active management not simply tolerance.</p>



<p class="wp-block-paragraph">Prolactin elevation is the hormonal side effect that most distinguishes Trenbolone from testosterone-based compounds and most commonly catches inexperienced users unprepared. Trenbolone&#8217;s progestogenic receptor activity elevates prolactin, which drives gynecomastia and sexual dysfunction through a mechanism completely different from estrogenic gyno. </p>



<p class="wp-block-paragraph">Aromatase inhibitors do not address this the appropriate tool is a <a href="https://www.ncbi.nlm.nih.gov/books/NBK554783/">dopamine agonist</a> such as Cabergoline at 0.25mg twice weekly, which reduces prolactin directly. Users who try to manage Trenbolone&#8217;s prolactin-driven gyno with an AI will find the intervention ineffective.</p>



<p class="wp-block-paragraph">Cardiovascular strain blood pressure elevation, HDL suppression, and with extended high-dose use, cardiac hypertrophy risk and severe HPTA suppression requiring aggressive PCT with HCG bridging round out a side effect burden that genuinely demands experienced management</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Tren-Max Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(120,0,220,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(160,50,255,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #07060d;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — deep purple/violet */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #2a0060, #6600cc, #9933ff, #cc66ff, #9933ff, #6600cc, #2a0060);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0a0812 0%, #0a0812 36%,
      #120028 36%, #1a0038 54%,
      #07060d 54%, #07060d 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(130,0,255,0.15) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(80,0,160,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(130,0,255,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(150,30,255,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(190,70,255,0.80))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #5500aa, #9933ff);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(120,0,220,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.3) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #9933ff; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(130,0,255,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #aa44ff; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(100,0,200,0.10);
    border: 1px solid rgba(140,40,255,0.28);
    color: #cc88ff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #9933ff; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(140,40,255,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #cc88ff; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(120,0,220,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(180,120,255,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #3d0088 0%, #7722cc 45%, #aa44ff 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(110,0,220,0.52), 0 0 0 1px rgba(150,50,255,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(140,0,255,0.7), 0 0 0 1px rgba(180,80,255,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(80,0,160,0.08);
    border-top: 1px solid rgba(120,40,220,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(100,20,200,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(100,0,180,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #9933ff; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #2a0060, #6600cc, #9933ff, #cc66ff, #9933ff, #6600cc, #2a0060);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/Q668W/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Versatile Beast</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Tren-Max — Legal Trenbolone Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Trenbolone Alternative</div>
          <div class="headline">
            <small>Raw Power &amp; Lean Muscle Mass</small>
            <em>Tren-Max</em>
          </div>
          <p class="sub"><strong>Awesome androgenic effects</strong> — immense muscle gains, superior conditioning &amp; fast recovery. Bulk or cut, <strong>Tren-Max delivers fast.</strong> No water retention, no needles.</p>
          <div class="tags">
            <span class="tag">Mega Muscle</span>
            <span class="tag">Shred Fat</span>
            <span class="tag">Quick Recovery</span>
            <span class="tag">Bulk &amp; Cut</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 89 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Mega Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Raw Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Shred Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Dianabol</th><th>Trenbolone</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Very High — C17-alpha oral</td><td>Low — injectable</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>Significant — aromatization</td><td>None — does not aromatize</td></tr><tr><td><strong>Prolactin Risk</strong></td><td>None</td><td>Significant — Cabergoline essential</td></tr><tr><td><strong>Gyno Management</strong></td><td>Aromatase inhibitor</td><td>SERM or Cabergoline — AI ineffective for prolactin</td></tr><tr><td><strong>Water Retention</strong></td><td>Significant</td><td>None</td></tr><tr><td><strong>Night Sweats</strong></td><td>None</td><td>Nearly universal</td></tr><tr><td><strong>Tren Cough</strong></td><td>Not applicable</td><td>Present — injection related</td></tr><tr><td><strong>Insomnia / Anxiety</strong></td><td>Uncommon</td><td>Common — neurological stimulation</td></tr><tr><td><strong>Cardiovascular Strain</strong></td><td>Moderate — fluid load</td><td>Significant — BP, HDL, cardiac risk</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Complete</td><td>Severe — aggressive PCT required</td></tr><tr><td><strong>Fat Loss Capacity</strong></td><td>None</td><td>Extreme — direct partitioning</td></tr><tr><td><strong>Female Appropriate</strong></td><td>No</td><td>Absolutely not</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Protocols</strong></h2>



<p class="wp-block-paragraph">The non-negotiable structural requirement for both compounds is a testosterone base. Dianabol&#8217;s complete HPTA suppression without testosterone replacement creates a low-androgen, high-estrogen environment that undermines both cycle quality and wellbeing. </p>



<p class="wp-block-paragraph">Trenbolone without testosterone creates a low-androgen, high-prolactin state that produces the severe sexual dysfunction and libido crash that gives Trenbolone-only use its well-deserved reputation for misery. Testosterone Enanthate at 400 to 500mg per week is the standard base for both cycle structures described below.</p>



<h3 class="wp-block-heading"><strong>Bulking Power Stack</strong></h3>



<p class="wp-block-paragraph">For advanced athletes prioritizing maximum mass accumulation within a single extended cycle, Testosterone Enanthate at 500mg per week across weeks 1 through 12, Dianabol at 40mg per day in weeks 1 through 4 as the kickstart, and Trenbolone Enanthate at 400mg per week from weeks 1 through 12 combines the rapid early mass momentum of Dianabol with the sustained lean mass and conditioning of Trenbolone across the full cycle duration. </p>



<p class="wp-block-paragraph">The practical challenge of this combination is that Trenbolone&#8217;s anti-estrogenic character runs partly counter to Dianabol&#8217;s estrogenic mass building the AI management needs to be calibrated carefully so that estrogen is controlled enough to prevent gyno from Dianabol without being so suppressed that the estrogenic mass-building quality of Dianabol is entirely eliminated.</p>



<h3 class="wp-block-heading"><strong>Recomposition Contest Stack</strong></h3>



<p class="wp-block-paragraph">For athletes targeting peak conditioning simultaneous lean mass gain and fat loss with maximum visual quality a testosterone base at 300 to 400mg per week, Trenbolone Acetate at 75mg every other day across 8 weeks, and a short Dianabol kickstart at 20mg per day in weeks 1 through 3 provides early training momentum while Trenbolone drives the sustained conditioning. </p>



<p class="wp-block-paragraph">Acetate ester allows faster dose adjustment if Trenbolone side effects require intervention, which suits a contest prep context where the cost of disrupting the prep is highest. Cabergoline at 0.25mg twice weekly runs throughout the Trenbolone phase.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Dianabol</th><th>Trenbolone</th></tr></thead><tbody><tr><td><strong>Dose Range</strong></td><td>30–50mg/day oral (4–6 weeks)</td><td>50–100mg EOD / 300–700mg/week (8–12 weeks)</td></tr><tr><td><strong>Mass Type</strong></td><td>Wet — 20–30lbs glycogen and water component</td><td>Dry — 10–20lbs predominantly lean tissue</td></tr><tr><td><strong>Post-Cycle Retention</strong></td><td>40–60% after water clears</td><td>80–90% genuine lean tissue</td></tr><tr><td><strong>Strength Onset</strong></td><td>Rapid — weeks 1 to 2</td><td>Sustained — builds across full cycle</td></tr><tr><td><strong>Fat Loss</strong></td><td>None</td><td>Extreme — direct nutrient partitioning</td></tr><tr><td><strong>Liver Risk</strong></td><td>Very High — oral alkylation</td><td>Low — injectable</td></tr><tr><td><strong>Estrogenic Activity</strong></td><td>Heavy aromatization</td><td>None</td></tr><tr><td><strong>Prolactin Risk</strong></td><td>None</td><td>Significant — Cabergoline mandatory</td></tr><tr><td><strong>Night Sweats</strong></td><td>None</td><td>Nearly universal</td></tr><tr><td><strong>PCT Complexity</strong></td><td>Full — HCG + SERM taper</td><td>Aggressive — HCG bridge + extended SERM taper</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Support and Post-Cycle Therapy</strong></h2>



<h3 class="wp-block-heading"><strong>On-Cycle Support</strong></h3>



<p class="wp-block-paragraph">TUDCA at 1.5g per day throughout the Dianabol phase is the hepatic support requirement reflecting the more significant liver burden of Methandienone compared to milder oral anabolics. Anastrozole at 0.5mg every other day manages Dianabol&#8217;s aromatization alongside the testosterone base&#8217;s estrogenic contribution. </p>



<p class="wp-block-paragraph">Cabergoline at 0.25mg twice weekly runs throughout any phase where Trenbolone is active, managing prolactin before sexual dysfunction and mood disruption develop rather than attempting to reverse them after onset. Fish oil at 4g per day supports the lipid parameters both compounds affect across the full cycle.</p>



<p class="wp-block-paragraph">The critical distinction in on-cycle management is that Dianabol&#8217;s estrogen side effects require an AI, and Trenbolone&#8217;s prolactin side effects require Cabergoline these are not interchangeable interventions, and using one where the other is needed produces no meaningful benefit.</p>



<h3 class="wp-block-heading"><strong>PCT Protocol</strong></h3>



<p class="wp-block-paragraph">The PCT following an advanced cycle containing Trenbolone demands the most comprehensive recovery protocol available. Trenbolone&#8217;s severe HPTA suppression, combined with testosterone&#8217;s complete suppression, produces a hormonal state that will not resolve without structured pharmacological intervention. </p>



<p class="wp-block-paragraph">The HCG bridge is essential beginning after the Trenbolone&#8217;s clearance window (3 to 4 days for Acetate, 2 weeks for Enanthate) and before SERMs are initiated, it restores testicular responsiveness that has been completely inactive for the cycle&#8217;s full duration.</p>



<p class="wp-block-paragraph"><strong>Days 1 to 14 — HCG Bridge</strong> HCG at 1,000iu every other day following Trenbolone clearance. Cabergoline at 0.25mg twice weekly continuing to ensure prolactin normalization. TUDCA at 1g per day for hepatic recovery as liver enzymes from the Dianabol phase normalize.</p>



<p class="wp-block-paragraph"><strong>Weeks 3 to 8 — SERM Taper</strong> Clomid at 100mg daily in week 3, 50mg daily in weeks 4 and 5, 25mg daily in weeks 6 and 7, discontinued week 8. Nolvadex at 40mg daily in weeks 3 and 4, 20mg daily in weeks 5 through 7. Fish oil at 4g per day continuing throughout. Zinc at 50mg per day for testosterone synthesis enzyme support.</p>



<p class="wp-block-paragraph">Bloodwork at six to eight weeks post-PCT total testosterone, free testosterone, LH, FSH, prolactin, and a full lipid and liver panel confirms whether the axis has restarted adequately and that prolactin has normalized. The prolactin reading is specifically important after Trenbolone cycles because progestogenic activity can sustain elevated prolactin beyond the compound&#8217;s detectability window.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="546" src="http://gymtrix.net/wp-content/uploads/2022/08/Calisthenics-biceps-1024x546.png" alt="" class="wp-image-2950" srcset="https://gymtrix.net/wp-content/uploads/2022/08/Calisthenics-biceps-1024x546.png 1024w, https://gymtrix.net/wp-content/uploads/2022/08/Calisthenics-biceps-300x160.png 300w, https://gymtrix.net/wp-content/uploads/2022/08/Calisthenics-biceps-768x410.png 768w, https://gymtrix.net/wp-content/uploads/2022/08/Calisthenics-biceps.png 1500w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>PCT and Support Protocol Reference Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Phase</th><th>Protocol</th><th>Duration</th><th>Purpose</th></tr></thead><tbody><tr><td><strong>On-Cycle — Dianabol Phase</strong></td><td>TUDCA 1.5g/day + Anastrozole 0.5mg EOD</td><td>Weeks 1–4/6</td><td>Hepatoprotection + aromatization management</td></tr><tr><td><strong>On-Cycle — Trenbolone Phase</strong></td><td>Cabergoline 0.25mg 2x/week</td><td>Full Tren duration + early PCT</td><td>Prolactin control</td></tr><tr><td><strong>Lipid Support</strong></td><td>Fish Oil 4g/day</td><td>Full cycle + PCT</td><td>Cardiovascular protection</td></tr><tr><td><strong>HCG Bridge</strong></td><td>HCG 1,000iu EOD</td><td>Days 1–14 post-Trenbolone clearance</td><td>Testicular responsiveness</td></tr><tr><td><strong>PCT Weeks 1–2</strong></td><td>Clomid 100mg + Nolvadex 40mg daily</td><td>Weeks 3–4</td><td>Aggressive HPTA restart</td></tr><tr><td><strong>PCT Weeks 3–4</strong></td><td>Clomid 50mg + Nolvadex 20mg daily</td><td>Weeks 5–6</td><td>Sustained recovery</td></tr><tr><td><strong>PCT Weeks 5–6</strong></td><td>Clomid 25mg + Nolvadex 20mg daily</td><td>Weeks 7–8</td><td>Final normalization taper</td></tr><tr><td><strong>Bloodwork Confirmation</strong></td><td>Full hormone + prolactin + liver + lipid panel</td><td>6–8 weeks post-PCT</td><td>Recovery verification</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Legal Status of Dianabol and Trenbolone</strong></h2>



<p class="wp-block-paragraph">Both Dianabol and Trenbolone are Schedule III controlled substances in the United States under the Controlled Substances Act. Dianabol has no FDA-approved medical indication and no legitimate pharmaceutical supply chain in the US its availability is exclusively through channels outside the legal pharmaceutical system. </p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">Trenbolone&#8217;s legal position is more restrictive still it has no approved human pharmaceutical application anywhere, existing legally only as a veterinary growth promoter for cattle. Possession of either compound for human use without a valid prescription constitutes a federal offense.</p>



<p class="wp-block-paragraph">The World Anti-Doping Agency prohibits both compounds across all competitive sport categories. Trenbolone&#8217;s metabolite detection window extends considerably beyond what many users estimate, and modern anti-doping laboratory methods have become substantially more sensitive to 19-nor metabolites in recent years making it a high detection risk for any tested athlete regardless of cycle management.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Tren-Max Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(120,0,220,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(160,50,255,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #07060d;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — deep purple/violet */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #2a0060, #6600cc, #9933ff, #cc66ff, #9933ff, #6600cc, #2a0060);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0a0812 0%, #0a0812 36%,
      #120028 36%, #1a0038 54%,
      #07060d 54%, #07060d 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(130,0,255,0.15) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(80,0,160,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(130,0,255,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(150,30,255,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(190,70,255,0.80))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #5500aa, #9933ff);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(120,0,220,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.3) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #9933ff; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(130,0,255,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #aa44ff; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(100,0,200,0.10);
    border: 1px solid rgba(140,40,255,0.28);
    color: #cc88ff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #9933ff; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(140,40,255,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #cc88ff; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(120,0,220,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(180,120,255,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #3d0088 0%, #7722cc 45%, #aa44ff 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(110,0,220,0.52), 0 0 0 1px rgba(150,50,255,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(140,0,255,0.7), 0 0 0 1px rgba(180,80,255,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(80,0,160,0.08);
    border-top: 1px solid rgba(120,40,220,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(100,20,200,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(100,0,180,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #9933ff; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #2a0060, #6600cc, #9933ff, #cc66ff, #9933ff, #6600cc, #2a0060);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/Q668W/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Versatile Beast</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Tren-Max — Legal Trenbolone Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Trenbolone Alternative</div>
          <div class="headline">
            <small>Raw Power &amp; Lean Muscle Mass</small>
            <em>Tren-Max</em>
          </div>
          <p class="sub"><strong>Awesome androgenic effects</strong> — immense muscle gains, superior conditioning &amp; fast recovery. Bulk or cut, <strong>Tren-Max delivers fast.</strong> No water retention, no needles.</p>
          <div class="tags">
            <span class="tag">Mega Muscle</span>
            <span class="tag">Shred Fat</span>
            <span class="tag">Quick Recovery</span>
            <span class="tag">Bulk &amp; Cut</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 89 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Mega Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Raw Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Shred Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Conclusion: Speed vs Quality — Two Tools for Two Different Missions</strong></h2>



<p class="wp-block-paragraph">Dianabol and Trenbolone are not competing for the same role in cycle architecture. They are tools for different objectives, different users, and different points in a training career.</p>



<p class="wp-block-paragraph">Dianabol belongs in bulking cycles as the kickstart the oral that fills the first four to six weeks of a testosterone-based mass phase with explosive early size, strength, and training quality while the injectable foundation builds to full effect. </p>



<p class="wp-block-paragraph">It is the most effective oral compound for rapid mass accumulation, and used correctly within its cycle length limits, with appropriate liver support and AI management, atop a testosterone base it delivers what decades of bodybuilding practice have established it for.</p>



<p class="wp-block-paragraph">Trenbolone belongs in advanced recomposition and conditioning cycles in the hands of experienced athletes who have established their individual response to less demanding compounds, who have current bloodwork, and who are prepared to manage prolactin, sleep, mood, and cardiovascular parameters with the same seriousness they apply to training. </p>



<p class="wp-block-paragraph">Its conditioning output lean, dry, hard, simultaneously building muscle and losing fat is simply not replicable with safer compounds for athletes pursuing elite competitive conditioning.</p>



<p class="wp-block-paragraph">Neither should be run solo. Neither should be approached without pre-cycle bloodwork, active monitoring throughout, and a PCT protocol planned and in hand before the first dose is taken. The mental and physical demands of both compounds are real, and respect for those demands is what separates outcomes that represent genuine athletic achievement from health consequences that were entirely avoidable.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-trenbolone/">Dianabol vs Trenbolone: Wet Mass Explosion vs Dry Power Beast</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dianabol vs Testosterone: Rapid Mass vs Cycle Foundation Battle</title>
		<link>https://gymtrix.net/dianabol-vs-testosterone/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Fri, 08 May 2026 05:17:37 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3081</guid>

					<description><![CDATA[<p>Every serious bulking cycle comes down to the same foundational decision: what provides the hormonal base, and what provides the early momentum? In the vast majority of well-constructed mass-building cycles, the answer to both questions involves Testosterone and Dianabol not as competing options, but as complementary tools that solve different problems within the same cycle...</p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-testosterone/">Dianabol vs Testosterone: Rapid Mass vs Cycle Foundation Battle</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Every serious bulking cycle comes down to the same foundational decision: what provides the hormonal base, and what provides the early momentum? In the vast majority of well-constructed mass-building cycles, the answer to both questions involves Testosterone and Dianabol not as competing options, but as complementary tools that solve different problems within the same cycle architecture.</p>



<p class="wp-block-paragraph">Testosterone is the prerequisite. It is the hormonal environment that every other anabolic compound depends on, the foundation that maintains libido, mood, joint health, and anabolic signaling while suppressive compounds shut down natural production. Running any steroid cycle without a testosterone base is not an aggressive approach it is an uninformed one that produces predictable hormonal dysfunction alongside whatever mass gains it creates.</p>



<p class="wp-block-paragraph">Dianabol (Methandienone) is the accelerant. Its rapid glycogen supercompensation, explosive early strength, and dramatic size accumulation in four to six weeks make it the most widely used oral kickstart compound in the history of bodybuilding. </p>



<p class="wp-block-paragraph">It cannot replace testosterone it has no place in a cycle without one but layered on top of a testosterone foundation, it produces the kind of rapid early results that make a long bulking cycle productive from week one rather than from week four when the testosterone finally reaches stable blood concentrations.</p>



<p class="wp-block-paragraph">Understanding these two compounds in the context of what each one actually does rather than treating them as alternatives competing for the same role is the starting point for building cycles that consistently deliver.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/dmwl8v7l8g4-1024x683.jpg" alt="man exercising in dip station" class="wp-image-3010" srcset="https://gymtrix.net/wp-content/uploads/2026/03/dmwl8v7l8g4-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/dmwl8v7l8g4-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/dmwl8v7l8g4-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/dmwl8v7l8g4-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/dmwl8v7l8g4.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Explosive Kickstart vs Sustained Foundation</strong></h2>



<p class="wp-block-paragraph">Dianabol&#8217;s pharmacological character reflects its design for maximum rapid anabolic output. Structurally a modified form of testosterone with a methyl group at the 17th carbon position enabling oral bioavailability and a double bond at the 1-2 carbon position that modifies its anabolic-to-androgenic profile, Methandienone aromatizes to estrogen with the estrogenic consequences glycogen supercompensation, cellular volumization, rapid size that define its mass-building reputation. </p>



<p class="wp-block-paragraph">Its short half-life of 3 to 6 hours means blood concentrations fluctuate significantly with once-daily dosing, which is why most experienced users split the daily dose across two or three administrations.</p>



<p class="wp-block-paragraph">Testosterone occupies a different position in the pharmacological hierarchy entirely. With a baseline anabolic-to-androgenic ratio of 100:100 the standard against which all other anabolic steroids are measured it is not an extraordinary compound in any particular dimension.</p>



<p class="wp-block-paragraph">What makes it indispensable is its completeness: it supports every androgen-dependent physiological process simultaneously, it aromatizes predictably and in a way that is well-characterized and manageable, and its long-ester forms <a href="https://www.ncbi.nlm.nih.gov/books/NBK526128/">Testosterone Enanthate and Testosterone Cypionate</a> maintain stable blood concentrations across 10 to 16-week cycles with twice-weekly injection schedules. </p>



<p class="wp-block-paragraph">No other compound provides the hormonal base that a multi-compound cycle requires as reliably and completely as testosterone.</p>



<p class="wp-block-paragraph">The relationship between them is not competitive. Dianabol provides what testosterone cannot deliver quickly enough. Testosterone provides what Dianabol cannot sustain long enough.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Dianabol for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Explosive Early Gains</strong></h3>



<p class="wp-block-paragraph">The size accumulation that a well-run Dianabol kickstart produces in four weeks is unlike what any other oral compound delivers in the same timeframe. </p>



<p class="wp-block-paragraph">Estrogen-driven glycogen supercompensation creates the intramuscular fullness and cellular volumization that drives 20 to 30 pounds of scale weight gain across the first cycle month a figure that combines genuine lean tissue accumulation, dramatically increased intramuscular glycogen storage, and the subcutaneous and intracellular water that estrogenic activity drives. </p>



<p class="wp-block-paragraph">The lean tissue component of this figure is the durable result that persists post-cycle. The glycogen and water provide the training conditions full muscles, shorter recovery between sets, superior pump that make the lean tissue gains possible through the training quality they support.</p>



<p class="wp-block-paragraph">For an athlete starting a 12-week testosterone-based bulking cycle, this rapid early accumulation provides both psychological momentum and the physical foundation increased body weight and muscle mass that supports the progressive overload the cycle&#8217;s remainder will build on.</p>



<h3 class="wp-block-heading"><strong>Kickstart Power Surge</strong></h3>



<p class="wp-block-paragraph">The strength increases Dianabol delivers in weeks 1 and 2 are one of its most practically valuable qualities. Testosterone Enanthate at 500mg per week reaches stable blood concentrations at approximately weeks 3 to 4, meaning the first two weeks of a long-ester testosterone cycle are pharmacologically underserved the testosterone is present but not yet at full effect. </p>



<p class="wp-block-paragraph">Dianabol fills this gap entirely. Bench press, squat, and deadlift numbers typically increase by 15 to 30 pounds across the first two weeks of a Dianabol kickstart, not through neural adaptation alone but through the genuine anabolic and glycogen-driven performance enhancement the compound creates. This means productive heavy training from day one rather than week four.</p>



<h3 class="wp-block-heading"><strong>Pump-Driven Training Intensity</strong></h3>



<p class="wp-block-paragraph">The training pump Dianabol produces is a direct consequence of its estrogenic activity and intramuscular volumization. </p>



<p class="wp-block-paragraph">Nitric oxide-enhanced vasodilation combined with glycogen-saturated muscle tissue creates the full, skin-tight pump during training that makes sessions feel maximally productive and provides the vascular feedback that motivates sustained training intensity across the full six-week window. </p>



<p class="wp-block-paragraph">At standard doses this pump enhances training quality without becoming uncomfortably limiting a meaningful distinction from Anadrol, where the pump at higher doses can genuinely restrict range of motion.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Testosterone for Cycles</strong></h2>



<h3 class="wp-block-heading"><strong>Sustained Muscle Foundation</strong></h3>



<p class="wp-block-paragraph">Testosterone&#8217;s anabolic mechanism is the baseline the 100:100 ratio that defines what consistent, sustainable hypertrophy looks like without the dramatic water component that estrogenic compounds add on top of it. Protein synthesis increases, nitrogen retention improves, and the cellular environment maintains the conditions for muscle protein accretion across the full cycle length. </p>



<p class="wp-block-paragraph">Unlike Dianabol&#8217;s front-loaded explosive effect, testosterone produces gains that continue building linearly across 10 to 16 weeks, with the strongest results typically occurring from weeks 6 through 12 as blood concentrations have fully stabilized and the compounding effect of sustained anabolic signaling reaches its peak expression.</p>



<p class="wp-block-paragraph">The keepable gains ratio approximately 70 to 85 percent of the scale weight gained on a testosterone-only cycle representing actual lean tissue rather than transient water reflects the superior durability of testosterone&#8217;s anabolic mechanism compared to the wet mass that oral kickstarters produce.</p>



<h3 class="wp-block-heading"><strong>Complete Hormonal Support</strong></h3>



<p class="wp-block-paragraph">Beyond the anabolic effects, testosterone maintains every androgen-dependent physiological process that running other suppressive compounds would otherwise eliminate. </p>



<p class="wp-block-paragraph">Libido, mood stability, energy, joint lubrication through estradiol conversion, IGF-1 elevation, sleep quality, and sexual function are all testosterone-dependent in ways that become immediately and unpleasantly obvious when they deteriorate during cycles run without a testosterone base. </p>



<p class="wp-block-paragraph">The concept of cycling without testosterone is not simply suboptimal it produces a predictable deterioration in quality of life that impairs training, recovery, and wellbeing simultaneously.</p>



<h3 class="wp-block-heading"><strong>Versatile Base Across All Cycle Structures</strong></h3>



<p class="wp-block-paragraph">The availability of multiple testosterone esters Enanthate and Cypionate for 10 to 16-week cycles with twice-weekly injections, Propionate for shorter cycles with every-other-day injections and faster clearance for PCT timing makes testosterone the only compound that suits every cycle structure without modification. </p>



<p class="wp-block-paragraph">Testosterone Enanthate at 500mg per week is the most widely used configuration for a reason: it provides the full hormonal base the cycle requires, aromatizes predictably, and responds to AI management in a well-characterized way that makes estrogen calibration straightforward.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="683" height="1024" src="http://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-683x1024.jpg" alt="grayscale photo of man working out" class="wp-image-2988" srcset="https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-683x1024.jpg 683w, https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-200x300.jpg 200w, https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu-768x1152.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/shfo3woggtu.jpg 800w" sizes="(max-width: 683px) 100vw, 683px" /></figure>



<h2 class="wp-block-heading"><strong>Side Effects: Different Risk Categories, Same Management Priority</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s hepatotoxicity from <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">C17-alpha alkylation</a> is the most significant liver risk in a combined Dianabol-Testosterone cycle. ALT and AST elevation is reliable, dose-dependent, and requires TUDCA at 1g per day throughout the oral phase, with the four to six-week cycle length ceiling enforced by the hepatic burden that accumulates at standard doses. </p>



<p class="wp-block-paragraph">Estrogenic side effects gynecomastia risk, water retention, and blood pressure elevation arise from Methandienone&#8217;s aromatization and respond effectively to aromatase inhibitors. Anastrozole at 0.5mg every other day started before the first Dianabol dose prevents estrogenic sides rather than managing them after symptoms develop.</p>



<p class="wp-block-paragraph">Blood pressure monitoring throughout the cycle is appropriate given the fluid load that Dianabol&#8217;s estrogenic activity produces alongside testosterone&#8217;s aromatization. Both contribute to the estrogen-driven fluid retention, which means AI management for the combined cycle often needs to be calibrated more carefully than for either compound alone.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h3 class="wp-block-heading"><strong>Testosterone Side Effects</strong></h3>



<p class="wp-block-paragraph">Testosterone&#8217;s side effects are the best-characterized in anabolic steroid use because the compound has been in clinical use for hormone replacement therapy for decades. Aromatization to estradiol is predictable and dose-dependent at 500mg per week, most users require AI support to keep estradiol in the optimal range of 20 to 40pg/mL. </p>



<p class="wp-block-paragraph">Androgenic effects acne, oily skin, and accelerated male pattern baldness in genetically predisposed individuals are dose-dependent and individually variable. </p>



<p class="wp-block-paragraph">Complete HPTA suppression at bodybuilding doses is guaranteed and requires structured PCT, though testosterone&#8217;s suppression is among the most responsive to standard SERM-based recovery protocols because the hypothalamic-pituitary axis remains structurally intact and responds predictably to negative feedback removal.</p>



<p class="wp-block-paragraph">The key calibration point for a combined Dianabol-Testosterone cycle is estrogen management. Both compounds aromatize, which means the combined estrogenic load is greater than either alone, and AI dosing needs to reflect this rather than being set based on testosterone use alone.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Testo-Max Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Rajdhani:wght@600;700&#038;family=Inter:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #f0f0f0;
    padding: 24px 16px;
    font-family: 'Inter', sans-serif;
  }

  /* ── NARROW CONTAINER ── */
  .banner-wrap {
    max-width: 680px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 10px;
    overflow: hidden;
    box-shadow: 0 8px 40px rgba(0,0,0,0.35);
    transition: box-shadow 0.25s, transform 0.25s;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 16px 56px rgba(0,0,0,0.45);
  }

  /* ── BANNER BODY ── */
  .banner {
    width: 100%;
    background: #0a0e17;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Top coloured bar */
  .top-bar {
    width: 100%;
    height: 5px;
    background: linear-gradient(90deg, #d4a800, #ffe066, #d4a800);
    flex-shrink: 0;
  }

  /* Background texture */
  .bg-noise {
    position: absolute;
    inset: 0;
    background-image:
      radial-gradient(ellipse 70% 60% at 80% 50%, rgba(212,168,0,0.12) 0%, transparent 70%),
      repeating-linear-gradient(-50deg, transparent, transparent 18px, rgba(255,255,255,0.012) 18px, rgba(255,255,255,0.012) 19px);
    z-index: 0;
    pointer-events: none;
  }

  /* Diagonal colour slash */
  .slash {
    position: absolute;
    top: 0; bottom: 0;
    right: 0;
    width: 48%;
    background: linear-gradient(108deg, transparent 0%, rgba(212,168,0,0.07) 100%);
    clip-path: polygon(15% 0%, 100% 0%, 100% 100%, 0% 100%);
    z-index: 0;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    padding: 18px 20px 14px 16px;
    gap: 14px;
  }

  /* PRODUCT IMAGE */
  .product-col {
    flex-shrink: 0;
    width: 108px;
    display: flex;
    align-items: center;
    justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 100px;
    height: auto;
    display: block;
    filter:
      drop-shadow(0 0 14px rgba(212,168,0,0.55))
      drop-shadow(0 4px 10px rgba(0,0,0,0.8));
    transform: rotate(-4deg) scale(1.05);
    transition: transform 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.11);
  }
  .pill-badge {
    position: absolute;
    top: -4px;
    right: -6px;
    background: linear-gradient(135deg, #d4a800, #ffe066);
    color: #0a0e17;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 7px;
    border-radius: 3px;
    box-shadow: 0 2px 8px rgba(212,168,0,0.5);
    white-space: nowrap;
    z-index: 3;
  }

  /* TEXT */
  .text-col {
    flex: 1;
    min-width: 0;
  }
  .eyebrow {
    font-family: 'Rajdhani', sans-serif;
    font-size: 9.5px;
    font-weight: 700;
    letter-spacing: 3px;
    text-transform: uppercase;
    color: #d4a800;
    margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(26px, 5vw, 42px);
    line-height: 0.92;
    letter-spacing: 1.5px;
    color: #fff;
    margin-bottom: 6px;
    text-shadow: 0 0 30px rgba(212,168,0,0.3);
  }
  .headline span { color: #ffe066; }
  .subtext {
    font-size: 11px;
    color: rgba(255,255,255,0.58);
    line-height: 1.45;
    margin-bottom: 9px;
    max-width: 340px;
    font-weight: 400;
  }
  .mini-pills {
    display: flex;
    flex-wrap: wrap;
    gap: 5px;
  }
  .mp {
    display: inline-flex;
    align-items: center;
    gap: 4px;
    border: 1px solid rgba(212,168,0,0.3);
    background: rgba(212,168,0,0.08);
    color: #d4a800;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 8px;
    border-radius: 2px;
  }
  .mp::before { content: '✓'; font-size: 8px; }

  /* CTA COLUMN */
  .cta-col {
    flex-shrink: 0;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 8px;
    min-width: 138px;
  }
  .price-stack { text-align: center; line-height: 1; }
  .price-was {
    font-size: 10.5px;
    color: rgba(255,255,255,0.3);
    text-decoration: line-through;
    letter-spacing: 0.5px;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 600;
  }
  .price-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 44px;
    color: #fff;
    letter-spacing: 1px;
    line-height: 1;
  }
  .price-save {
    font-family: 'Rajdhani', sans-serif;
    font-size: 9.5px;
    font-weight: 700;
    color: #4edf8a;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    margin-top: 1px;
  }

  .cta-btn {
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 6px;
    width: 100%;
    background: linear-gradient(135deg, #c49a00 0%, #ffe066 50%, #c49a00 100%);
    background-size: 200% 100%;
    background-position: 0% 50%;
    color: #0a0e17;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 13px;
    letter-spacing: 1.8px;
    text-transform: uppercase;
    padding: 12px 14px;
    border-radius: 5px;
    box-shadow: 0 4px 20px rgba(212,168,0,0.45);
    transition: background-position 0.4s, box-shadow 0.2s, transform 0.2s;
    white-space: nowrap;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 28px rgba(212,168,0,0.7);
  }
  .cta-arrow {
    font-size: 14px;
    transition: transform 0.2s;
  }
  .banner-link:hover .cta-arrow { transform: translateX(3px); }

  .guarantee-line {
    font-size: 8.5px;
    color: rgba(255,255,255,0.28);
    text-align: center;
    letter-spacing: 0.8px;
    text-transform: uppercase;
  }

  /* ── BOTTOM STRIP ── */
  .bottom-strip {
    position: relative;
    z-index: 2;
    background: rgba(212,168,0,0.1);
    border-top: 1px solid rgba(212,168,0,0.18);
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 20px;
    padding: 7px 16px;
    flex-wrap: wrap;
  }
  .strip-item {
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 9px;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.42);
    display: flex;
    align-items: center;
    gap: 5px;
  }
  .strip-item .dot {
    width: 4px;
    height: 4px;
    border-radius: 50%;
    background: #d4a800;
    opacity: 0.5;
  }

  /* Bottom accent */
  .bottom-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #d4a800, #ffe066, #d4a800);
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 520px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 80px; }
    .product-col img { width: 72px; }
    .headline { font-size: 26px; }
    .price-now { font-size: 36px; }
    .cta-col { min-width: 118px; }
    .mini-pills { display: none; }
    .bottom-strip { gap: 12px; }
  }
  @media (max-width: 400px) {
    .product-col { display: none; }
    .subtext { display: none; }
  }
</style>
</head>
<body>

<div class="banner-wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/K6L72/" target="_blank" rel="noopener sponsored">
    <div class="banner">
      <div class="top-bar"></div>
      <div class="bg-noise"></div>
      <div class="slash"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="pill-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> T-Booster</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Testo-Max Testosterone Booster">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Natural T-Booster</div>
          <div class="headline">
            <span>Testo-Max</span><br>
            Max Your T-Levels
          </div>
          <p class="subtext">Push testosterone to the max — more energy, lean muscle &amp; drive. 11 natural ingredients. No needles.</p>
          <div class="mini-pills">
            <span class="mp">More Energy</span>
            <span class="mp">Lean Muscle</span>
            <span class="mp">Fat Burn</span>
            <span class="mp">60-Day Guarantee</span>
          </div>
        </div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-stack">
            <div class="price-was">Was $79.99</div>
            <div class="price-now">$64.99</div>
            <div class="price-save">Save $15 · 2+1 Free</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="cta-arrow">→</span></div>
          <div class="guarantee-line"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Bottom strip -->
      <div class="bottom-strip">
        <div class="strip-item"><span class="dot"></span>Over 400,000 Bottles Sold</div>
        <div class="strip-item"><span class="dot"></span>Natural Ingredients</div>
        <div class="strip-item"><span class="dot"></span>Free Shipping Over $100</div>
        <div class="strip-item"><span class="dot"></span>No Prescription Needed</div>
      </div>

      <div class="bottom-bar"></div>
    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Dianabol</th><th>Testosterone</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Very High — C17-alpha ALT/AST elevation</td><td>None — injectable</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>Significant — aromatization driven</td><td>Significant — dose-dependent aromatization</td></tr><tr><td><strong>Gyno Management</strong></td><td>Aromatase inhibitor — before symptoms</td><td>Aromatase inhibitor — calibrated to dose</td></tr><tr><td><strong>Water Retention</strong></td><td>Significant — glycogen and fluid</td><td>Moderate — estradiol driven</td></tr><tr><td><strong>Blood Pressure</strong></td><td>Elevated — fluid load</td><td>Moderate elevation</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Complete</td><td>Complete</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Significant</td><td>Moderate</td></tr><tr><td><strong>Androgenic Effects</strong></td><td>Moderate — acne, aggression</td><td>Acne, oily skin, MPB risk</td></tr><tr><td><strong>Liver Monitoring</strong></td><td>Required — weekly ALT/AST advisable</td><td>Not required</td></tr><tr><td><strong>Cycle Role</strong></td><td>4–6 week kickstart maximum</td><td>10–16 week foundation</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Protocols: The Architecture That Wins</strong></h2>



<p class="wp-block-paragraph">The classic Dianabol-Testosterone stack is among the most time-tested cycle structures in bodybuilding for a straightforward reason: it works with the pharmacological reality of how each compound operates rather than against it. </p>



<p class="wp-block-paragraph">Testosterone needs time to reach full effect. Dianabol reaches full effect immediately. Running them together means the cycle is productive from week one, not week four.</p>



<h3 class="wp-block-heading"><strong>Classic Bulking Stack</strong></h3>



<p class="wp-block-paragraph">Testosterone Enanthate at 500mg per week across weeks 1 through 12, with Dianabol at 30 to 50mg per day split across two or three daily doses in weeks 1 through 6. The Dianabol provides explosive early mass and strength while testosterone builds toward stable concentrations. </p>



<p class="wp-block-paragraph">By week 6 when Dianabol is discontinued, testosterone is fully active and continues driving the cycle for the remaining six weeks without the hepatic burden of the oral compound. </p>



<p class="wp-block-paragraph">Anastrozole at 0.5mg every other day manages the combined estrogenic activity of both aromatizing compounds throughout. TUDCA at 1g per day from week 1 through 6 covers the Dianabol hepatotoxicity window.</p>



<p class="wp-block-paragraph">This structure produces the most complete bulking outcome available from an oral-plus-injectable combination rapid early size and strength momentum from Dianabol, sustainable and durable mass accumulation from testosterone across the full cycle length.</p>



<h3 class="wp-block-heading"><strong>Testosterone Propionate Kickstart Variation</strong></h3>



<p class="wp-block-paragraph">For athletes who prefer a shorter overall cycle with faster PCT readiness, Testosterone Propionate at 100mg every other day providing stable blood concentrations within days rather than weeks combined with Dianabol at 40mg per day across four weeks delivers the complete stack benefit in a shorter timeline. </p>



<p class="wp-block-paragraph">Testosterone Propionate&#8217;s 3 to 4-day clearance time after the last injection means PCT can begin considerably sooner than with Enanthate, which suits athletes with tighter off-cycle timelines.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Dianabol</th><th>Testosterone</th></tr></thead><tbody><tr><td><strong>Dose Range</strong></td><td>20–50mg/day oral (4–6 weeks)</td><td>250–750mg/week injectable (10–16 weeks)</td></tr><tr><td><strong>Mass Accumulation Speed</strong></td><td>Explosive — 20–30lbs in 4 weeks</td><td>Steady — 15–25lbs across full cycle</td></tr><tr><td><strong>Strength Onset</strong></td><td>Rapid — week 1 to 2</td><td>Progressive — weeks 4 through 12</td></tr><tr><td><strong>Lean Tissue Retention Post-Cycle</strong></td><td>40–60% after water clears</td><td>70–85% genuine lean tissue</td></tr><tr><td><strong>Liver Risk</strong></td><td>Very High — oral alkylation</td><td>None — injectable</td></tr><tr><td><strong>Estrogenic Management</strong></td><td>AI required — aromatization</td><td>AI required — dose-dependent aromatization</td></tr><tr><td><strong>Cycle Role</strong></td><td>Kickstart — weeks 1 to 6 maximum</td><td>Foundation — full cycle duration</td></tr><tr><td><strong>PCT Timing</strong></td><td>Governed by testosterone ester clearance</td><td>10–14 days post-last injection (Enanthate)</td></tr><tr><td><strong>Female Appropriate</strong></td><td>No</td><td>No at bodybuilding doses</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Support and Post-Cycle Therapy</strong></h2>



<h3 class="wp-block-heading"><strong>On-Cycle Support</strong></h3>



<p class="wp-block-paragraph">The combined cycle requires two distinct support categories running simultaneously during the Dianabol phase and one continuing after it. TUDCA at 1g per day from week 1 through 6 covers Dianabol&#8217;s hepatic burden this dose reflects the moderately high liver stress of Methandienone at standard doses, distinct from the 1.5g required for Anadrol&#8217;s more severe hepatotoxicity. </p>



<p class="wp-block-paragraph">Anastrozole at 0.5mg every other day manages the combined aromatization of both compounds throughout the full cycle, with dose adjustment based on mid-cycle bloodwork estradiol readings rather than fixed protocol adherence. Fish oil at 4g per day supports the lipid parameters that both compounds affect HDL suppression from Dianabol and the moderate cardiovascular impact of testosterone at bodybuilding doses.</p>



<p class="wp-block-paragraph">The AI dose during the Dianabol phase often needs to be slightly higher than during the testosterone-only phase because the combined estrogenic load of two aromatizing compounds is greater than testosterone alone. Tapering the AI slightly when Dianabol is discontinued and recalibrating based on bloodwork is the appropriate management approach.</p>



<h3 class="wp-block-heading"><strong>PCT Protocol</strong></h3>



<p class="wp-block-paragraph">The PCT following this cycle is governed entirely by testosterone&#8217;s clearance timeline Dianabol&#8217;s 3 to 6-hour half-life means it clears within days of the last dose, leaving testosterone as the sole suppressive compound determining when recovery can begin. For Testosterone Enanthate, beginning HCG 7 to 10 days after the last injection and running SERM-based PCT from days 10 through 38 is the standard structure.</p>



<p class="wp-block-paragraph"><strong>Days 1 to 10 — HCG Bridge</strong> HCG at 1,000iu every other day restores testicular responsiveness that has been suppressed throughout the 12-week cycle. TUDCA at 500mg per day continues for hepatic recovery support as liver enzymes from the Dianabol phase normalize.</p>



<p class="wp-block-paragraph"><strong>Weeks 3 to 6 — SERM Taper</strong> Clomid at 100mg daily in week 3, dropping to 50mg daily in weeks 4 and 5, then 25mg in week 6. Nolvadex at 40mg daily in weeks 3 and 4, dropping to 20mg in weeks 5 and 6. Fish oil at 4g per day continuing for lipid recovery. Zinc at 50mg per day for testosterone synthesis enzyme support throughout.</p>



<p class="wp-block-paragraph">Bloodwork at six to eight weeks post-PCT total testosterone, free testosterone, LH, FSH, estradiol, and a full lipid and liver panel confirms recovery trajectory and identifies any parameters requiring extended support.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1024x683.jpg" alt="a group of men standing next to each other on a stage" class="wp-image-3014" srcset="https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>PCT and Support Protocol Reference Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Phase</th><th>Protocol</th><th>Duration</th><th>Purpose</th></tr></thead><tbody><tr><td><strong>On-Cycle Liver — Dianabol Phase</strong></td><td>TUDCA 1g/day</td><td>Weeks 1–6</td><td>Hepatoprotection</td></tr><tr><td><strong>On-Cycle Estrogen — Full Cycle</strong></td><td>Anastrozole 0.5mg EOD</td><td>Weeks 1–12</td><td>Combined aromatization management</td></tr><tr><td><strong>Lipid Support</strong></td><td>Fish Oil 4g/day</td><td>Full cycle + PCT</td><td>Cardiovascular and lipid protection</td></tr><tr><td><strong>HCG Bridge</strong></td><td>HCG 1,000iu EOD</td><td>Days 1–10 post-last injection</td><td>Testicular responsiveness restoration</td></tr><tr><td><strong>PCT Week 1</strong></td><td>Clomid 100mg + Nolvadex 40mg daily</td><td>Week 3</td><td>Aggressive HPTA restart</td></tr><tr><td><strong>PCT Weeks 2–3</strong></td><td>Clomid 50mg + Nolvadex 40/20mg daily</td><td>Weeks 4–5</td><td>Sustained hormonal recovery</td></tr><tr><td><strong>PCT Week 4</strong></td><td>Clomid 25mg + Nolvadex 20mg daily</td><td>Week 6</td><td>Final normalization taper</td></tr><tr><td><em>Bloodwork Confirmation</em></td><td>Full hormone + liver + lipid panel</td><td>6–8 weeks post-PCT</td><td>Recovery verification</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Legal Status of Dianabol and Testosterone</strong></h2>



<p class="wp-block-paragraph">Both Dianabol and Testosterone are Schedule III controlled substances under the United States Controlled Substances Act. Testosterone has the broader legitimate clinical footprint <a href="https://www.endocrine.org/patient-engagement/endocrine-library/low-testosterone">testosterone replacement therapy</a> is a recognized medical treatment for hypogonadism, and TRT prescriptions obtained from licensed physicians for genuine medical indications are legal. </p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">Dianabol has no FDA-approved indication and no legitimate pharmaceutical supply chain in the United States it is available exclusively through sources that fall outside legal pharmaceutical distribution.</p>



<p class="wp-block-paragraph">The legal distinction that matters for bodybuilding purposes is that supraphysiological doses of testosterone for performance enhancement the 300 to 750mg weekly doses used in bodybuilding contexts rather than the 100 to 200mg therapeutic range fall outside any valid TRT prescription and constitute use without a legitimate medical indication, which is a federal offense under Schedule III enforcement. </p>



<p class="wp-block-paragraph">Both compounds are prohibited by the World Anti-Doping Agency in competitive sport without exception.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Testo-Max Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Rajdhani:wght@600;700&#038;family=Inter:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #f0f0f0;
    padding: 24px 16px;
    font-family: 'Inter', sans-serif;
  }

  /* ── NARROW CONTAINER ── */
  .banner-wrap {
    max-width: 680px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 10px;
    overflow: hidden;
    box-shadow: 0 8px 40px rgba(0,0,0,0.35);
    transition: box-shadow 0.25s, transform 0.25s;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 16px 56px rgba(0,0,0,0.45);
  }

  /* ── BANNER BODY ── */
  .banner {
    width: 100%;
    background: #0a0e17;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Top coloured bar */
  .top-bar {
    width: 100%;
    height: 5px;
    background: linear-gradient(90deg, #d4a800, #ffe066, #d4a800);
    flex-shrink: 0;
  }

  /* Background texture */
  .bg-noise {
    position: absolute;
    inset: 0;
    background-image:
      radial-gradient(ellipse 70% 60% at 80% 50%, rgba(212,168,0,0.12) 0%, transparent 70%),
      repeating-linear-gradient(-50deg, transparent, transparent 18px, rgba(255,255,255,0.012) 18px, rgba(255,255,255,0.012) 19px);
    z-index: 0;
    pointer-events: none;
  }

  /* Diagonal colour slash */
  .slash {
    position: absolute;
    top: 0; bottom: 0;
    right: 0;
    width: 48%;
    background: linear-gradient(108deg, transparent 0%, rgba(212,168,0,0.07) 100%);
    clip-path: polygon(15% 0%, 100% 0%, 100% 100%, 0% 100%);
    z-index: 0;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    padding: 18px 20px 14px 16px;
    gap: 14px;
  }

  /* PRODUCT IMAGE */
  .product-col {
    flex-shrink: 0;
    width: 108px;
    display: flex;
    align-items: center;
    justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 100px;
    height: auto;
    display: block;
    filter:
      drop-shadow(0 0 14px rgba(212,168,0,0.55))
      drop-shadow(0 4px 10px rgba(0,0,0,0.8));
    transform: rotate(-4deg) scale(1.05);
    transition: transform 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.11);
  }
  .pill-badge {
    position: absolute;
    top: -4px;
    right: -6px;
    background: linear-gradient(135deg, #d4a800, #ffe066);
    color: #0a0e17;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 7px;
    border-radius: 3px;
    box-shadow: 0 2px 8px rgba(212,168,0,0.5);
    white-space: nowrap;
    z-index: 3;
  }

  /* TEXT */
  .text-col {
    flex: 1;
    min-width: 0;
  }
  .eyebrow {
    font-family: 'Rajdhani', sans-serif;
    font-size: 9.5px;
    font-weight: 700;
    letter-spacing: 3px;
    text-transform: uppercase;
    color: #d4a800;
    margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(26px, 5vw, 42px);
    line-height: 0.92;
    letter-spacing: 1.5px;
    color: #fff;
    margin-bottom: 6px;
    text-shadow: 0 0 30px rgba(212,168,0,0.3);
  }
  .headline span { color: #ffe066; }
  .subtext {
    font-size: 11px;
    color: rgba(255,255,255,0.58);
    line-height: 1.45;
    margin-bottom: 9px;
    max-width: 340px;
    font-weight: 400;
  }
  .mini-pills {
    display: flex;
    flex-wrap: wrap;
    gap: 5px;
  }
  .mp {
    display: inline-flex;
    align-items: center;
    gap: 4px;
    border: 1px solid rgba(212,168,0,0.3);
    background: rgba(212,168,0,0.08);
    color: #d4a800;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 8px;
    border-radius: 2px;
  }
  .mp::before { content: '✓'; font-size: 8px; }

  /* CTA COLUMN */
  .cta-col {
    flex-shrink: 0;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 8px;
    min-width: 138px;
  }
  .price-stack { text-align: center; line-height: 1; }
  .price-was {
    font-size: 10.5px;
    color: rgba(255,255,255,0.3);
    text-decoration: line-through;
    letter-spacing: 0.5px;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 600;
  }
  .price-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 44px;
    color: #fff;
    letter-spacing: 1px;
    line-height: 1;
  }
  .price-save {
    font-family: 'Rajdhani', sans-serif;
    font-size: 9.5px;
    font-weight: 700;
    color: #4edf8a;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    margin-top: 1px;
  }

  .cta-btn {
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 6px;
    width: 100%;
    background: linear-gradient(135deg, #c49a00 0%, #ffe066 50%, #c49a00 100%);
    background-size: 200% 100%;
    background-position: 0% 50%;
    color: #0a0e17;
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 13px;
    letter-spacing: 1.8px;
    text-transform: uppercase;
    padding: 12px 14px;
    border-radius: 5px;
    box-shadow: 0 4px 20px rgba(212,168,0,0.45);
    transition: background-position 0.4s, box-shadow 0.2s, transform 0.2s;
    white-space: nowrap;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 28px rgba(212,168,0,0.7);
  }
  .cta-arrow {
    font-size: 14px;
    transition: transform 0.2s;
  }
  .banner-link:hover .cta-arrow { transform: translateX(3px); }

  .guarantee-line {
    font-size: 8.5px;
    color: rgba(255,255,255,0.28);
    text-align: center;
    letter-spacing: 0.8px;
    text-transform: uppercase;
  }

  /* ── BOTTOM STRIP ── */
  .bottom-strip {
    position: relative;
    z-index: 2;
    background: rgba(212,168,0,0.1);
    border-top: 1px solid rgba(212,168,0,0.18);
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 20px;
    padding: 7px 16px;
    flex-wrap: wrap;
  }
  .strip-item {
    font-family: 'Rajdhani', sans-serif;
    font-weight: 700;
    font-size: 9px;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.42);
    display: flex;
    align-items: center;
    gap: 5px;
  }
  .strip-item .dot {
    width: 4px;
    height: 4px;
    border-radius: 50%;
    background: #d4a800;
    opacity: 0.5;
  }

  /* Bottom accent */
  .bottom-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #d4a800, #ffe066, #d4a800);
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 520px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 80px; }
    .product-col img { width: 72px; }
    .headline { font-size: 26px; }
    .price-now { font-size: 36px; }
    .cta-col { min-width: 118px; }
    .mini-pills { display: none; }
    .bottom-strip { gap: 12px; }
  }
  @media (max-width: 400px) {
    .product-col { display: none; }
    .subtext { display: none; }
  }
</style>
</head>
<body>

<div class="banner-wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/K6L72/" target="_blank" rel="noopener sponsored">
    <div class="banner">
      <div class="top-bar"></div>
      <div class="bg-noise"></div>
      <div class="slash"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="pill-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> T-Booster</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Testo-Max Testosterone Booster">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Natural T-Booster</div>
          <div class="headline">
            <span>Testo-Max</span><br>
            Max Your T-Levels
          </div>
          <p class="subtext">Push testosterone to the max — more energy, lean muscle &amp; drive. 11 natural ingredients. No needles.</p>
          <div class="mini-pills">
            <span class="mp">More Energy</span>
            <span class="mp">Lean Muscle</span>
            <span class="mp">Fat Burn</span>
            <span class="mp">60-Day Guarantee</span>
          </div>
        </div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-stack">
            <div class="price-was">Was $79.99</div>
            <div class="price-now">$64.99</div>
            <div class="price-save">Save $15 · 2+1 Free</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="cta-arrow">→</span></div>
          <div class="guarantee-line"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Bottom strip -->
      <div class="bottom-strip">
        <div class="strip-item"><span class="dot"></span>Over 400,000 Bottles Sold</div>
        <div class="strip-item"><span class="dot"></span>Natural Ingredients</div>
        <div class="strip-item"><span class="dot"></span>Free Shipping Over $100</div>
        <div class="strip-item"><span class="dot"></span>No Prescription Needed</div>
      </div>

      <div class="bottom-bar"></div>
    </div>
  </a>
</div>

</body>
</html>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Conclusion: Foundation and Accelerant Never One Without the Other</strong></h2>



<p class="wp-block-paragraph">The strategic conclusion of this comparison is the same one that the most experienced bodybuilders reach after their first few cycles: Testosterone is not optional, and Dianabol is most valuable when it is not trying to be.</p>



<p class="wp-block-paragraph">Testosterone provides everything the body needs to run a productive and healthy bulking cycle hormonal base, joint support, sustained anabolic drive, and the consistent gains that compound over months. </p>



<p class="wp-block-paragraph">Dianabol provides what testosterone alone cannot deliver quickly enough the rapid early size and strength momentum that makes the first four weeks of a cycle as productive as the last, and the glycogen-driven training quality that supports the heavy volume work that mass building requires.</p>



<p class="wp-block-paragraph">Together, the combination of Testosterone Enanthate at 500mg per week as the foundation and Dianabol at 30 to 50mg per day as the weeks 1 through 6 kickstart represents the most proven, most widely validated, and most consistently effective oral-plus-injectable bulking protocol in competitive bodybuilding. It is not the most sophisticated approach possible. </p>



<p class="wp-block-paragraph">It is simply the one that works with the pharmacological reality of how both compounds operate, in the roles they were each designed to fill.</p>



<p class="wp-block-paragraph">Bloodwork before the cycle establishes the baseline. AI management during keeps estrogen in range. PCT runs to completion. Bloodwork post-PCT confirms the recovery happened. Nothing about this is optional, and nothing about it is complicated once the framework is understood.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-testosterone/">Dianabol vs Testosterone: Rapid Mass vs Cycle Foundation Battle</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dianabol vs Anadrol: Explosive Mass Showdown Wet Bulking Kings Compared</title>
		<link>https://gymtrix.net/dianabol-vs-anadrol/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Fri, 08 May 2026 05:00:19 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3079</guid>

					<description><![CDATA[<p>When bodybuilders talk about explosive mass-building compounds, two names surface above everything else in the oral steroid category: Dianabol and Anadrol. Not because they are the safest. Not because they are the most nuanced. But because nothing else in the oral class comes close to what either one can do to a physique in four...</p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-anadrol/">Dianabol vs Anadrol: Explosive Mass Showdown Wet Bulking Kings Compared</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">When bodybuilders talk about explosive mass-building compounds, two names surface above everything else in the oral steroid category: Dianabol and Anadrol. Not because they are the safest. Not because they are the most nuanced. But because nothing else in the oral class comes close to what either one can do to a physique in four weeks. </p>



<p class="wp-block-paragraph">Between them, they represent the two most potent mass-building oral anabolic steroids ever developed, and the comparison between them is not about which one works they both work dramatically but about which one works in the specific way your training phase requires, and what each one costs in terms of the side effect burden you will need to manage.</p>



<p class="wp-block-paragraph">Dianabol (Methandienone) is the compound that built the golden era of bodybuilding. Its classic combination of glycogen supercompensation, estrogenic mass building, and the kind of strength surge that makes every training session feel productive has made it the default kickstart oral for bulking cycles since the 1960s. It is powerful, reliable, and its side effects while significant follow predictable estrogenic and hepatic patterns that experienced users know how to manage.</p>



<p class="wp-block-paragraph">Anadrol (Oxymetholone) is in a different category of intensity. It does not simply produce more of what Dianabol produces. It operates through a partly different mechanism, drives strength gains that exceed Dianabol by a meaningful margin, builds even more mass in the same four-week window, and does so with a hepatotoxic burden and a set of side effects that make it the more demanding compound to manage by any measure. The gap between them is the gap between powerful and extreme.</p>



<p class="wp-block-paragraph">This guide maps exactly where that gap lies, what each compound actually delivers, and how to structure cycles around both without turning a mass phase into a medical event.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg" alt="topless man in black shorts holding orange bar" class="wp-image-3005" srcset="https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Classic Reliability vs Extreme Output</strong></h2>



<p class="wp-block-paragraph">Dianabol&#8217;s pharmacological profile is built around its close structural relationship to testosterone. Methandienone aromatizes readily to estradiol, and it is this estrogenic activity driving glycogen supercompensation, intracellular water uptake, and cellular volumization that produces the rapid size and fullness the compound is famous for. </p>



<p class="wp-block-paragraph">Its anabolic-to-androgenic ratio of approximately 210:60 reflects strong but not extreme anabolic activity alongside meaningful androgenic drive. The result is a compound that produces dramatic results while remaining predictable enough for experienced users to calibrate effectively.</p>



<p class="wp-block-paragraph">Anadrol&#8217;s mechanism has puzzled researchers for decades. Oxymetholone does not aromatize it has no estrogenic conversion pathway yet it produces estrogenic effects more pronounced than most aromatizing compounds. The current understanding is that Oxymetholone acts as a <a href="https://www.ncbi.nlm.nih.gov/books/NBK526128/">direct agonist at estrogen receptors</a> without requiring aromatization, which has a critical practical implication: aromatase inhibitors do not effectively manage Anadrol&#8217;s estrogenic side effects. SERMs do. </p>



<p class="wp-block-paragraph">This distinction separates informed Anadrol management from the approach that works for Dianabol, and getting it wrong is how users end up with gynecomastia despite running an AI throughout.</p>



<p class="wp-block-paragraph">Both compounds are C17-alpha alkylated oral steroids. Both carry significant hepatotoxic burden. Both produce full HPTA shutdown. Neither is appropriate for a first cycle, and neither should be run without current bloodwork and a fully planned support and PCT protocol.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Dianabol for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Rapid Glycogen Fullness</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s size-building mechanism is estrogenic glycogen supercompensation the process by which estrogen-driven cellular signaling dramatically increases intramuscular glycogen and water storage, creating the full, pumped, volumized appearance that has defined the classic bulking aesthetic since Dianabol became the compound of choice for competitive bodybuilders in the 1960s and 1970s. </p>



<p class="wp-block-paragraph">The 20 to 25 pounds gained in a typical four-week Dianabol kickstart represent a combination of actual lean tissue, significantly increased intramuscular glycogen, and subcutaneous and intracellular water. The lean tissue component perhaps 6 to 10 pounds in a well-run cycle is the durable result. The glycogen and water are transient but contribute to training performance and psychological momentum throughout the cycle.</p>



<p class="wp-block-paragraph">This glycogen loading has a genuine performance benefit beyond aesthetics: fully glycogen-saturated muscle tissue performs better, recovers faster between sets, and supports the training volume that drives the hypertrophy that will remain after the water clears.</p>



<h3 class="wp-block-heading"><strong>Classic Strength Surge</strong></h3>



<p class="wp-block-paragraph">The strength increases Dianabol produces are the reason it became the defining kickstart compound for longer injectable-based bulking cycles. </p>



<p class="wp-block-paragraph">As testosterone and other long-ester injectables build slowly toward stable blood concentrations across the first three to four weeks of a cycle, Dianabol fills the performance gap immediately producing strength gains within the first week that allow productive heavy training from day one rather than waiting for the injectables to reach full effect. </p>



<p class="wp-block-paragraph">Personal records on major compound lifts typically improve consistently across the four-week Dianabol window, and the combination of increased strength with the volumizing pump effect creates training sessions that feel maximally productive.</p>



<h3 class="wp-block-heading"><strong>Pump-Driven Workout Quality</strong></h3>



<p class="wp-block-paragraph">The vascular pump Dianabol produces during training is a direct consequence of its estrogenic activity and the intramuscular volumization it drives. Enhanced nitric oxide activity combined with glycogen-saturated muscle tissue creates engorgement during sets that is motivating, training-quality enhancing, and a reliable indicator that the compound is working at full effect. </p>



<p class="wp-block-paragraph">Unlike Anadrol&#8217;s pump, which can become uncomfortably intense at higher doses, Dianabol&#8217;s pump at standard doses tends to stay within the range that enhances training rather than limiting it.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Anadrol for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Extreme Raw Power</strong></h3>



<p class="wp-block-paragraph">Anadrol&#8217;s strength-building capacity is genuinely in a different tier from Dianabol. The red blood cell production elevation that Oxymetholone drives the mechanism behind its original medical application for anemia treatment increases oxygen-carrying capacity to working muscle tissue in a way that produces strength increases that experienced users describe as almost pharmacologically alarming in their speed and magnitude. </p>



<p class="wp-block-paragraph">Where Dianabol produces impressive strength gains, Anadrol produces strength gains that can make a lifter feel like a different athlete. This is not hyperbole the oxygen delivery enhancement combined with the extreme cellular volumization creates a physiological environment where heavy compound lifting reaches performance levels that would otherwise require years of additional training to approach.</p>



<h3 class="wp-block-heading"><strong>Size Beyond Limits</strong></h3>



<p class="wp-block-paragraph">Anadrol&#8217;s mass accumulation in four weeks 25 to 35 pounds on the scale for many users is the most dramatic body weight change any oral anabolic steroid produces. The caveat applies here as it does to Dianabol: a significant portion of this number is transient glycogen, water, and the cellular volumization driven by Oxymetholone&#8217;s direct estrogenic receptor activity. </p>



<p class="wp-block-paragraph">The lean tissue component is real and meaningful typically 8 to 12 pounds of actual muscle in a well-run four-week cycle with appropriate nutrition but the gross number is inflated by the same fluid dynamics that make Anadrol look so dramatic on the scale and in the mirror during the cycle.</p>



<p class="wp-block-paragraph">The post-cycle deflation the loss of the water and glycogen component when Anadrol is discontinued is one of the most psychologically challenging aspects of using the compound. Users who understand this in advance manage it rationally. Users who do not tend to dose the compound for longer than is safe in an attempt to maintain the peak number.</p>



<h3 class="wp-block-heading"><strong>Aggression Edge and Training Drive</strong></h3>



<p class="wp-block-paragraph">Anadrol&#8217;s neurological intensity is distinct from what Dianabol produces. The androgenic drive, combined with the extreme physical sensation of the compound&#8217;s cardiovascular and muscular effects during training, creates a psychological state that experienced users describe as uniquely aggressive and focused. </p>



<p class="wp-block-paragraph">This quality supports the kind of maximum-effort training that produces the strength gains and overload stimulus that mass building requires. It is also the same quality that makes some users find Anadrol genuinely difficult to manage outside the gym the aggression and mood intensity that drives performance in training does not always stay contained to training sessions.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anadrole Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(180,100,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(220,140,0,0.38);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #08070a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — amber/bronze/gold */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0c0a06 0%, #0c0a06 36%,
      #1a1000 36%, #241600 54%,
      #08070a 54%, #08070a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(200,120,0,0.15) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(140,80,0,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(200,130,0,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(220,140,0,0.60))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,180,0,0.78))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #7a3d00, #cc7700);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,90,0,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(255,200,0,0.32) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #e08000; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(200,120,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ffaa00; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(180,90,0,0.10);
    border: 1px solid rgba(220,130,0,0.28);
    color: #ffbb55;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #e08000; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(220,130,0,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #ffbb55; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(200,120,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,180,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #7a3d00 0%, #bb6600 45%, #ee9900 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,90,0,0.52), 0 0 0 1px rgba(230,140,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(220,110,0,0.7), 0 0 0 1px rgba(255,160,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(150,70,0,0.08);
    border-top: 1px solid rgba(200,110,0,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(180,90,0,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(170,80,0,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #e08000; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/2BCRGX/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /> O₂ Booster</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anadrole — Legal Anadrol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anadrol Alternative</div>
          <div class="headline">
            <small>Extreme Gains &amp; O₂ Power</small>
            <em>Anadrole</em>
          </div>
          <p class="sub"><strong>Supercharges red blood cell production</strong> — floods muscles with oxygen for explosive power, massive gains &amp; rapid recovery. Results in <strong>2 weeks.</strong></p>
          <div class="tags">
            <span class="tag">Extreme Muscle</span>
            <span class="tag">Boosts O₂</span>
            <span class="tag">Fast Recovery</span>
            <span class="tag">Delays Fatigue</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Anadrol Alt</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Extreme Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">More O₂ Flow</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>2 Weeks</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects: Where Each Compound Concentrates Its Cost</strong></h2>



<h3 class="wp-block-heading"><strong>Dianabol Side Effects</strong></h3>



<p class="wp-block-paragraph">Dianabol&#8217;s <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">hepatotoxicity from C17-alpha alkylation</a> is significant but falls below Anadrol in terms of severity at comparable doses. ALT and AST elevation is reliable, dose-dependent, and requires TUDCA support throughout. The four to six-week cycle length ceiling reflects the practical point where hepatic accumulation becomes untenable. </p>



<p class="wp-block-paragraph">Estrogenic side effects gynecomastia risk, water retention, and blood pressure elevation from the fluid load are managed through aromatase inhibitors, specifically because Dianabol&#8217;s estrogenic effects arise from genuine aromatization. </p>



<p class="wp-block-paragraph">Anastrozole at 0.5mg every other day or Aromasin at 12.5mg every other day, started before the first Dianabol dose rather than reactively after symptoms appear, keeps estradiol in an appropriate range for most users.</p>



<p class="wp-block-paragraph">Blood pressure elevation from the combination of fluid retention and androgenic cardiovascular stimulation requires monitoring throughout the cycle. HPTA suppression is complete at standard doses and requires structured PCT.</p>



<h3 class="wp-block-heading"><strong>Anadrol Side Effects</strong></h3>



<p class="wp-block-paragraph">Anadrol&#8217;s hepatotoxicity is the most severe of any oral anabolic steroid in common use not marginally more demanding than Dianabol, but substantially so. ALT and AST elevation at 50 to 100mg per day reaches levels that move from elevated into clinically alarming territory without aggressive hepatic support. </p>



<p class="wp-block-paragraph">TUDCA at 1.5g per day and NAC at 2.4g per day represent the minimum appropriate support protocol, and weekly liver enzyme monitoring during the cycle is the responsible management approach rather than simply waiting for symptoms to develop.</p>



<p class="wp-block-paragraph">The estrogenic effects driven by direct estrogen receptor agonism gynecomastia and water retention do not respond to aromatase inhibitors. <a href="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-modulator">Selective estrogen receptor modulators</a> are the appropriate tool for managing Anadrol&#8217;s gyno risk. </p>



<p class="wp-block-paragraph">Nolvadex at 10 to 20mg per day run throughout the cycle blocks estrogen receptor activity at breast tissue, which is the relevant mechanism. Users who reach for Anastrozole or Aromasin to manage Anadrol&#8217;s estrogenic effects are using the wrong pharmacological tool and will find the intervention unreliable.</p>



<p class="wp-block-paragraph">Headaches are severe enough in some users to be the primary dose-limiting side effect. The extreme vascular filling and blood pressure elevation that Anadrol produces creates intracranial pressure that a meaningful percentage of users find genuinely disruptive. </p>



<p class="wp-block-paragraph">Insomnia from the neurological stimulation and appetite dysregulation the compound drives extreme hunger in many users are additional consistent reports that require management.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Dianabol</th><th>Anadrol</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Very High — significant ALT/AST elevation</td><td>Extreme — highest among oral AAS</td></tr><tr><td><strong>Estrogenic Mechanism</strong></td><td>Aromatization to estradiol</td><td>Direct estrogen receptor agonism</td></tr><tr><td><strong>Gyno Management</strong></td><td>Aromatase inhibitor — Anastrozole / Aromasin</td><td>SERM only — Nolvadex; AI ineffective</td></tr><tr><td><strong>Water Retention</strong></td><td>Significant</td><td>Extreme</td></tr><tr><td><strong>Blood Pressure</strong></td><td>Elevated from fluid load</td><td>Severely elevated</td></tr><tr><td><strong>Headaches</strong></td><td>Mild to Moderate</td><td>Severe — frequent dose-limiting side effect</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Complete</td><td>Complete</td></tr><tr><td><strong>Androgenic Effects</strong></td><td>Moderate — acne, aggression</td><td>Significant — pronounced neurological drive</td></tr><tr><td><strong>Insomnia</strong></td><td>Uncommon</td><td>Common at standard doses</td></tr><tr><td><strong>Maximum Cycle Length</strong></td><td>4–6 weeks</td><td>4 weeks absolute maximum</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Protocols</strong></h2>



<p class="wp-block-paragraph">The most important structural principle governing both compounds is the same: neither should be run without a testosterone base. Both produce complete HPTA suppression, and running either without exogenous testosterone replacement creates the low-androgen, high-estrogenic state that produces libido crash, erectile dysfunction, and wellbeing deterioration that has nothing to do with the training outcome and everything to do with the hormonal vacuum that suppression without replacement creates.</p>



<h3 class="wp-block-heading"><strong>Ultimate Kickstart — Choose One</strong></h3>



<p class="wp-block-paragraph">The most rational use of either compound is as a kickstart to a longer testosterone-based injectable cycle not both simultaneously. Dianabol at 30mg per day or Anadrol at 50mg per day across weeks 1 through 4, alongside Testosterone Enanthate at 500mg per week, provides the immediate mass and strength stimulus that fills the window while the long-ester testosterone builds to stable blood concentrations.</p>



<p class="wp-block-paragraph"> By week 4 to 5, when the oral is discontinued, testosterone is fully active and continues driving the cycle without the oral&#8217;s hepatic burden.</p>



<p class="wp-block-paragraph">The choice between them for this application comes down to side effect tolerance and strength priority. Dianabol is the more manageable compound with the more predictable estrogenic side effect profile appropriate for anyone who has not previously run Anadrol. </p>



<p class="wp-block-paragraph">Anadrol is appropriate for users who specifically need the extreme strength output it produces and who have already established their individual response to Dianabol in a previous cycle.</p>



<h3 class="wp-block-heading"><strong>Sequential Powerbuilding Bridge</strong></h3>



<p class="wp-block-paragraph">For advanced users who want to experience both compounds across a single extended cycle, a sequential rather than simultaneous approach is the only hepatically defensible structure: Dianabol at 20 to 30mg per day in weeks 1 through 4, followed by a two-week washout where neither oral is active and the injectable testosterone carries the cycle, followed by Anadrol at 50mg per day in weeks 7 through 10. </p>



<p class="wp-block-paragraph">This gives each compound its own window without compounding their hepatic burden simultaneously, allows liver enzymes to partially normalize between phases, and produces a cycle that benefits from both compounds&#8217; specific contributions in sequence.</p>



<p class="wp-block-paragraph">The three-week simultaneous overlap Dianabol in the morning, Anadrol in the evening described in some advanced cycle discussions is the highest-risk approach and requires not just TUDCA and NAC but weekly bloodwork with a clear stopping criterion for liver enzyme values that trigger immediate discontinuation.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Dianabol</th><th>Anadrol</th></tr></thead><tbody><tr><td><strong>Dose Range</strong></td><td>20–50mg/day oral (4–6 weeks)</td><td>50–100mg/day oral (4 weeks maximum)</td></tr><tr><td><strong>Mass Accumulation</strong></td><td>Fast — 20–25lbs typical</td><td>Explosive — 25–35lbs typical</td></tr><tr><td><strong>Lean Tissue Component</strong></td><td>6–10lbs post-water clearance</td><td>8–12lbs post-water clearance</td></tr><tr><td><strong>Strength Tier</strong></td><td>Excellent</td><td>Elite — categorically higher output</td></tr><tr><td><strong>Liver Risk</strong></td><td>Very High</td><td>Extreme</td></tr><tr><td><strong>Estrogenic Management</strong></td><td>Aromatase inhibitor effective</td><td>SERM required — AI ineffective</td></tr><tr><td><strong>Headache Frequency</strong></td><td>Mild — occasional</td><td>Severe — common dose-limiting factor</td></tr><tr><td><strong>Female Appropriate</strong></td><td>No</td><td>Absolutely not</td></tr><tr><td><strong>Testosterone Base Required</strong></td><td>Non-negotiable</td><td>Non-negotiable</td></tr><tr><td><strong>PCT Complexity</strong></td><td>Full protocol — HCG + SERM taper</td><td>Full protocol — aggressive SERM taper</td></tr></tbody></table></figure>



<p class="wp-block-paragraph"></p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/04/wt5jg8_wrjg-1024x683.jpg" alt="topless man wearing black and white cap" class="wp-image-3057" srcset="https://gymtrix.net/wp-content/uploads/2026/04/wt5jg8_wrjg-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/04/wt5jg8_wrjg-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/04/wt5jg8_wrjg-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/04/wt5jg8_wrjg-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/04/wt5jg8_wrjg.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Cycle Support and Post-Cycle Therapy</strong></h2>



<h3 class="wp-block-heading"><strong>On-Cycle Support</strong></h3>



<p class="wp-block-paragraph">The hepatic support requirements for either compound exceed what a standard Anavar or Winstrol cycle demands. TUDCA at 1.5g per day is the appropriate dose for both not the 500mg that suffices for milder oral anabolics, but 1.5g to meaningfully address the ALT and AST elevation these compounds produce. </p>



<p class="wp-block-paragraph">NAC at 2.4g per day adds glutathione precursor support that enhances the hepatoprotective effect and provides antioxidant coverage for the oxidative stress these compounds generate. Fish oil at 4g per day addresses the lipid disruption both compounds cause. </p>



<p class="wp-block-paragraph">Arimidex at 0.5mg every other day manages Dianabol&#8217;s estrogenic aromatization but note this does not apply to Anadrol, where Nolvadex at 10mg per day throughout is the appropriate estrogenic management tool.</p>



<p class="wp-block-paragraph">Weekly liver enzyme testing during the cycle is not optional paranoia it is the monitoring protocol that allows early identification of values that have crossed from elevated into dangerous, triggering discontinuation before permanent hepatic damage occurs.</p>



<h3 class="wp-block-heading"><strong>PCT Protocol</strong></h3>



<p class="wp-block-paragraph">The HPTA suppression from a testosterone-based cycle with either oral as the kickstart requires the most complete PCT protocol: HCG bridging before SERMs, followed by a full Clomid and Nolvadex taper. </p>



<p class="wp-block-paragraph">The HCG bridge is particularly important here because the combination of a long-ester testosterone base and a potent oral compound produces deep and sustained suppression that leaves testes in a state of extended inactivity. HCG restores testicular responsiveness before the SERM phase begins.</p>



<p class="wp-block-paragraph"><strong>Days 1 to 10 — HCG Bridge</strong> HCG at 1,000iu every other day beginning 7 to 10 days after the last testosterone injection. TUDCA continuing at 1g per day for hepatic recovery support.</p>



<p class="wp-block-paragraph"><strong>Weeks 3 to 6 — SERM Taper</strong> Clomid at 100mg daily in week 3, 50mg daily in weeks 4 and 5, 25mg daily in week 6. Nolvadex at 40mg daily in weeks 3 and 4, 20mg daily in weeks 5 and 6. Fish oil at 4g per day continuing. Zinc at 50mg per day for testosterone synthesis enzyme support.</p>



<p class="wp-block-paragraph">Bloodwork at six to eight weeks post-PCT total testosterone, free testosterone, LH, FSH, and a comprehensive liver enzyme and lipid panel confirms whether recovery is proceeding adequately across all parameters.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>PCT and Support Protocol Reference Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Phase</th><th>Protocol</th><th>Duration</th><th>Purpose</th></tr></thead><tbody><tr><td><strong>On-Cycle Liver — Both Compounds</strong></td><td>TUDCA 1.5g/day + NAC 2.4g/day</td><td>Full oral cycle duration</td><td>Hepatoprotection — high burden</td></tr><tr><td><strong>On-Cycle Estrogen — Dianabol</strong></td><td>Anastrozole 0.5mg EOD</td><td>Dianabol weeks</td><td>Aromatization management</td></tr><tr><td><strong>On-Cycle Estrogen — Anadrol</strong></td><td>Nolvadex 10mg/day</td><td>Anadrol weeks</td><td>Direct ER agonism management</td></tr><tr><td><strong>Lipid Support</strong></td><td>Fish Oil 4g/day</td><td>Full cycle + PCT</td><td>Cardiovascular protection</td></tr><tr><td><strong>HCG Bridge</strong></td><td>HCG 1,000iu EOD</td><td>Days 1–10 post-testosterone clearance</td><td>Testicular responsiveness</td></tr><tr><td><strong>PCT Weeks 1–2</strong></td><td>Clomid 100/50mg + Nolvadex 40mg daily</td><td>Weeks 3–4</td><td>Aggressive HPTA restart</td></tr><tr><td><strong>PCT Weeks 3–4</strong></td><td>Clomid 25mg + Nolvadex 20mg daily</td><td>Weeks 5–6</td><td>Hormonal normalization taper</td></tr><tr><td><strong>Bloodwork Confirmation</strong></td><td>Full hormone + liver + lipid panel</td><td>6–8 weeks post-PCT</td><td>Recovery verification</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Legal Status of Dianabol and Anadrol</strong></h2>



<p class="wp-block-paragraph">Both Dianabol and Anadrol are Schedule III controlled substances under the United States Controlled Substances Act. Anadrol retains approved medical applications treatment of anemia and red blood cell deficiency conditions for which it is still occasionally prescribed in clinical practice. </p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D-BAL Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c8c8c8;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.55), 0 0 0 1px rgba(180,0,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.65), 0 0 0 1px rgba(220,0,0,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #0a0a0a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0f0f0f 0%, #0d0d0d 36%,
      #1a0000 36%, #220000 54%,
      #0a0a0a 54%, #0a0a0a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(180,0,0,0.2) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8% 50%, rgba(100,0,0,0.12) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.013) 16px, rgba(255,255,255,0.013) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.07) 3px, rgba(0,0,0,0.07) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 20px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 110px; height: 110px; border-radius: 50%;
    background: radial-gradient(circle, rgba(180,0,0,0.25) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 106px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(200,0,0,0.65))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
    transform: rotate(-5deg) scale(1.05);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,40,0,0.8))
      drop-shadow(0 5px 12px rgba(0,0,0,0.95));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #990000, #ee2200);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.3px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,0,0,0.7);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.28) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #cc2200; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(180,0,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ff2200; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(10px, 1.5vw, 13px);
    letter-spacing: 4px; color: rgba(255,255,255,0.38);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 300px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(160,0,0,0.12);
    border: 1px solid rgba(200,0,0,0.28);
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #ff2200; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(200,0,0,0.35), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-star {
    display: inline-block;
    color: #ff6644;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.5px;
    text-transform: uppercase; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(180,0,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,100,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #880000 0%, #cc1a00 45%, #ff3300 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,0,0,0.55), 0 0 0 1px rgba(220,0,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 32px rgba(220,0,0,0.72), 0 0 0 1px rgba(255,60,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(100,0,0,0.1);
    border-top: 1px solid rgba(160,0,0,0.18);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(160,0,0,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(140,0,0,0.08); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.33);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center;
    gap: 0;
  }
  .ps-item {
    flex: 1; text-align: center;
    padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #cc2200; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28);
    white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #6b0000, #bb1500, #ff2200, #ff5500, #ff2200, #bb1500, #6b0000);
    background-size: 300% 100%;
    animation: barSweep 3s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/FFX5M/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> #1 Bestseller</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk D-BAL Legal Dianabol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Dianabol Alternative</div>
          <div class="headline">
            <small>Massive Gains &amp; Strength</small>
            <em>D-BAL</em>
          </div>
          <p class="sub"><strong>7x stronger formula</strong> — fast muscle gains, super strength &amp; rapid results in 30 days. No needles, no prescription.</p>
          <div class="tags">
            <span class="tag">Fast Muscle Gains</span>
            <span class="tag">Super Strength</span>
            <span class="tag">Burns Fat</span>
            <span class="tag">Boosts Testosterone</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-star"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 252 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Massive Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Super Strength</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9ec.png" alt="🧬" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Boosts T-Levels</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Bottles Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results in <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">Dianabol has no current FDA-approved indication and is available exclusively through channels outside the pharmaceutical supply chain for bodybuilding purposes. Possession of either compound without a valid prescription constitutes a federal offense under DEA enforcement, and distribution carries sentences of 5 to 40 years depending on quantity and circumstances.</p>



<p class="wp-block-paragraph">Both compounds are prohibited by the World Anti-Doping Agency across all competitive sport categories. Detection windows for both Methandienone and Oxymetholone metabolites in urine testing extend weeks beyond the last dose using modern analytical methods, making either compound a significant anti-doping risk for any tested athlete regardless of cycle management.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anadrole Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(180,100,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(220,140,0,0.38);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #08070a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — amber/bronze/gold */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0c0a06 0%, #0c0a06 36%,
      #1a1000 36%, #241600 54%,
      #08070a 54%, #08070a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(200,120,0,0.15) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(140,80,0,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(200,130,0,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(220,140,0,0.60))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,180,0,0.78))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #7a3d00, #cc7700);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,90,0,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(255,200,0,0.32) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #e08000; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(200,120,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ffaa00; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(180,90,0,0.10);
    border: 1px solid rgba(220,130,0,0.28);
    color: #ffbb55;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #e08000; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(220,130,0,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #ffbb55; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(200,120,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,180,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #7a3d00 0%, #bb6600 45%, #ee9900 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,90,0,0.52), 0 0 0 1px rgba(230,140,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(220,110,0,0.7), 0 0 0 1px rgba(255,160,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(150,70,0,0.08);
    border-top: 1px solid rgba(200,110,0,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(180,90,0,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(170,80,0,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #e08000; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/2BCRGX/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /> O₂ Booster</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anadrole — Legal Anadrol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anadrol Alternative</div>
          <div class="headline">
            <small>Extreme Gains &amp; O₂ Power</small>
            <em>Anadrole</em>
          </div>
          <p class="sub"><strong>Supercharges red blood cell production</strong> — floods muscles with oxygen for explosive power, massive gains &amp; rapid recovery. Results in <strong>2 weeks.</strong></p>
          <div class="tags">
            <span class="tag">Extreme Muscle</span>
            <span class="tag">Boosts O₂</span>
            <span class="tag">Fast Recovery</span>
            <span class="tag">Delays Fatigue</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Anadrol Alt</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Extreme Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">More O₂ Flow</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>2 Weeks</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Conclusion: Matching Compound to Goal and Managing the Cost</strong></h2>



<p class="wp-block-paragraph">The comparison between Dianabol and Anadrol is not a competition for the title of better mass-building oral. They are both exceptional at what they do, and the question is not which is superior in the abstract but which one is appropriate for the specific goal and risk tolerance of the individual running the cycle.</p>



<p class="wp-block-paragraph">Dianabol is the more accessible compound of the two. Its estrogenic mechanism is the standard aromatization pathway that experienced users know how to manage with AIs, its side effect profile is predictable, and its hepatotoxic burden while serious is lower than Anadrol&#8217;s by a meaningful margin. </p>



<p class="wp-block-paragraph">For anyone who wants a reliable, powerful oral kickstart to a bulking cycle and who has not yet established their individual response to Oxymetholone, Dianabol is the appropriate choice. It delivers the mass and strength results that define a successful bulk while remaining in a risk category that diligent monitoring and support can manage.</p>



<p class="wp-block-paragraph">Anadrol is for users who need the strength output that Dianabol does not provide, who have already run Dianabol and want to understand what the next tier of oral mass building produces, and who are prepared for the more demanding management it requires weekly bloodwork, higher-dose hepatic support, SERM-based estrogen management rather than AI management, and the psychological discipline to discontinue the compound at four weeks regardless of how good the scale numbers look.</p>



<p class="wp-block-paragraph">Never run either beyond their cycle length limits. Never run both simultaneously without a clear sequential structure and pre-planned stopping criteria based on liver enzyme values. Bloodwork before the first dose and weekly during the cycle is not a suggestion it is the minimum responsible management for compounds at this level of hepatic impact.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/dianabol-vs-anadrol/">Dianabol vs Anadrol: Explosive Mass Showdown Wet Bulking Kings Compared</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Anavar vs Deca Durabolin: Dry Cutting vs Joint-Friendly Bulking</title>
		<link>https://gymtrix.net/anavar-vs-deca-durabolin/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Tue, 05 May 2026 00:35:12 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3069</guid>

					<description><![CDATA[<p>Most steroid comparisons involve compounds that at least share some philosophical overlap similar goals, similar risk categories, similar users. Anavar and Deca Durabolin share almost none of that. They operate through different mechanisms, belong to different structural families, serve different phases of training, and carry side effect profiles that require different management strategies. What they...</p>
<p>The post <a href="https://gymtrix.net/anavar-vs-deca-durabolin/">Anavar vs Deca Durabolin: Dry Cutting vs Joint-Friendly Bulking</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Most steroid comparisons involve compounds that at least share some philosophical overlap similar goals, similar risk categories, similar users. Anavar and Deca Durabolin share almost none of that. They operate through different mechanisms, belong to different structural families, serve different phases of training, and carry side effect profiles that require different management strategies. </p>



<p class="wp-block-paragraph">What they do share is a reputation for being among the more tolerable compounds in their respective categories Anavar as the gentlest oral anabolic for cutting, Deca Durabolin as the most joint-friendly mass builder among injectables.</p>



<p class="wp-block-paragraph">That shared quality of relative tolerability has made them a popular pairing in more experienced bodybuilding cycles. </p>



<p class="wp-block-paragraph">When used sequentially Deca building the dense, joint-supported mass foundation, Anavar refining and hardening the physique in the cutting phase that follows they address opposite ends of a complete training year with compounds that are each doing exactly what they were designed to do. </p>



<p class="wp-block-paragraph">When used simultaneously at the right doses, they can deliver simultaneous recomposition benefits that neither achieves as efficiently alone.</p>



<p class="wp-block-paragraph">Getting this comparison right requires understanding both compounds on their own terms before discussing how they interact.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="819" src="http://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg" alt="man in black shorts and black tank top doing push up" class="wp-image-2993" srcset="https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-300x240.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-768x614.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu.jpg 1500w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Oral Precision vs Injectable Foundation</strong></h2>



<p class="wp-block-paragraph">Anavar (Oxandrolone) was engineered for therapeutic safety alongside anabolic efficacy. Its original clinical applications muscle wasting treatment, recovery from burns and surgery, bone density support shaped a compound with a high anabolic-to-androgenic ratio, zero estrogenic activity, and the mildest hepatotoxicity profile of any <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">C17-alpha alkylated oral steroid</a> in common use. </p>



<p class="wp-block-paragraph">In bodybuilding, these properties make it the most accessible oral anabolic for cutting purposes reliable lean tissue preservation, polished dry definition, and beginner-appropriate safety margins that no other compound in the oral class can claim with equal confidence.</p>



<p class="wp-block-paragraph">Deca Durabolin (Nandrolone Decanoate) is a 19-nor testosterone derivative a structural modification that removes the carbon atom at the 19th position of the steroid nucleus, producing a compound with profoundly different tissue interactions than testosterone-based steroids. </p>



<p class="wp-block-paragraph">It aromatizes mildly, promotes collagen synthesis and synovial fluid production in a way that is clinically unique among anabolic steroids, and builds dense and durable muscle mass through sustained nitrogen retention and IGF-1 elevation. </p>



<p class="wp-block-paragraph">Its results come slowly compared to <a href="https://gymtrix.net/dianabol-vs-anadrol/">Dianabol or Anadrol</a>, but they are considerably more keepable post-cycle because the gains reflect genuine muscle tissue rather than a glycogen and water component that clears when estrogenic drive diminishes.</p>



<p class="wp-block-paragraph">These are not two approaches to the same destination. They are purpose-built tools for opposite phases of training, and the clarity of that distinction should govern every decision about how and when to use them.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Anavar for Cutting</strong></h2>



<h3 class="wp-block-heading"><strong>Lean Tissue Preservation</strong></h3>



<p class="wp-block-paragraph">The mechanism that makes Anavar indispensable in a cutting context is nitrogen retention under catabolic conditions. Significant caloric restriction creates a physiological environment where muscle protein catabolism accelerates alongside the fat catabolism the deficit is designed to produce and without anabolic support, meaningful lean mass is lost during the process of getting lean. </p>



<p class="wp-block-paragraph">Anavar directly counteracts this by maintaining elevated protein synthesis and positive nitrogen balance even in a deficit, preserving the muscle built during previous phases so that the physique arriving at the end of a cut reflects the work done rather than a compromised version of it.</p>



<p class="wp-block-paragraph">The lean tissue preserved on Anavar is durable and genuine. It does not represent glycogen supercompensation or estrogenic intracellular water it is actual contractile muscle fiber that holds post-cycle and contributes to the aesthetic result of the cut and the anabolic capacity of whatever training phase follows.</p>



<h3 class="wp-block-heading"><strong>Polished Dry Definition</strong></h3>



<p class="wp-block-paragraph">Without aromatization, without subcutaneous water retention, and without the harsh joint-drying androgenic activity of DHT-derivative compounds at high doses, Anavar allows existing muscle definition to express progressively and cleanly as body fat decreases. </p>



<p class="wp-block-paragraph">Muscle separations sharpen, vascularity increases as fluid thins, and the overall density of the physique reads as developed and athletic rather than simply reduced in size. This refined visual quality suits first competitive prep, photoshoot preparation, and the finishing phase of any cycle where the goal is looking as lean and defined as the nutrition has made possible.</p>



<h3 class="wp-block-heading"><strong>Beginner-Friendly Strength</strong></h3>



<p class="wp-block-paragraph">Strength on Anavar builds steadily rather than explosively an improvement in training quality and recovery capacity that keeps performance meaningfully above drug-free levels through caloric restriction, without the androgenic aggression and psychological intensity that more potent compounds introduce. </p>



<p class="wp-block-paragraph">For beginners establishing their first experience with anabolic compounds, this predictable and manageable delivery is the most appropriate entry point available in the oral steroid class.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anvarol Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800&#038;family=Barlow:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #d5d8db;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 8px 44px rgba(0,0,0,0.42);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.52);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #090c10;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — teal/cyan/green for Anvarol cutting theme */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }
  @keyframes sweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* Background FX */
  .bg-fx {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background:
      radial-gradient(ellipse 55% 80% at 88% 50%, rgba(0,200,150,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 35% 60% at 10% 50%, rgba(0,180,130,0.07) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 17px,
        rgba(255,255,255,0.012) 17px, rgba(255,255,255,0.012) 18px);
  }
  .slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      transparent 0%, transparent 40%,
      rgba(0,180,130,0.08) 40%, rgba(0,220,160,0.04) 100%
    );
  }

  /* Gold accent line — from bottle cap */
  .gold-line {
    position: absolute;
    top: 4px; left: 0; right: 0;
    height: 1px;
    background: linear-gradient(90deg, transparent, rgba(212,168,0,0.25), transparent);
    z-index: 1;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 2;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 112px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 18px rgba(0,200,140,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
    transform: rotate(-4deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.12);
    filter:
      drop-shadow(0 0 26px rgba(0,230,160,0.7))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
  }
  .img-badge {
    position: absolute; top: -5px; right: -5px; z-index: 3;
    background: linear-gradient(135deg, #007a5e, #00c896);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 7px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,180,120,0.6);
    white-space: nowrap;
  }
  /* Gold cap glow hint */
  .cap-glow {
    position: absolute;
    top: 0; left: 50%;
    transform: translateX(-50%);
    width: 70px; height: 20px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.25) 0%, transparent 70%);
    pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }
  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3px;
    text-transform: uppercase; color: #00c896; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.9; letter-spacing: 1.5px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,200,140,0.35);
  }
  .headline em { color: #00e0a0; font-style: normal; }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.53);
    line-height: 1.5; margin-bottom: 10px; max-width: 310px;
  }
  .sub strong { color: rgba(255,255,255,0.75); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,180,130,0.1);
    border: 1px solid rgba(0,200,140,0.28);
    color: #00d4a0;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #00c896; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,200,140,0.3), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 48px; line-height: 1; color: #fff; letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(0,220,160,0.6); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #006644 0%, #00a873 50%, #00d4a0 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 13px; letter-spacing: 1.8px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,180,120,0.5);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.22), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,200,140,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.24);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 2;
    display: flex; align-items: stretch;
    background: rgba(0,180,130,0.07);
    border-top: 1px solid rgba(0,200,140,0.14);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,200,140,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,200,140,0.06); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.1px;
    text-transform: uppercase; color: rgba(255,255,255,0.36);
  }

  /* ── USE FOR STRIP ── */
  .use-strip {
    position: relative; z-index: 2;
    display: flex; align-items: center; justify-content: center;
    background: rgba(0,0,0,0.2);
    border-top: 1px solid rgba(255,255,255,0.04);
    gap: 0;
    overflow: hidden;
  }
  .us-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 2px;
    text-transform: uppercase; color: #00c896;
    padding: 6px 12px;
    border-right: 1px solid rgba(0,200,140,0.15);
    white-space: nowrap;
    flex-shrink: 0;
  }
  .us-items {
    display: flex; flex: 1; align-items: center;
    flex-wrap: wrap;
  }
  .us-item {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
    padding: 6px 10px;
    border-right: 1px solid rgba(255,255,255,0.05);
    display: flex; align-items: center; gap: 5px;
  }
  .us-item:last-child { border-right: none; }
  .us-dot { width: 3px; height: 3px; border-radius: 50%; background: #00c896; opacity: 0.5; }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .us-item { padding: 5px 7px; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .us-items { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/MND7Z/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>
      <div class="gold-line"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Cutting</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anvarol — Legal Anavar Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anavar Alternative</div>
          <div class="headline">
            <em>Anvarol</em><br>
            Shred &amp; Define
          </div>
          <p class="sub">Incinerate fat, preserve lean muscle &amp; boost <strong>explosive power</strong> — no water retention, no needles, rapid results in 30 days.</p>
          <div class="tags">
            <span class="tag">Fast Fat Loss</span>
            <span class="tag">Lean Muscle</span>
            <span class="tag">Explosive Power</span>
            <span class="tag">Men &amp; Women</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label">Single Bottle</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">Bulk 3-pack only $129.98</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back Guarantee</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Visceral Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Muscle Hardness</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Energy</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4a7.png" alt="💧" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Zero Water Retention</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Use for / stack strip -->
      <div class="use-strip">
        <div class="us-label">Use For:</div>
        <div class="us-items">
          <div class="us-item"><span class="us-dot"></span>Cutting Cycles</div>
          <div class="us-item"><span class="us-dot"></span>Enhanced Vascularity</div>
          <div class="us-item"><span class="us-dot"></span>Post-Workout Recovery</div>
          <div class="us-item"><span class="us-dot"></span>509,389 Bottles Sold</div>
        </div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Deca Durabolin for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Thick Muscle Hypertrophy</strong></h3>



<p class="wp-block-paragraph">Nandrolone Decanoate builds mass differently from testosterone-based anabolic steroids. Its mild estrogenic activity less than testosterone at equivalent doses limits the excessive water retention associated with heavily aromatizing compounds while still supporting the positive nitrogen balance and cellular volumization that genuine hypertrophy requires. </p>



<p class="wp-block-paragraph">The <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303131/">collagen synthesis enhancement</a> that Nandrolone drives adds a structural quality to the muscle tissue being built tendons and connective tissue strengthen alongside the muscle, which is why Deca-built mass has a reputation for staying power that rapid wet-bulk gains from Dianabol or Anadrol do not match. What accumulates slowly accumulates with integrity.</p>



<h3 class="wp-block-heading"><strong>Joint Lubrication Therapy</strong></h3>



<p class="wp-block-paragraph">This is the property that makes Deca Durabolin genuinely unique in the anabolic steroid class. The increase in synovial fluid production that Nandrolone drives the lubricating fluid within joint capsules is measurable and clinically relevant for athletes with accumulated joint stress from years of heavy training. </p>



<p class="wp-block-paragraph">Deca at doses as low as 200mg per week provides enough synovial support to meaningfully reduce or eliminate chronic joint pain in many users, and this therapeutic joint benefit continues throughout the cycle duration rather than fading with receptor adaptation. </p>



<p class="wp-block-paragraph">For athletes who have accumulated the kind of shoulder, knee, and hip wear that extended heavy compound training produces, low-dose Deca as a joint maintenance protocol has legitimate utility beyond pure mass building.</p>



<h3 class="wp-block-heading"><strong>Steady Power Progression</strong></h3>



<p class="wp-block-paragraph">Unlike compounds that deliver rapid front-loaded strength surges followed by plateaus, Deca Durabolin&#8217;s strength increases come progressively and consistently across the full cycle length. The long decanoate ester which produces a 15-day half-life and gradual release profile means blood concentrations rise slowly to a stable plateau rather than spiking and fluctuating. </p>



<p class="wp-block-paragraph">Strength improvements tend to be linear across weeks 4 through 16, which is when the compound is expressing its full potential, and recovery capacity between heavy training sessions improves in tandem. </p>



<p class="wp-block-paragraph">This progressive quality makes Deca the most appropriate injectable for athletes pursuing sustainable progressive overload rather than the rapid peak-and-crash pattern that shorter ester compounds can produce.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Deca-Max Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(0,100,200,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(0,140,255,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #060810;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — steel blue/cyan */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #080a14 0%, #080a14 36%,
      #001428 36%, #001e3a 54%,
      #060810 54%, #060810 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(0,100,220,0.16) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(0,60,140,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(0,100,220,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(0,120,255,0.62))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(0,160,255,0.80))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #003399, #0066dd);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,80,200,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.3) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #0088ff; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,100,220,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #3399ff; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,80,180,0.10);
    border: 1px solid rgba(0,120,230,0.28);
    color: #66bbff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #0088ff; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,120,220,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #66bbff; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(0,100,220,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(100,180,255,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #002299 0%, #0055cc 45%, #0088ff 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(0,80,200,0.52), 0 0 0 1px rgba(0,130,255,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,120,255,0.7), 0 0 0 1px rgba(0,160,255,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(0,60,150,0.08);
    border-top: 1px solid rgba(0,100,200,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,80,180,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,80,170,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #0088ff; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/SMZ9S/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Deca</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Deca-Max — Legal Deca Steroid Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Deca Steroid Alternative</div>
          <div class="headline">
            <small>Mega Strength, Endurance &amp; Gains</small>
            <em>Deca-Max</em>
          </div>
          <p class="sub"><strong>Advanced anabolic formula</strong> — maximises nitrogen retention &amp; red blood cells for <strong>huge muscle gains</strong>. Even soothes joint pain. Bulk or cut.</p>
          <div class="tags">
            <span class="tag">Huge Muscle</span>
            <span class="tag">Extreme Strength</span>
            <span class="tag">Joint Relief</span>
            <span class="tag">Fast Recovery</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 47 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Huge Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9b4.png" alt="🦴" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Joint Relief</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects: Where Each Compound Concentrates Its Risk</strong></h2>



<h3 class="wp-block-heading"><strong>Anavar Side Effects</strong></h3>



<p class="wp-block-paragraph">Anavar&#8217;s hepatotoxicity from C17-alpha alkylation is genuine but represents the mildest end of what oral anabolic steroids produce at standard doses. ALT and AST elevation is dose-dependent, present but manageable at 20 to 60mg per day, and normalizes reliably post-cycle with TUDCA at 500mg per day used throughout. </p>



<p class="wp-block-paragraph">The six to eight-week continuous use ceiling reflects the practical point where hepatic accumulation becomes meaningful without proportional additional benefit. Cholesterol disruption HDL suppression of 20 to 30 percent with mild LDL elevation is the more consequential long-term cardiovascular concern, and regular lipid monitoring allows early identification of values that warrant intervention. </p>



<p class="wp-block-paragraph">HPTA suppression is mild relative to injectable compounds and testosterone-based steroids, making PCT a lighter commitment than most alternatives in the class.</p>



<h3 class="wp-block-heading"><strong>Deca Durabolin Side Effects</strong></h3>



<p class="wp-block-paragraph">Deca Durabolin&#8217;s most distinctive side effect is the prolactin elevation that earned the compound its most notorious colloquial reputation. Nandrolone converts not to DHT but to dihydronandrolone a metabolite with far lower androgenic activity at tissues responsible for libido and erectile function while simultaneously elevating prolactin through progestogenic receptor interaction. </p>



<p class="wp-block-paragraph">The resulting hormonal imbalance creates the erectile dysfunction and libido suppression collectively known as Deca Dick, which can be severe if not proactively managed. Cabergoline at 0.25mg twice weekly throughout the cycle is the appropriate preventive approach a dopamine agonist that reduces prolactin directly, addressing the mechanism rather than the downstream consequence.</p>



<p class="wp-block-paragraph">HPTA suppression with Deca is among the most severe and most prolonged of any commonly used anabolic compound. </p>



<p class="wp-block-paragraph">The decanoate ester&#8217;s long clearance time potentially 12 to 18 months for complete metabolic elimination at standard doses means that PCT cannot begin immediately after the last injection and requires careful timing to ensure Nandrolone has cleared sufficiently before SERM-based hormonal restart is initiated. </p>



<p class="wp-block-paragraph">This prolonged clearance is the single most practically demanding aspect of Deca cycle management and the primary reason the PCT protocol for Nandrolone-containing cycles is more complex than most.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/lnlliopmy2e-1024x683.jpg" alt="topless man facing sea horizon" class="wp-image-3002" srcset="https://gymtrix.net/wp-content/uploads/2026/03/lnlliopmy2e-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/lnlliopmy2e-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/lnlliopmy2e-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/lnlliopmy2e-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/lnlliopmy2e.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Anavar</th><th>Deca Durabolin</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Low-Moderate — manageable ALT/AST</td><td>None — injectable</td></tr><tr><td><strong>Prolactin Risk</strong></td><td>None</td><td>Significant — Cabergoline essential</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>None</td><td>Mild — modest water retention</td></tr><tr><td><strong>Joint Impact</strong></td><td>Neutral — mild dryness at high doses</td><td>Therapeutic — synovial fluid increase</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Mild to Moderate</td><td>Severe — very long clearance time</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Moderate — 20–30%</td><td>Moderate</td></tr><tr><td><strong>Sexual Function Risk</strong></td><td>Minimal</td><td>Significant without Cabergoline</td></tr><tr><td><strong>Female Suitability</strong></td><td>Excellent at 5–20mg/day</td><td>No — virilization and hormonal risk</td></tr><tr><td><strong>Cycle Length</strong></td><td>6–8 weeks maximum</td><td>10–16 weeks typical</td></tr><tr><td><strong>PCT Complexity</strong></td><td>Light — short SERM taper</td><td>Extended — HCG bridge + full SERM protocol</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Protocols: Sequential and Simultaneous Applications</strong></h2>



<p class="wp-block-paragraph">The pairing of Anavar and Deca Durabolin is most coherent when understood as a cycle architecture decision rather than a compound combination decision. Their mechanisms do not overlap Anavar works through oral androgenic activity with lean preservation emphasis, Deca through injectable nandrolone with collagen synthesis and mass emphasis. </p>



<p class="wp-block-paragraph">The non-negotiable structural requirement is a testosterone base alongside any Deca-containing cycle. Running Nandrolone without exogenous testosterone creates a hormonal environment where HPTA suppression eliminates natural testosterone production without replacing it, producing the low-androgen, high-prolactin state that drives Deca Dick and general wellbeing deterioration that is entirely avoidable with testosterone at minimum TRT-replacement doses.</p>



<h3 class="wp-block-heading"><strong>Bulk-to-Cut Transition Stack</strong></h3>



<p class="wp-block-paragraph">The most complete approach uses Deca Durabolin at 400mg per week alongside Testosterone Enanthate at 400 to 500mg per week across a 12-week mass phase, then introduces Anavar at 40mg per day in weeks 9 through 14 as the physique transitions toward definition. </p>



<p class="wp-block-paragraph">The logic is sequential: Deca builds the dense mass foundation with joint support throughout the bulk, and Anavar enters as the cycle winds toward conclusion to harden the physique, reduce water retention from the modest estrogenic activity of the Deca phase, and arrive at the end with size and definition simultaneously expressed. </p>



<p class="wp-block-paragraph">Cabergoline at 0.25mg twice weekly runs throughout the Deca phase to prevent prolactin-driven dysfunction.</p>



<h3 class="wp-block-heading"><strong>Joint-Safe Recomposition Stack</strong></h3>



<p class="wp-block-paragraph">For athletes managing chronic joint issues who want simultaneous fat loss and lean mass improvement, Deca Durabolin at 200mg per week low enough to limit estrogenic water retention while delivering full joint-therapeutic benefit alongside Anavar at 30mg per day and Testosterone Propionate at 100mg every other day as the hormonal base, creates an 8-week recomposition protocol that serves both goals. </p>



<p class="wp-block-paragraph">The Deca&#8217;s synovial support counteracts the mild joint dryness that Anavar can produce at higher doses in some users, and the combination of Anavar&#8217;s lean preservation with Deca&#8217;s mild anabolic drive produces genuine simultaneous fat loss and lean mass improvement. </p>



<p class="wp-block-paragraph">The shorter Testosterone Propionate ester allows faster adjustment if side effects require dose modification, which suits the more conservative simultaneous stack structure.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Anavar</th><th>Deca Durabolin</th></tr></thead><tbody><tr><td><strong>Dose Range</strong></td><td>20–60mg/day oral (6–8 weeks)</td><td>300–600mg/week injectable (10–16 weeks)</td></tr><tr><td><strong>Primary Goal</strong></td><td>Cutting, recomposition, lean preservation</td><td>Bulking, joint repair, mass accumulation</td></tr><tr><td><strong>Muscle Quality</strong></td><td>Dry, dense, high post-cycle retention</td><td>Thick, dense — durable and keepable</td></tr><tr><td><strong>Joint Impact</strong></td><td>Neutral to mildly dry at high doses</td><td>Therapeutic — significant synovial support</td></tr><tr><td><strong>Estrogenic Activity</strong></td><td>None</td><td>Mild — AI rarely needed at standard doses</td></tr><tr><td><strong>Onset of Effect</strong></td><td>7–14 days</td><td>4–6 weeks to stable blood levels</td></tr><tr><td><strong>Female Appropriate</strong></td><td>Yes at 5–20mg/day</td><td>No</td></tr><tr><td><strong>Prolactin Management</strong></td><td>Not required</td><td>Cabergoline 0.25mg twice weekly</td></tr><tr><td><strong>PCT Complexity</strong></td><td>Light — 2–4 week SERM taper</td><td>Extended — HCG bridge + 4–6 week SERM protocol</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Support and Post-Cycle Therapy</strong></h2>



<h3 class="wp-block-heading"><strong>On-Cycle Support</strong></h3>



<p class="wp-block-paragraph">TUDCA at 500mg per day throughout the Anavar phase is the hepatic support requirement Deca requires no liver protection given its injectable nature and absence of C17-alpha alkylation.</p>



<p class="wp-block-paragraph">Cabergoline at 0.25mg twice weekly is essential throughout any phase where Nandrolone is active, and should continue into the early PCT period until prolactin normalization is confirmed by bloodwork. </p>



<p class="wp-block-paragraph">Fish oil at 4g per day supports the lipid parameters both compounds modestly affect. Zinc at 50mg per day provides cofactor support for testosterone synthesis throughout the cycle and into recovery.</p>



<h3 class="wp-block-heading"><strong>PCT Protocol</strong></h3>



<p class="wp-block-paragraph">The PCT following a Deca-containing cycle is more demanding than most because of Nandrolone&#8217;s extended clearance time and severe HPTA suppression. Beginning PCT three to four weeks after the last Deca Durabolin injection once blood concentrations have fallen sufficiently is standard practice. </p>



<p class="wp-block-paragraph">Running PCT while Deca is still active in the bloodstream produces incomplete hormonal recovery because the suppressive signal continues even as the SERM attempts to restart LH and FSH production.</p>



<p class="wp-block-paragraph"><strong>Days 1 to 10 — HCG Bridge</strong> HCG at 1,000iu every other day to restore testicular responsiveness during the Nandrolone clearance window. Cabergoline at 0.25mg twice weekly continuing from the cycle to normalize prolactin before the SERM phase begins.</p>



<p class="wp-block-paragraph"><strong>Weeks 2 to 6 — SERM Taper</strong> Clomid at 50mg per day through weeks 2 and 3, dropping to 25mg per day through weeks 4 and 5. Nolvadex at 40mg per day through weeks 2 and 3, dropping to 20mg per day through weeks 4 and 5. Fish oil continuing at 4g per day. Zinc at 50mg per day.</p>



<p class="wp-block-paragraph">Bloodwork at six to eight weeks post-PCT total testosterone, free testosterone, LH, FSH, prolactin, and a full lipid panel is the only reliable confirmation that the hormonal axis has restarted adequately, that prolactin has normalized, and that lipid values are trending toward pre-cycle baseline.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>PCT and Support Protocol Reference Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Phase</th><th>Protocol</th><th>Duration</th><th>Purpose</th></tr></thead><tbody><tr><td><strong>On-Cycle — Anavar Phase</strong></td><td>TUDCA 500mg/day</td><td>Anavar weeks only</td><td>Hepatoprotection</td></tr><tr><td><strong>On-Cycle — Deca Phase</strong></td><td>Cabergoline 0.25mg 2x/week</td><td>Full Deca duration + early PCT</td><td>Prolactin control</td></tr><tr><td><strong>Lipid and General Support</strong></td><td>Fish Oil 4g/day + Zinc 50mg/day</td><td>Full cycle + PCT</td><td>Cardiovascular and enzyme support</td></tr><tr><td><strong>HCG Bridge</strong></td><td>HCG 1,000iu EOD</td><td>Days 1–10 post-Deca clearance</td><td>Testicular responsiveness</td></tr><tr><td><strong>PCT SERM — Weeks 1–2</strong></td><td>Clomid 50mg + Nolvadex 40mg daily</td><td>Weeks 2–3</td><td>Aggressive HPTA restart</td></tr><tr><td><strong>PCT SERM — Taper</strong></td><td>Clomid 25mg + Nolvadex 20mg daily</td><td>Weeks 4–5</td><td>Hormonal normalization</td></tr><tr><td><strong>Bloodwork Confirmation</strong></td><td>Full hormone + prolactin + lipid panel</td><td>6–8 weeks post-PCT</td><td>Recovery verification</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Legal Status of Anavar and Deca Durabolin</strong></h2>



<p class="wp-block-paragraph">Both Anavar and Deca Durabolin are Schedule III controlled substances under the United States Controlled Substances Act, subject to identical DEA enforcement frameworks. Anavar has approved medical indications muscle wasting treatment, burn recovery, osteoporosis for which it is occasionally prescribed in clinical practice. </p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anvarol Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800&#038;family=Barlow:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #d5d8db;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 8px 44px rgba(0,0,0,0.42);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.52);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #090c10;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — teal/cyan/green for Anvarol cutting theme */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }
  @keyframes sweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* Background FX */
  .bg-fx {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background:
      radial-gradient(ellipse 55% 80% at 88% 50%, rgba(0,200,150,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 35% 60% at 10% 50%, rgba(0,180,130,0.07) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 17px,
        rgba(255,255,255,0.012) 17px, rgba(255,255,255,0.012) 18px);
  }
  .slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      transparent 0%, transparent 40%,
      rgba(0,180,130,0.08) 40%, rgba(0,220,160,0.04) 100%
    );
  }

  /* Gold accent line — from bottle cap */
  .gold-line {
    position: absolute;
    top: 4px; left: 0; right: 0;
    height: 1px;
    background: linear-gradient(90deg, transparent, rgba(212,168,0,0.25), transparent);
    z-index: 1;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 2;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 112px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 18px rgba(0,200,140,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
    transform: rotate(-4deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.12);
    filter:
      drop-shadow(0 0 26px rgba(0,230,160,0.7))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
  }
  .img-badge {
    position: absolute; top: -5px; right: -5px; z-index: 3;
    background: linear-gradient(135deg, #007a5e, #00c896);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 7px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,180,120,0.6);
    white-space: nowrap;
  }
  /* Gold cap glow hint */
  .cap-glow {
    position: absolute;
    top: 0; left: 50%;
    transform: translateX(-50%);
    width: 70px; height: 20px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.25) 0%, transparent 70%);
    pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }
  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3px;
    text-transform: uppercase; color: #00c896; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.9; letter-spacing: 1.5px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,200,140,0.35);
  }
  .headline em { color: #00e0a0; font-style: normal; }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.53);
    line-height: 1.5; margin-bottom: 10px; max-width: 310px;
  }
  .sub strong { color: rgba(255,255,255,0.75); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,180,130,0.1);
    border: 1px solid rgba(0,200,140,0.28);
    color: #00d4a0;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #00c896; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,200,140,0.3), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 48px; line-height: 1; color: #fff; letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(0,220,160,0.6); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #006644 0%, #00a873 50%, #00d4a0 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 13px; letter-spacing: 1.8px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,180,120,0.5);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.22), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,200,140,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.24);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 2;
    display: flex; align-items: stretch;
    background: rgba(0,180,130,0.07);
    border-top: 1px solid rgba(0,200,140,0.14);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,200,140,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,200,140,0.06); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.1px;
    text-transform: uppercase; color: rgba(255,255,255,0.36);
  }

  /* ── USE FOR STRIP ── */
  .use-strip {
    position: relative; z-index: 2;
    display: flex; align-items: center; justify-content: center;
    background: rgba(0,0,0,0.2);
    border-top: 1px solid rgba(255,255,255,0.04);
    gap: 0;
    overflow: hidden;
  }
  .us-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 2px;
    text-transform: uppercase; color: #00c896;
    padding: 6px 12px;
    border-right: 1px solid rgba(0,200,140,0.15);
    white-space: nowrap;
    flex-shrink: 0;
  }
  .us-items {
    display: flex; flex: 1; align-items: center;
    flex-wrap: wrap;
  }
  .us-item {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
    padding: 6px 10px;
    border-right: 1px solid rgba(255,255,255,0.05);
    display: flex; align-items: center; gap: 5px;
  }
  .us-item:last-child { border-right: none; }
  .us-dot { width: 3px; height: 3px; border-radius: 50%; background: #00c896; opacity: 0.5; }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .us-item { padding: 5px 7px; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .us-items { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/MND7Z/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>
      <div class="gold-line"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Cutting</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anvarol — Legal Anavar Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anavar Alternative</div>
          <div class="headline">
            <em>Anvarol</em><br>
            Shred &amp; Define
          </div>
          <p class="sub">Incinerate fat, preserve lean muscle &amp; boost <strong>explosive power</strong> — no water retention, no needles, rapid results in 30 days.</p>
          <div class="tags">
            <span class="tag">Fast Fat Loss</span>
            <span class="tag">Lean Muscle</span>
            <span class="tag">Explosive Power</span>
            <span class="tag">Men &amp; Women</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label">Single Bottle</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">Bulk 3-pack only $129.98</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back Guarantee</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Visceral Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Muscle Hardness</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Energy</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4a7.png" alt="💧" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Zero Water Retention</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Use for / stack strip -->
      <div class="use-strip">
        <div class="us-label">Use For:</div>
        <div class="us-items">
          <div class="us-item"><span class="us-dot"></span>Cutting Cycles</div>
          <div class="us-item"><span class="us-dot"></span>Enhanced Vascularity</div>
          <div class="us-item"><span class="us-dot"></span>Post-Workout Recovery</div>
          <div class="us-item"><span class="us-dot"></span>509,389 Bottles Sold</div>
        </div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">Deca Durabolin similarly has medical applications including anemia treatment and osteoporosis management. Possession of either compound without a valid prescription for an approved medical indication constitutes a federal offense, and distribution carries sentences of 5 to 40 years depending on quantity and circumstances.</p>



<p class="wp-block-paragraph">Both compounds are prohibited by the <a href="https://www.wada-ama.org/en/prohibited-list">World Anti-Doping Agency</a> across all competitive sport categories. Nandrolone&#8217;s particularly long detection window metabolites remain detectable in urine testing for 12 to 18 months after the last dose at standard bodybuilding doses makes it an extreme risk for any athlete competing in tested sport regardless of how the cycle is managed. </p>



<p class="wp-block-paragraph">This detection characteristic is not theoretical; it has ended the careers of numerous competitive athletes who underestimated the clearance timeline.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Deca-Max Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(0,100,200,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(0,140,255,0.35);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #060810;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — steel blue/cyan */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #080a14 0%, #080a14 36%,
      #001428 36%, #001e3a 54%,
      #060810 54%, #060810 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(0,100,220,0.16) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(0,60,140,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(0,100,220,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(0,120,255,0.62))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(0,160,255,0.80))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #003399, #0066dd);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,80,200,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.3) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #0088ff; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,100,220,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #3399ff; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,80,180,0.10);
    border: 1px solid rgba(0,120,230,0.28);
    color: #66bbff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #0088ff; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,120,220,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #66bbff; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(0,100,220,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(100,180,255,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #002299 0%, #0055cc 45%, #0088ff 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(0,80,200,0.52), 0 0 0 1px rgba(0,130,255,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,120,255,0.7), 0 0 0 1px rgba(0,160,255,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(0,60,150,0.08);
    border-top: 1px solid rgba(0,100,200,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,80,180,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,80,170,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #0088ff; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #002266, #0044bb, #0088ff, #00ccff, #0088ff, #0044bb, #002266);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/SMZ9S/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Deca</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Deca-Max — Legal Deca Steroid Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Deca Steroid Alternative</div>
          <div class="headline">
            <small>Mega Strength, Endurance &amp; Gains</small>
            <em>Deca-Max</em>
          </div>
          <p class="sub"><strong>Advanced anabolic formula</strong> — maximises nitrogen retention &amp; red blood cells for <strong>huge muscle gains</strong>. Even soothes joint pain. Bulk or cut.</p>
          <div class="tags">
            <span class="tag">Huge Muscle</span>
            <span class="tag">Extreme Strength</span>
            <span class="tag">Joint Relief</span>
            <span class="tag">Fast Recovery</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 47 Reviews</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Huge Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f9b4.png" alt="🦴" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Joint Relief</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>30 Days</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Conclusion: Sequential Logic and Phase-Appropriate Application</strong></h2>



<p class="wp-block-paragraph">The principle that governs this comparison resolves cleanly once both compounds are understood in the context of what each training phase requires.</p>



<p class="wp-block-paragraph">Deca Durabolin belongs in the mass phase run always alongside a testosterone base, across 10 to 16 weeks, building the dense and joint-supported foundation that makes a physique both impressive and structurally resilient. </p>



<p class="wp-block-paragraph">It is for intermediate to advanced athletes who understand prolactin management, accept the extended clearance time and its PCT implications, and are pursuing genuine mass accumulation rather than modest lean gains that a milder compound could deliver.</p>



<p class="wp-block-paragraph">Anavar belongs in the cutting phase as a finishing compound on top of the mass that Deca built, or as a standalone cutting tool for beginners and women for whom the complexity and risk of injectable compounds is not appropriate at their current stage of experience. Its oral convenience, minimal PCT requirement, and beginner-appropriate safety profile make it the most accessible anabolic cutting compound available.</p>



<p class="wp-block-paragraph">The sequential architecture Deca Durabolin building the mass foundation, Anavar hardening and defining what was built is not just logical in theory. It is the approach that uses each compound in the phase where its pharmacological character is an asset rather than a complication. Never run Deca without testosterone. </p>



<p class="wp-block-paragraph">Never skip Cabergoline on a Nandrolone cycle. Complete bloodwork before every cycle and at every post-PCT checkpoint. The compounds are capable of producing outstanding results when managed correctly. The management is not optional.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/anavar-vs-deca-durabolin/">Anavar vs Deca Durabolin: Dry Cutting vs Joint-Friendly Bulking</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Anavar vs Anadrol: Mild Cutting vs Extreme Bulking Power Clash</title>
		<link>https://gymtrix.net/anavar-vs-anadrol/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 05:54:24 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3066</guid>

					<description><![CDATA[<p>There are steroid comparisons where the choice requires genuine nuance where experience level, goals, and individual physiology make either option defensible. Anavar versus Anadrol is not that kind of comparison. These two compounds are pharmacological opposites in almost every meaningful respect, and the decision between them is less a judgment call than a function of...</p>
<p>The post <a href="https://gymtrix.net/anavar-vs-anadrol/">Anavar vs Anadrol: Mild Cutting vs Extreme Bulking Power Clash</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">There are steroid comparisons where the choice requires genuine nuance where experience level, goals, and individual physiology make either option defensible. Anavar versus Anadrol is not that kind of comparison. These two compounds are pharmacological opposites in almost every meaningful respect, and the decision between them is less a judgment call than a function of asking one honest question: what phase of training are you in?</p>



<p class="wp-block-paragraph">Anavar (Oxandrolone) is precision work. It preserves lean tissue in a caloric deficit, produces polished dry definition without harsh systemic cost, and carries the most manageable safety profile of any C17-alpha alkylated oral anabolic steroid in common use. It is appropriate for beginners, appropriate for women at low doses, and appropriate for anyone whose goal is sustainable body recomposition rather than maximum mass accumulation.</p>



<p class="wp-block-paragraph">Anadrol (Oxymetholone) is the opposite in practically every dimension. It is arguably the most powerful oral mass-building compound ever developed capable of producing 20 to 30 pounds of scale weight in four weeks, strength surges that dwarf what most other oral compounds deliver, and the most significant hepatotoxicity burden in its class. </p>



<p class="wp-block-paragraph">It is not appropriate for beginners, not appropriate for women, and not appropriate for anyone who approaches cycle planning without current bloodwork and a serious commitment to monitoring.</p>



<p class="wp-block-paragraph">The only thing these two compounds share in a meaningful sense is their oral C17-alpha alkylated structure and even that shared trait expresses itself at dramatically different levels of hepatic impact. This guide covers everything that separates them and the specific contexts in which each one serves its purpose.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1024x683.jpg" alt="a group of men standing next to each other on a stage" class="wp-image-3014" srcset="https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/04/unocpnm2rwy.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Precision Preservation vs Mass Explosion</strong></h2>



<p class="wp-block-paragraph">Anavar&#8217;s pharmaceutical origins reflect a compound designed for safety alongside efficacy. Originally developed to treat muscle wasting, recovery from severe burns, and bone density loss, <a href="https://pubchem.ncbi.nlm.nih.gov/compound/Oxandrolone">Oxandrolone</a> was engineered to preserve lean tissue in metabolically stressed patients precisely the physiological state that an aggressive caloric deficit creates in a bodybuilding context. </p>



<p class="wp-block-paragraph">The result is a compound that maintains nitrogen balance and protein synthesis under catabolic conditions, produces dry and durable muscle quality without estrogenic interference, and does so within a hepatotoxicity and suppression profile that is genuinely the mildest in its class.</p>



<p class="wp-block-paragraph">Anadrol&#8217;s design mandate was fundamentally different. Developed to treat severe anemia and conditions causing red blood cell deficiency, Oxymetholone was built to produce rapid and significant anabolic effects in patients who needed them urgently. </p>



<p class="wp-block-paragraph">What emerged from that mandate is a compound with mass-building capacity that has never been replicated by any other oral steroid driven by a combination of extreme glycogen supercompensation, direct estrogen receptor agonism despite not aromatizing, and red blood cell production elevation that amplifies both performance and recovery. The side effect burden it carries is the proportional cost of that capacity, and it is not small.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Anavar for Cutting</strong></h2>



<h3 class="wp-block-heading"><strong>Clean Muscle Retention</strong></h3>



<p class="wp-block-paragraph">The core value of Anavar in a cutting cycle is its ability to maintain a positive nitrogen balance in muscle tissue even when caloric intake is significantly reduced. When energy availability drops below maintenance, the body&#8217;s default response includes breaking down muscle protein for gluconeogenesis alongside the fat catabolism the deficit is designed to produce. </p>



<p class="wp-block-paragraph">Anavar directly counteracts this by sustaining the intramuscular anabolic signaling elevated protein synthesis, maintained nitrogen retention that tells the body lean tissue is worth preserving. </p>



<p class="wp-block-paragraph">The result is that muscle accumulated during a previous building phase survives a cut in a way that would not occur without pharmacological support, and the physique arriving at the end of the deficit reflects the work done rather than a compromised version of it.</p>



<p class="wp-block-paragraph">This lean tissue retention is genuine and durable. It does not represent glycogen or water that clears post-cycle it is actual muscle fiber that contributes to the aesthetic result of the cut and the anabolic capacity of whatever follows.</p>



<h3 class="wp-block-heading"><strong>Polished Dry Definition</strong></h3>



<p class="wp-block-paragraph">Anavar&#8217;s visual contribution to a cutting cycle is refinement. Without aromatization, without subcutaneous water retention, and without the harsh androgenic drying that compounds like Winstrol produce at the cost of joint discomfort, it allows existing muscle definition to express progressively as body fat decreases. </p>



<p class="wp-block-paragraph">Muscle group separations sharpen. Vascularity becomes more visible. The overall texture of the physique reads as dense and developed rather than simply reduced in volume. </p>



<p class="wp-block-paragraph">For first-cut cycles, for intermediate competitive prep, and for anyone whose goal is looking genuinely athletic rather than simply leaner, this reliable and photogenic quality is precisely what a cutting compound should deliver.</p>



<h3 class="wp-block-heading"><strong>Beginner Strength Gains</strong></h3>



<p class="wp-block-paragraph">Strength gains on Anavar are modest and steady rather than dramatic an improvement in training quality and session-to-session recovery that keeps performance meaningfully above where it would be drug-free through the same caloric restriction. </p>



<p class="wp-block-paragraph">The low androgenic profile delivers this without the psychological intensity, sleep disruption, and mood volatility that higher-androgenic compounds introduce. </p>



<p class="wp-block-paragraph">For beginners in particular, this manageable profile is a significant advantage the compound works reliably, the results are predictable, and the absence of harsh side effects allows focus on training and nutrition rather than constant side effect management.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anvarol Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800&#038;family=Barlow:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #d5d8db;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 8px 44px rgba(0,0,0,0.42);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.52);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #090c10;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — teal/cyan/green for Anvarol cutting theme */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }
  @keyframes sweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* Background FX */
  .bg-fx {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background:
      radial-gradient(ellipse 55% 80% at 88% 50%, rgba(0,200,150,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 35% 60% at 10% 50%, rgba(0,180,130,0.07) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 17px,
        rgba(255,255,255,0.012) 17px, rgba(255,255,255,0.012) 18px);
  }
  .slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      transparent 0%, transparent 40%,
      rgba(0,180,130,0.08) 40%, rgba(0,220,160,0.04) 100%
    );
  }

  /* Gold accent line — from bottle cap */
  .gold-line {
    position: absolute;
    top: 4px; left: 0; right: 0;
    height: 1px;
    background: linear-gradient(90deg, transparent, rgba(212,168,0,0.25), transparent);
    z-index: 1;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 2;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 112px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 18px rgba(0,200,140,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
    transform: rotate(-4deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.12);
    filter:
      drop-shadow(0 0 26px rgba(0,230,160,0.7))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
  }
  .img-badge {
    position: absolute; top: -5px; right: -5px; z-index: 3;
    background: linear-gradient(135deg, #007a5e, #00c896);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 7px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,180,120,0.6);
    white-space: nowrap;
  }
  /* Gold cap glow hint */
  .cap-glow {
    position: absolute;
    top: 0; left: 50%;
    transform: translateX(-50%);
    width: 70px; height: 20px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.25) 0%, transparent 70%);
    pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }
  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3px;
    text-transform: uppercase; color: #00c896; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.9; letter-spacing: 1.5px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,200,140,0.35);
  }
  .headline em { color: #00e0a0; font-style: normal; }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.53);
    line-height: 1.5; margin-bottom: 10px; max-width: 310px;
  }
  .sub strong { color: rgba(255,255,255,0.75); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,180,130,0.1);
    border: 1px solid rgba(0,200,140,0.28);
    color: #00d4a0;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #00c896; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,200,140,0.3), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 48px; line-height: 1; color: #fff; letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(0,220,160,0.6); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #006644 0%, #00a873 50%, #00d4a0 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 13px; letter-spacing: 1.8px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,180,120,0.5);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.22), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,200,140,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.24);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 2;
    display: flex; align-items: stretch;
    background: rgba(0,180,130,0.07);
    border-top: 1px solid rgba(0,200,140,0.14);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,200,140,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,200,140,0.06); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.1px;
    text-transform: uppercase; color: rgba(255,255,255,0.36);
  }

  /* ── USE FOR STRIP ── */
  .use-strip {
    position: relative; z-index: 2;
    display: flex; align-items: center; justify-content: center;
    background: rgba(0,0,0,0.2);
    border-top: 1px solid rgba(255,255,255,0.04);
    gap: 0;
    overflow: hidden;
  }
  .us-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 2px;
    text-transform: uppercase; color: #00c896;
    padding: 6px 12px;
    border-right: 1px solid rgba(0,200,140,0.15);
    white-space: nowrap;
    flex-shrink: 0;
  }
  .us-items {
    display: flex; flex: 1; align-items: center;
    flex-wrap: wrap;
  }
  .us-item {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
    padding: 6px 10px;
    border-right: 1px solid rgba(255,255,255,0.05);
    display: flex; align-items: center; gap: 5px;
  }
  .us-item:last-child { border-right: none; }
  .us-dot { width: 3px; height: 3px; border-radius: 50%; background: #00c896; opacity: 0.5; }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .us-item { padding: 5px 7px; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .us-items { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/MND7Z/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>
      <div class="gold-line"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Cutting</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anvarol — Legal Anavar Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anavar Alternative</div>
          <div class="headline">
            <em>Anvarol</em><br>
            Shred &amp; Define
          </div>
          <p class="sub">Incinerate fat, preserve lean muscle &amp; boost <strong>explosive power</strong> — no water retention, no needles, rapid results in 30 days.</p>
          <div class="tags">
            <span class="tag">Fast Fat Loss</span>
            <span class="tag">Lean Muscle</span>
            <span class="tag">Explosive Power</span>
            <span class="tag">Men &amp; Women</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label">Single Bottle</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">Bulk 3-pack only $129.98</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back Guarantee</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Visceral Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Muscle Hardness</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Energy</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4a7.png" alt="💧" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Zero Water Retention</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Use for / stack strip -->
      <div class="use-strip">
        <div class="us-label">Use For:</div>
        <div class="us-items">
          <div class="us-item"><span class="us-dot"></span>Cutting Cycles</div>
          <div class="us-item"><span class="us-dot"></span>Enhanced Vascularity</div>
          <div class="us-item"><span class="us-dot"></span>Post-Workout Recovery</div>
          <div class="us-item"><span class="us-dot"></span>509,389 Bottles Sold</div>
        </div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of Anadrol for Bulking</strong></h2>



<h3 class="wp-block-heading"><strong>Rapid Size Explosion</strong></h3>



<p class="wp-block-paragraph">Anadrol&#8217;s mass-building mechanism is unique in the oral steroid class. Unlike most anabolic steroids that produce their effects primarily through androgen receptor binding and downstream protein synthesis, Oxymetholone appears to act as a direct agonist at estrogen receptors despite not converting to estrogen through the aromatase pathway which is why aromatase inhibitors do not reliably manage its estrogenic effects. </p>



<p class="wp-block-paragraph">This direct estrogenic activity drives extreme glycogen supercompensation and cellular volumization that creates a degree of rapid size accumulation no other oral compound matches. </p>



<p class="wp-block-paragraph">Gains of 20 to 30 pounds in four weeks are consistent across user reports, though it is important to understand that this figure combines genuine lean tissue, glycogen, and significant water retention. The lean tissue component is real and meaningful. The water clears when the cycle ends.</p>



<h3 class="wp-block-heading"><strong>Unmatched Strength Surge</strong></h3>



<p class="wp-block-paragraph">The red blood cell production elevation that Anadrol drives the same mechanism behind its original pharmaceutical application for anemia treatment translates into enhanced oxygen delivery to working muscle tissue that produces strength increases of a magnitude that genuinely surprises first-time users. Personal records fall regularly in weeks 2 and 3. </p>



<p class="wp-block-paragraph">Compound lift numbers increase week over week with a consistency that other oral compounds do not sustain. For powerlifters, strongmen, and bodybuilders in a dedicated mass phase where maximum overload is the training priority, there is no oral compound that provides the strength platform Anadrol creates in its four-week effective window.</p>



<h3 class="wp-block-heading"><strong>Skin-Tearing Pumps</strong></h3>



<p class="wp-block-paragraph">The intramuscular pump that Anadrol produces during training is one of the most extreme in performance enhancement enhanced nitric oxide activity combined with the cellular volumization the compound drives creates vasodilation and muscle engorgement that some users describe as uncomfortably intense during high-volume work. </p>



<p class="wp-block-paragraph">For athletes using training intensity as a tool for hypertrophic stimulus, this quality supports both the psychological drive and the physiological conditions for maximal productive sessions. It is worth noting that at very high doses, the pump can become severe enough to limit range of motion a threshold that most users encounter around 100mg per day and that informs the dose ceiling recommendations.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anadrole Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(180,100,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(220,140,0,0.38);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #08070a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — amber/bronze/gold */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0c0a06 0%, #0c0a06 36%,
      #1a1000 36%, #241600 54%,
      #08070a 54%, #08070a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(200,120,0,0.15) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(140,80,0,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(200,130,0,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(220,140,0,0.60))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,180,0,0.78))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #7a3d00, #cc7700);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,90,0,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(255,200,0,0.32) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #e08000; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(200,120,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ffaa00; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(180,90,0,0.10);
    border: 1px solid rgba(220,130,0,0.28);
    color: #ffbb55;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #e08000; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(220,130,0,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #ffbb55; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(200,120,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,180,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #7a3d00 0%, #bb6600 45%, #ee9900 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,90,0,0.52), 0 0 0 1px rgba(230,140,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(220,110,0,0.7), 0 0 0 1px rgba(255,160,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(150,70,0,0.08);
    border-top: 1px solid rgba(200,110,0,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(180,90,0,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(170,80,0,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #e08000; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/2BCRGX/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /> O₂ Booster</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anadrole — Legal Anadrol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anadrol Alternative</div>
          <div class="headline">
            <small>Extreme Gains &amp; O₂ Power</small>
            <em>Anadrole</em>
          </div>
          <p class="sub"><strong>Supercharges red blood cell production</strong> — floods muscles with oxygen for explosive power, massive gains &amp; rapid recovery. Results in <strong>2 weeks.</strong></p>
          <div class="tags">
            <span class="tag">Extreme Muscle</span>
            <span class="tag">Boosts O₂</span>
            <span class="tag">Fast Recovery</span>
            <span class="tag">Delays Fatigue</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Anadrol Alt</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Extreme Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">More O₂ Flow</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>2 Weeks</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects: The Divide Is Wider Than It Appears</strong></h2>



<h3 class="wp-block-heading"><strong>Anavar Side Effects</strong></h3>



<p class="wp-block-paragraph">Anavar&#8217;s <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744441/">hepatotoxicity from C17-alpha alkylation</a> is genuine but represents the most manageable end of what oral anabolic steroids produce. ALT and AST elevation at 20 to 60mg per day is dose-dependent and present, but the clinical magnitude is significantly lower than Anadrol, Winstrol, or Dianabol at comparable doses. </p>



<p class="wp-block-paragraph">Six to eight weeks of continuous use with TUDCA or UDCA at 500mg per day throughout is the standard harm reduction approach, and liver enzyme normalization post-cycle is reliable in users without pre-existing hepatic compromise.</p>



<p class="wp-block-paragraph">Cholesterol disruption is moderate HDL suppression of 20 to 30 percent with mild LDL elevation and lipid monitoring through a standard panel is appropriate for anyone running multiple cycles annually. </p>



<p class="wp-block-paragraph">HPTA suppression is light enough that PCT is sometimes abbreviated to a two to three-week Nolvadex taper at 20mg per day for moderate-dose Anavar-only cycles, though bloodwork confirming testosterone recovery is always the reliable verification rather than subjective assessment of how the user feels.</p>



<h3 class="wp-block-heading"><strong>Anadrol Side Effects</strong></h3>



<p class="wp-block-paragraph">Anadrol&#8217;s hepatotoxicity is categorically more severe than Anavar&#8217;s it is widely regarded as the most hepatotoxic oral anabolic steroid in common use, not marginally more liver-stressful but substantially so. </p>



<p class="wp-block-paragraph">ALT and AST elevation at standard bodybuilding doses (50 to 100mg per day) is aggressive and requires active monitoring rather than simply TUDCA support as a precaution. Liver enzyme panels before, during, and at the conclusion of the cycle are essential. </p>



<p class="wp-block-paragraph">The four-week cycle length ceiling exists specifically because hepatic burden at these doses cannot be sustained for longer without the risk profile becoming untenable.</p>



<p class="wp-block-paragraph">The estrogenic effects of Anadrol present a pharmacological complexity worth understanding clearly: the compound does not aromatize, yet it causes gynecomastia, water retention, and the clinical picture of high estrogen through what appears to be direct estrogen receptor agonism. </p>



<p class="wp-block-paragraph">This means aromatase inhibitors Anastrozole, Aromasin do not reliably manage Anadrol-related gynecomastia. <a href="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-modulator">Selective estrogen receptor modulators</a> like Nolvadex are more appropriate for managing this specific mechanism. Blood pressure elevation from the fluid load and headaches from the extreme vascular filling are additional consistent side effects that require monitoring and management rather than dismissal.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Anavar</th><th>Anadrol</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Low-Moderate — manageable ALT/AST</td><td>Extreme — highest among oral AAS</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>None</td><td>Gynecomastia and water retention — non-aromatase mechanism</td></tr><tr><td><strong>Gyno Management</strong></td><td>Not required</td><td>Nolvadex — AI ineffective</td></tr><tr><td><strong>Blood Pressure</strong></td><td>Mild elevation</td><td>Severe spikes from fluid load</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Mild to Moderate</td><td>Severe</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Moderate — 20–30%</td><td>Significant</td></tr><tr><td><strong>Androgenic Effects</strong></td><td>Mild — acne uncommon</td><td>Moderate</td></tr><tr><td><strong>Female Suitability</strong></td><td>Yes at 5–20mg/day</td><td>Absolutely not</td></tr><tr><td><strong>Maximum Cycle Length</strong></td><td>6–8 weeks</td><td>4 weeks</td></tr><tr><td><strong>Headaches</strong></td><td>Rare</td><td>Common — particularly at higher doses</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Protocols: Sequential Use Is the Only Sensible Approach</strong></h2>



<p class="wp-block-paragraph">The simultaneous combination of Anavar and Anadrol is one of the genuinely inadvisable stacks in oral steroid use. The rationale for avoiding it is twofold and straightforward. First, both compounds are C17-alpha alkylated orals running them simultaneously compounds hepatotoxic burden in a way that pushes liver enzyme elevation into clinically dangerous territory without providing any pharmacological justification. </p>



<p class="wp-block-paragraph">The mechanisms do not complement each other at the hepatic level; they simply add. Second, their physiological goals are directly contradictory: Anadrol creates the wet, volumized, estrogenically-driven fullness that a cut is designed to eliminate. Running them together produces neither a clean bulk nor a clean cut it produces an expensive and hepatically costly compromise.</p>



<p class="wp-block-paragraph">Sequential use follows a logic that is both pharmacologically sound and practically effective.</p>



<h3 class="wp-block-heading"><strong>Bulk-to-Cut Transition Stack</strong></h3>



<p class="wp-block-paragraph">The most coherent sequential approach runs Anadrol at 50mg per day across weeks 1 through 4 alongside a testosterone base Testosterone Enanthate at 400 to 500mg per week building the mass and strength foundation while the longer-acting injectable reaches stable blood levels. </p>



<p class="wp-block-paragraph">After Anadrol is discontinued and a transition window allows the water and glycogen to begin clearing, Anavar enters at 40mg per day in weeks 7 through 10 as the cutting and finishing compound.</p>



<p class="wp-block-paragraph">The result is a cycle that delivers both rapid mass accumulation and genuine definition each compound doing the work it was designed for, in the phase where that work is appropriate, without one mechanism actively opposing the other.</p>



<p class="wp-block-paragraph">The testosterone base runs the full duration, providing the hormonal foundation that prevents the low-androgen state that either compound alone would produce through HPTA suppression without replacement.</p>



<h3 class="wp-block-heading"><strong>Short Power Stack</strong></h3>



<p class="wp-block-paragraph">For advanced users who want to explore simultaneous use in the most controlled possible format, Anadrol at 25mg in the morning alongside Anavar at 25mg in the afternoon split dosing to reduce peak concentration overlap across a maximum three-week window represents the shortest practical overlap that provides any meaningful dual-compound effect. </p>



<p class="wp-block-paragraph">This is specifically an advanced approach requiring pre-cycle bloodwork, midpoint liver enzyme testing, and TUDCA at 1.5g per day combined with NAC at 2.4g per day as the minimum hepatic support protocol. It is not a recommendation for anyone who has not already run both compounds independently and established their individual liver response to each.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg" alt="topless man in black shorts holding orange bar" class="wp-image-3005" srcset="https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/izw5zlhmfd4.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Anavar</th><th>Anadrol</th></tr></thead><tbody><tr><td><strong>Dose Range</strong></td><td>20–60mg/day oral (6–8 weeks)</td><td>50–100mg/day oral (4 weeks maximum)</td></tr><tr><td><strong>Primary Goal</strong></td><td>Cutting, recomposition, lean preservation</td><td>Bulking, strength, mass accumulation</td></tr><tr><td><strong>Muscle Quality</strong></td><td>Dry, dense, high post-cycle retention</td><td>Wet, full — significant water component</td></tr><tr><td><strong>Liver Risk</strong></td><td>Low-Moderate</td><td>Extreme — most hepatotoxic oral AAS</td></tr><tr><td><strong>Strength Effect</strong></td><td>Moderate, steady</td><td>Explosive — PR-breaking capacity</td></tr><tr><td><strong>Estrogenic Management</strong></td><td>Not required</td><td>Nolvadex — AI not appropriate</td></tr><tr><td><strong>Female Appropriate</strong></td><td>Yes at 5–20mg/day</td><td>No under any circumstances</td></tr><tr><td><strong>Keepable Gains Post-Cycle</strong></td><td>Approximately 80% lean tissue</td><td>40–60% after water and glycogen clear</td></tr><tr><td><strong>Onset Speed</strong></td><td>7–14 days</td><td>3–7 days</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Support and Post-Cycle Therapy</strong></h2>



<h3 class="wp-block-heading"><strong>On-Cycle Support</strong></h3>



<p class="wp-block-paragraph">The hepatic support requirements for a sequential cycle involving Anadrol followed by Anavar reflect the dramatically different liver burden of each phase. During the Anadrol phase, TUDCA at 1.5g per day is the minimum not 500mg as for a standard Anavar cycle, but 1.5g to address the significantly higher enzyme elevation Oxymetholone produces. </p>



<p class="wp-block-paragraph">NAC at 2.4g per day adds glutathione precursor support that provides additional hepatoprotective benefit during the most hepatotoxically demanding weeks. Fish oil at 4g per day supports the lipid parameters both compounds affect. </p>



<p class="wp-block-paragraph">Weekly liver enzyme monitoring during the Anadrol phase is not cautious paranoia it is the appropriate surveillance frequency given the compound&#8217;s documented hepatotoxic burden.</p>



<p class="wp-block-paragraph">During the Anavar phase, TUDCA can reduce to 500mg per day reflecting the lower hepatic demand, with fish oil continuing at 4g per day and zinc at 50mg per day for testosterone synthesis enzyme support.</p>



<h3 class="wp-block-heading"><strong>PCT Protocol</strong></h3>



<p class="wp-block-paragraph">The combined HPTA suppression of a testosterone base plus Anadrol followed by Anavar produces a significant suppression burden that requires a full structured PCT rather than a minimal taper. </p>



<p class="wp-block-paragraph">Clomid at 50mg per day in week 1, dropping to 25mg per day through weeks 2 to 4, combined with Nolvadex at 40mg per day in week 1 and 20mg per day through weeks 2 to 4, addresses the LH and FSH stimulation required for testicular restart after the testosterone base&#8217;s complete HPTA shutdown. </p>



<p class="wp-block-paragraph">The Clomid dose front-loading in week 1 reflects the more aggressive suppression that the Anadrol-containing cycle produces relative to a simpler oral-only stack.</p>



<p class="wp-block-paragraph">Bloodwork at four to six weeks post-PCT total testosterone, free testosterone, LH, FSH, and a full lipid and liver enzyme panel is the reliable confirmation that recovery is proceeding adequately and that hepatic values have returned toward pre-cycle baseline.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>PCT and Support Protocol Reference Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Phase</th><th>Protocol</th><th>Duration</th><th>Purpose</th></tr></thead><tbody><tr><td><strong>Anadrol Phase Liver Support</strong></td><td>TUDCA 1.5g/day + NAC 2.4g/day</td><td>Weeks 1–4</td><td>Hepatoprotection — high burden phase</td></tr><tr><td><strong>Anavar Phase Liver Support</strong></td><td>TUDCA 500mg/day</td><td>Weeks 7–10</td><td>Ongoing hepatic support</td></tr><tr><td><strong>Lipid Support — Throughout</strong></td><td>Fish Oil 4g/day</td><td>Full cycle + PCT</td><td>Cardiovascular and lipid management</td></tr><tr><td><strong>PCT Week 1</strong></td><td>Clomid 50mg + Nolvadex 40mg daily</td><td>Week 1</td><td>Aggressive HPTA restart</td></tr><tr><td><strong>PCT Weeks 2–4</strong></td><td>Clomid 25mg + Nolvadex 20mg daily</td><td>Weeks 2–4</td><td>Sustained hormonal normalization</td></tr><tr><td><strong>Daily Support — PCT</strong></td><td>Zinc 50mg/day</td><td>Throughout PCT</td><td>Testosterone synthesis support</td></tr><tr><td><strong>Bloodwork Confirmation</strong></td><td>Full hormone + liver + lipid panel</td><td>4–6 weeks post-PCT</td><td>Recovery verification</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Legal Status of Anavar and Anadrol</strong></h2>



<p class="wp-block-paragraph">Both Anavar and Anadrol are Schedule III controlled substances under the United States Controlled Substances Act, subject to DEA enforcement with identical legal consequences for possession and distribution. Anavar has legitimate clinical applications muscle wasting, burn recovery, osteoporosis for which it is occasionally prescribed. </p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anvarol Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800&#038;family=Barlow:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #d5d8db;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 8px 44px rgba(0,0,0,0.42);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.52);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #090c10;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — teal/cyan/green for Anvarol cutting theme */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }
  @keyframes sweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* Background FX */
  .bg-fx {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background:
      radial-gradient(ellipse 55% 80% at 88% 50%, rgba(0,200,150,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 35% 60% at 10% 50%, rgba(0,180,130,0.07) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 17px,
        rgba(255,255,255,0.012) 17px, rgba(255,255,255,0.012) 18px);
  }
  .slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      transparent 0%, transparent 40%,
      rgba(0,180,130,0.08) 40%, rgba(0,220,160,0.04) 100%
    );
  }

  /* Gold accent line — from bottle cap */
  .gold-line {
    position: absolute;
    top: 4px; left: 0; right: 0;
    height: 1px;
    background: linear-gradient(90deg, transparent, rgba(212,168,0,0.25), transparent);
    z-index: 1;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 2;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 112px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 18px rgba(0,200,140,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
    transform: rotate(-4deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.12);
    filter:
      drop-shadow(0 0 26px rgba(0,230,160,0.7))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
  }
  .img-badge {
    position: absolute; top: -5px; right: -5px; z-index: 3;
    background: linear-gradient(135deg, #007a5e, #00c896);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 7px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,180,120,0.6);
    white-space: nowrap;
  }
  /* Gold cap glow hint */
  .cap-glow {
    position: absolute;
    top: 0; left: 50%;
    transform: translateX(-50%);
    width: 70px; height: 20px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.25) 0%, transparent 70%);
    pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }
  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3px;
    text-transform: uppercase; color: #00c896; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.9; letter-spacing: 1.5px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,200,140,0.35);
  }
  .headline em { color: #00e0a0; font-style: normal; }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.53);
    line-height: 1.5; margin-bottom: 10px; max-width: 310px;
  }
  .sub strong { color: rgba(255,255,255,0.75); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,180,130,0.1);
    border: 1px solid rgba(0,200,140,0.28);
    color: #00d4a0;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #00c896; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,200,140,0.3), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 48px; line-height: 1; color: #fff; letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(0,220,160,0.6); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #006644 0%, #00a873 50%, #00d4a0 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 13px; letter-spacing: 1.8px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,180,120,0.5);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.22), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,200,140,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.24);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 2;
    display: flex; align-items: stretch;
    background: rgba(0,180,130,0.07);
    border-top: 1px solid rgba(0,200,140,0.14);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,200,140,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,200,140,0.06); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.1px;
    text-transform: uppercase; color: rgba(255,255,255,0.36);
  }

  /* ── USE FOR STRIP ── */
  .use-strip {
    position: relative; z-index: 2;
    display: flex; align-items: center; justify-content: center;
    background: rgba(0,0,0,0.2);
    border-top: 1px solid rgba(255,255,255,0.04);
    gap: 0;
    overflow: hidden;
  }
  .us-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 2px;
    text-transform: uppercase; color: #00c896;
    padding: 6px 12px;
    border-right: 1px solid rgba(0,200,140,0.15);
    white-space: nowrap;
    flex-shrink: 0;
  }
  .us-items {
    display: flex; flex: 1; align-items: center;
    flex-wrap: wrap;
  }
  .us-item {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
    padding: 6px 10px;
    border-right: 1px solid rgba(255,255,255,0.05);
    display: flex; align-items: center; gap: 5px;
  }
  .us-item:last-child { border-right: none; }
  .us-dot { width: 3px; height: 3px; border-radius: 50%; background: #00c896; opacity: 0.5; }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .us-item { padding: 5px 7px; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .us-items { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/MND7Z/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>
      <div class="gold-line"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Cutting</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anvarol — Legal Anavar Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anavar Alternative</div>
          <div class="headline">
            <em>Anvarol</em><br>
            Shred &amp; Define
          </div>
          <p class="sub">Incinerate fat, preserve lean muscle &amp; boost <strong>explosive power</strong> — no water retention, no needles, rapid results in 30 days.</p>
          <div class="tags">
            <span class="tag">Fast Fat Loss</span>
            <span class="tag">Lean Muscle</span>
            <span class="tag">Explosive Power</span>
            <span class="tag">Men &amp; Women</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label">Single Bottle</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">Bulk 3-pack only $129.98</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back Guarantee</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Visceral Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Muscle Hardness</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Energy</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4a7.png" alt="💧" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Zero Water Retention</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Use for / stack strip -->
      <div class="use-strip">
        <div class="us-label">Use For:</div>
        <div class="us-items">
          <div class="us-item"><span class="us-dot"></span>Cutting Cycles</div>
          <div class="us-item"><span class="us-dot"></span>Enhanced Vascularity</div>
          <div class="us-item"><span class="us-dot"></span>Post-Workout Recovery</div>
          <div class="us-item"><span class="us-dot"></span>509,389 Bottles Sold</div>
        </div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">Anadrol similarly has approved medical indications, primarily the treatment of anemia and red blood cell deficiency conditions for which it remains in clinical use in some contexts. In both cases, possession without a valid prescription and use for bodybuilding purposes falls outside any legal framework and constitutes a federal offense.</p>



<p class="wp-block-paragraph">Both compounds are prohibited by the World Anti-Doping Agency across all competitive sport categories. Anadrol&#8217;s detection window in standard urine testing extends several weeks beyond the last dose, making it a particularly significant risk for any athlete operating in a tested environment regardless of how the compound is managed during the cycle.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anadrole Narrow Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800;900&#038;family=Barlow:wght@400;500;600&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #c0c0c0;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 10px 48px rgba(0,0,0,0.5), 0 0 0 1px rgba(180,100,0,0.2);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 20px 64px rgba(0,0,0,0.6), 0 0 0 1px rgba(220,140,0,0.38);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #08070a;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — amber/bronze/gold */
  .top-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }
  @keyframes barSweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG layers */
  .bg-slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      #0c0a06 0%, #0c0a06 36%,
      #1a1000 36%, #241600 54%,
      #08070a 54%, #08070a 100%
    );
  }
  .bg-fx {
    position: absolute; inset: 0; z-index: 1; pointer-events: none;
    background:
      radial-gradient(ellipse 58% 90% at 88% 50%, rgba(200,120,0,0.15) 0%, transparent 65%),
      radial-gradient(ellipse 30% 60% at 8%  50%, rgba(140,80,0,0.10)  0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 16px,
        rgba(255,255,255,0.012) 16px, rgba(255,255,255,0.012) 17px);
  }
  .scanlines {
    position: absolute; inset: 0; z-index: 2; pointer-events: none;
    background-image: repeating-linear-gradient(
      0deg, transparent, transparent 3px,
      rgba(0,0,0,0.06) 3px, rgba(0,0,0,0.06) 4px
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 5;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 114px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col::before {
    content: '';
    position: absolute;
    width: 108px; height: 108px; border-radius: 50%;
    background: radial-gradient(circle, rgba(200,130,0,0.22) 0%, transparent 70%);
    z-index: 0;
  }
  .product-col img {
    position: relative; z-index: 1;
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 16px rgba(220,140,0,0.60))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
    transform: rotate(-5deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-2deg) scale(1.12);
    filter:
      drop-shadow(0 0 24px rgba(255,180,0,0.78))
      drop-shadow(0 5px 12px rgba(0,0,0,0.96));
  }
  .img-badge {
    position: absolute; top: -5px; right: -4px; z-index: 3;
    background: linear-gradient(135deg, #7a3d00, #cc7700);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(180,90,0,0.65);
    white-space: nowrap;
  }
  .cap-glow {
    position: absolute; top: 0; left: 50%;
    transform: translateX(-50%);
    width: 72px; height: 16px;
    background: radial-gradient(ellipse, rgba(255,200,0,0.32) 0%, transparent 70%);
    z-index: 2; pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }

  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3.5px;
    text-transform: uppercase; color: #e08000; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.88; letter-spacing: 2px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(200,120,0,0.45), 0 2px 4px rgba(0,0,0,0.8);
  }
  .headline em { color: #ffaa00; font-style: normal; }
  .headline small {
    display: block;
    font-size: clamp(9px, 1.3vw, 11px);
    letter-spacing: 3.5px; color: rgba(255,255,255,0.35);
    margin-bottom: 2px;
  }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.52);
    line-height: 1.5; margin-bottom: 10px; max-width: 305px;
  }
  .sub strong { color: rgba(255,255,255,0.78); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(180,90,0,0.10);
    border: 1px solid rgba(220,130,0,0.28);
    color: #ffbb55;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #e08000; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(220,130,0,0.30), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: #ffbb55; margin-bottom: 3px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 50px; line-height: 1; color: #fff; letter-spacing: 1px;
    text-shadow: 0 0 18px rgba(200,120,0,0.4);
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(255,180,80,0.5); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #7a3d00 0%, #bb6600 45%, #ee9900 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 900; font-size: 13px; letter-spacing: 2px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 22px rgba(180,90,0,0.52), 0 0 0 1px rgba(230,140,0,0.2);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::before {
    content: ''; position: absolute; inset: 0;
    background: linear-gradient(180deg, rgba(255,255,255,0.08) 0%, transparent 50%);
    pointer-events: none;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(220,110,0,0.7), 0 0 0 1px rgba(255,160,0,0.35);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.22);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 4;
    display: flex; align-items: stretch;
    background: rgba(150,70,0,0.08);
    border-top: 1px solid rgba(200,110,0,0.15);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(180,90,0,0.10);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(170,80,0,0.07); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 7.5px; letter-spacing: 1px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
  }

  /* ── PROOF STRIP ── */
  .proof-strip {
    position: relative; z-index: 4;
    background: rgba(0,0,0,0.28);
    border-top: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 0;
  }
  .ps-item {
    flex: 1; padding: 6px 4px;
    border-right: 1px solid rgba(255,255,255,0.04);
    display: flex; align-items: center; justify-content: center; gap: 5px;
  }
  .ps-item:last-child { border-right: none; }
  .ps-dot { width: 3px; height: 3px; border-radius: 50%; background: #e08000; opacity: 0.6; flex-shrink: 0; }
  .ps-text {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); white-space: nowrap;
  }
  .ps-text strong { color: rgba(255,255,255,0.48); }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px; flex-shrink: 0;
    background: linear-gradient(90deg,
      #5a2e00, #aa5500, #e08000, #ffcc00, #e08000, #aa5500, #5a2e00);
    background-size: 300% 100%;
    animation: barSweep 3.2s linear infinite;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .sub { display: none; }
    .ps-item:last-child { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .proof-strip { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/2BCRGX/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-slash"></div>
      <div class="bg-fx"></div>
      <div class="scanlines"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /> O₂ Booster</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anadrole — Legal Anadrol Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anadrol Alternative</div>
          <div class="headline">
            <small>Extreme Gains &amp; O₂ Power</small>
            <em>Anadrole</em>
          </div>
          <p class="sub"><strong>Supercharges red blood cell production</strong> — floods muscles with oxygen for explosive power, massive gains &amp; rapid recovery. Results in <strong>2 weeks.</strong></p>
          <div class="tags">
            <span class="tag">Extreme Muscle</span>
            <span class="tag">Boosts O₂</span>
            <span class="tag">Fast Recovery</span>
            <span class="tag">Delays Fatigue</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2b50.png" alt="⭐" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal Anadrol Alt</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">3-pack only $129.99</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Extreme Muscle</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1fa78.png" alt="🩸" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">More O₂ Flow</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Power</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f504.png" alt="🔄" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Fast Recovery</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Social proof -->
      <div class="proof-strip">
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text"><strong>509,389</strong> Sold</span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Results <strong>2 Weeks</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">Free Ship <strong>$100+</strong></span></div>
        <div class="ps-item"><span class="ps-dot"></span><span class="ps-text">No Prescription</span></div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Conclusion: Sequential Logic, Non-Negotiable Separation</strong></h2>



<p class="wp-block-paragraph">The strategic framework for using Anavar and Anadrol intelligently is not complicated once the compounds are understood on their own terms.</p>



<p class="wp-block-paragraph">Anadrol belongs at the beginning of a dedicated mass phase the first four weeks of a longer injectable-based bulk, building the strength foundation and size accumulation that creates the physique worth refining in the cutting phase that follows. Anavar belongs at the other end of the timeline the finishing phase of a cut, applied to the lean tissue that survived the transition from bulk to deficit, hardening and defining what was built when the scale numbers were going up.</p>



<p class="wp-block-paragraph">Never overlap them. The hepatic mathematics of running two C17-alpha alkylated orals simultaneously one of which is the most liver-toxic in the class are not in your favor, and the physiological contradiction of their effects means the simultaneous combination produces neither outcome cleanly. Sequential use with adequate transition time between phases is the architecture that allows each compound to do its best work without the other working against it.</p>



<p class="wp-block-paragraph">Anavar for beginners, for women, for safety-first cutting phases, and for anyone building their experience with anabolic compounds systematically. Anadrol for advanced users in a dedicated mass phase with pre-cycle bloodwork, active monitoring throughout, and a full PCT protocol planned before the first tablet is taken.</p>



<p class="wp-block-paragraph">Goals dictate the choice. Bloodwork governs the execution.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/anavar-vs-anadrol/">Anavar vs Anadrol: Mild Cutting vs Extreme Bulking Power Clash</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Anavar vs SARMs: Proven Steroid vs Research Cutting Alternatives</title>
		<link>https://gymtrix.net/anavar-vs-sarms/</link>
		
		<dc:creator><![CDATA[gymtrix]]></dc:creator>
		<pubDate>Tue, 28 Apr 2026 06:17:24 +0000</pubDate>
				<category><![CDATA[Steroids]]></category>
		<guid isPermaLink="false">https://gymtrix.net/?p=3064</guid>

					<description><![CDATA[<p>The conversation between Anavar and SARMs sounds straightforward on the surface an established pharmaceutical compound with decades of clinical data versus a newer class of research chemicals promising similar results with fewer side effects. In practice, the comparison is considerably more nuanced than the marketing around SARMs tends to acknowledge, and considerably less favorable to...</p>
<p>The post <a href="https://gymtrix.net/anavar-vs-sarms/">Anavar vs SARMs: Proven Steroid vs Research Cutting Alternatives</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The conversation between Anavar and SARMs sounds straightforward on the surface an established pharmaceutical compound with decades of clinical data versus a newer class of research chemicals promising similar results with fewer side effects. </p>



<p class="wp-block-paragraph">In practice, the comparison is considerably more nuanced than the marketing around SARMs tends to acknowledge, and considerably less favorable to SARMs than most of the communities promoting them would have you believe.</p>



<p class="wp-block-paragraph">Anavar (Oxandrolone) has been in clinical use since 1964. Its pharmacology is understood in detail, its side effect profile is documented across decades of human use, its pharmaceutical-grade formulation guarantees purity and consistent dosing, and its risk-to-benefit ratio in a cutting context is the most favorable of any oral anabolic steroid. </p>



<p class="wp-block-paragraph">Selective androgen receptor modulators Ostarine (MK-2866), LGD-4033 (Ligandrol), and RAD-140 (Testolone) being the three most commonly discussed are research chemicals. They were designed with a legitimate pharmacological rationale, some have promising early clinical data, and they produce real anabolic effects. </p>



<p class="wp-block-paragraph">They are also unregulated, frequently contaminated, inconsistently dosed in commercial products, and genuinely lacking in the long-term human safety data that would allow confident risk assessment.</p>



<p class="wp-block-paragraph">That asymmetry matters enormously when making decisions about what to put in your body, and it is the context that should frame every point in this comparison.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="819" src="http://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg" alt="man in black shorts and black tank top doing push up" class="wp-image-2993" srcset="https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-1024x819.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-300x240.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu-768x614.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/0hli76m4jxu.jpg 1500w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Overview: Pharmaceutical Certainty vs Research Chemical Promise</strong></h2>



<p class="wp-block-paragraph">Anavar&#8217;s design mandate was specific: provide anabolic support for muscle wasting and tissue repair with minimal systemic side effects. The result was a compound with an anabolic rating of 322 to 630 relative to testosterone substantially higher than its androgenic rating combined with no estrogenic activity and the mildest hepatotoxicity profile among C17-alpha alkylated oral steroids. </p>



<p class="wp-block-paragraph">In a cutting context, these properties translate directly into lean tissue preservation, subtle definition enhancement, and strength retention through caloric deficits without the water retention, hormonal complexity, or severe liver burden that more aggressive compounds carry.</p>



<p class="wp-block-paragraph">SARMs were designed on a different premise: exploit the tissue selectivity of androgen receptor binding to produce anabolic effects primarily in muscle and bone while minimizing androgenic activity in tissues like the prostate, skin, and liver that drive traditional steroid side effects. </p>



<p class="wp-block-paragraph">In concept, this is a genuinely valuable pharmacological goal. In practice, the selectivity is partial rather than absolute, the research is predominantly preclinical or early-phase human data, and the compounds available through bodybuilding channels are research chemicals subject to none of the quality control that pharmaceutical manufacturing requires. </p>



<p class="wp-block-paragraph"><a href="https://www.fda.gov/consumers/consumer-updates/fda-in-brief-fda-warns-against-using-sarms-body-building-products">The FDA has issued multiple warnings</a> about SARMs products marketed for bodybuilding, citing undisclosed ingredients, inaccurate dosing, and the presence of unapproved drug substances in tested products.</p>



<p class="wp-block-paragraph">This is not a reason to dismiss SARMs as worthless. It is a reason to understand them accurately rather than through the lens of community enthusiasm.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Benefits of Anavar for Cutting</strong></h2>



<h3 class="wp-block-heading"><strong>Clean Muscle Retention</strong></h3>



<p class="wp-block-paragraph">Anavar&#8217;s primary cutting value is its ability to maintain a positive nitrogen balance in muscle tissue under conditions of caloric restriction that would otherwise drive catabolism. Protein synthesis remains elevated, lean tissue is preferentially preserved over adipose as the body&#8217;s energy substrate, and the result is genuine muscle fiber retention rather than the weight-scale changes that a combination of fat loss and muscle catabolism would produce. </p>



<p class="wp-block-paragraph">This lean mass preservation is durable it does not represent glycogen or intracellular water that clears post-cycle, but actual contractile tissue that contributes to both the aesthetic result of the cut and the anabolic platform for subsequent training phases.</p>



<p class="wp-block-paragraph">At the doses used in bodybuilding 20 to 60mg per day this nitrogen retention effect is clinically meaningful. At the lower end of that range, the effect is sufficient for lean preservation in a moderate deficit. At the higher end, it produces the stronger anabolic support that advanced athletes cutting aggressively require.</p>



<h3 class="wp-block-heading"><strong>Polished Dry Definition</strong></h3>



<p class="wp-block-paragraph">Anavar produces the kind of visual improvement during a cut that photographs well and persists after the cycle ends. Without aromatization or subcutaneous water contribution, muscle definition becomes progressively more visible as body fat decreases separations sharpen, vascularity increases, and the density of the physique reads as genuinely developed rather than simply smaller. </p>



<p class="wp-block-paragraph">This is not the extreme grainy hardness of Masteron or the dramatic drying of Winstrol. It is polished, sustainable definition that suits a wide range of physique goals from first competitive prep to advanced recomposition cycles.</p>



<p class="wp-block-paragraph">For beginners in particular, this reliability is significant. The outcome is predictable, the timeline is consistent, and the visual feedback through a cycle confirms that the compound is working rather than leaving users to guess whether subtle changes represent compound activity or just the effects of the diet.</p>



<h3 class="wp-block-heading"><strong>Strength Without Compounding Toxicity</strong></h3>



<p class="wp-block-paragraph">Anavar&#8217;s strength benefit is not dramatic in the way that <a href="https://gymtrix.net/dianabol-vs-anadrol/">Dianabol or Anadrol</a> delivers acute power surges. It is a steady maintenance and modest enhancement of training performance through a caloric deficit the kind of strength preservation that keeps training quality high enough to maintain the anabolic stimulus that muscle retention depends on. </p>



<p class="wp-block-paragraph">Critically, this is delivered through a compound with a documented pharmaceutical-grade safety profile and a liver toxicity burden that, while present, is the lowest in its oral anabolic class. The FDA-regulated pharmaceutical formulation guarantees that what is labeled is what is present, at the stated dose, without undisclosed additives.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anvarol Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800&#038;family=Barlow:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #d5d8db;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 8px 44px rgba(0,0,0,0.42);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.52);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #090c10;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — teal/cyan/green for Anvarol cutting theme */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }
  @keyframes sweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* Background FX */
  .bg-fx {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background:
      radial-gradient(ellipse 55% 80% at 88% 50%, rgba(0,200,150,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 35% 60% at 10% 50%, rgba(0,180,130,0.07) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 17px,
        rgba(255,255,255,0.012) 17px, rgba(255,255,255,0.012) 18px);
  }
  .slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      transparent 0%, transparent 40%,
      rgba(0,180,130,0.08) 40%, rgba(0,220,160,0.04) 100%
    );
  }

  /* Gold accent line — from bottle cap */
  .gold-line {
    position: absolute;
    top: 4px; left: 0; right: 0;
    height: 1px;
    background: linear-gradient(90deg, transparent, rgba(212,168,0,0.25), transparent);
    z-index: 1;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 2;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 112px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 18px rgba(0,200,140,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
    transform: rotate(-4deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.12);
    filter:
      drop-shadow(0 0 26px rgba(0,230,160,0.7))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
  }
  .img-badge {
    position: absolute; top: -5px; right: -5px; z-index: 3;
    background: linear-gradient(135deg, #007a5e, #00c896);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 7px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,180,120,0.6);
    white-space: nowrap;
  }
  /* Gold cap glow hint */
  .cap-glow {
    position: absolute;
    top: 0; left: 50%;
    transform: translateX(-50%);
    width: 70px; height: 20px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.25) 0%, transparent 70%);
    pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }
  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3px;
    text-transform: uppercase; color: #00c896; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.9; letter-spacing: 1.5px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,200,140,0.35);
  }
  .headline em { color: #00e0a0; font-style: normal; }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.53);
    line-height: 1.5; margin-bottom: 10px; max-width: 310px;
  }
  .sub strong { color: rgba(255,255,255,0.75); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,180,130,0.1);
    border: 1px solid rgba(0,200,140,0.28);
    color: #00d4a0;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #00c896; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,200,140,0.3), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 48px; line-height: 1; color: #fff; letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(0,220,160,0.6); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #006644 0%, #00a873 50%, #00d4a0 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 13px; letter-spacing: 1.8px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,180,120,0.5);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.22), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,200,140,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.24);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 2;
    display: flex; align-items: stretch;
    background: rgba(0,180,130,0.07);
    border-top: 1px solid rgba(0,200,140,0.14);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,200,140,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,200,140,0.06); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.1px;
    text-transform: uppercase; color: rgba(255,255,255,0.36);
  }

  /* ── USE FOR STRIP ── */
  .use-strip {
    position: relative; z-index: 2;
    display: flex; align-items: center; justify-content: center;
    background: rgba(0,0,0,0.2);
    border-top: 1px solid rgba(255,255,255,0.04);
    gap: 0;
    overflow: hidden;
  }
  .us-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 2px;
    text-transform: uppercase; color: #00c896;
    padding: 6px 12px;
    border-right: 1px solid rgba(0,200,140,0.15);
    white-space: nowrap;
    flex-shrink: 0;
  }
  .us-items {
    display: flex; flex: 1; align-items: center;
    flex-wrap: wrap;
  }
  .us-item {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
    padding: 6px 10px;
    border-right: 1px solid rgba(255,255,255,0.05);
    display: flex; align-items: center; gap: 5px;
  }
  .us-item:last-child { border-right: none; }
  .us-dot { width: 3px; height: 3px; border-radius: 50%; background: #00c896; opacity: 0.5; }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .us-item { padding: 5px 7px; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .us-items { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/MND7Z/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>
      <div class="gold-line"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Cutting</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anvarol — Legal Anavar Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anavar Alternative</div>
          <div class="headline">
            <em>Anvarol</em><br>
            Shred &amp; Define
          </div>
          <p class="sub">Incinerate fat, preserve lean muscle &amp; boost <strong>explosive power</strong> — no water retention, no needles, rapid results in 30 days.</p>
          <div class="tags">
            <span class="tag">Fast Fat Loss</span>
            <span class="tag">Lean Muscle</span>
            <span class="tag">Explosive Power</span>
            <span class="tag">Men &amp; Women</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label">Single Bottle</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">Bulk 3-pack only $129.98</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back Guarantee</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Visceral Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Muscle Hardness</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Energy</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4a7.png" alt="💧" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Zero Water Retention</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Use for / stack strip -->
      <div class="use-strip">
        <div class="us-label">Use For:</div>
        <div class="us-items">
          <div class="us-item"><span class="us-dot"></span>Cutting Cycles</div>
          <div class="us-item"><span class="us-dot"></span>Enhanced Vascularity</div>
          <div class="us-item"><span class="us-dot"></span>Post-Workout Recovery</div>
          <div class="us-item"><span class="us-dot"></span>509,389 Bottles Sold</div>
        </div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Benefits of SARMs for Cutting</strong></h2>



<h3 class="wp-block-heading"><strong>Tissue-Selective Lean Gains</strong></h3>



<p class="wp-block-paragraph">The tissue selectivity principle that defines SARMs produces genuinely different effects depending on the specific compound. Ostarine at 15 to 25mg per day is the most studied and most appropriate for lean mass preservation in a caloric deficit its partial HPTA suppression and modest anabolic activity make it the closest equivalent in the SARM class to Anavar&#8217;s cutting role. </p>



<p class="wp-block-paragraph">LGD-4033 at 5 to 10mg per day produces more pronounced lean mass accumulation but also more significant suppression, making it better suited to a modest bulk than a cut. RAD-140 delivers the most potent anabolic stimulus of the three, with a longer half-life of approximately 60 hours that makes once-daily dosing consistent, and produces strength and lean mass gains that approach the lower end of injectable steroid outcomes alongside correspondingly more significant androgenic activity.</p>



<p class="wp-block-paragraph">The selectivity advantage is real in the sense that these compounds do not cause hepatotoxicity through C17-alpha alkylation. But the claim that they avoid liver impact entirely is not accurate Ostarine and LGD-4033 have both demonstrated liver enzyme elevation in clinical observation that in some cases approaches what 50mg per day of Anavar produces.</p>



<h3 class="wp-block-heading"><strong>Lower Perceived Suppression</strong></h3>



<p class="wp-block-paragraph">The degree of HPTA suppression that SARMs cause is genuinely lower than the complete shutdown that testosterone-based anabolic steroids produce. Testosterone suppression of 30 to 70 percent depending on the compound and dose is the typical range, rather than the near-total suppression that conventional anabolic steroids guarantee. </p>



<p class="wp-block-paragraph">This means that natural testosterone recovery post-cycle is faster and frequently occurs without pharmaceutical PCT intervention, particularly after mild cycles of Ostarine at conservative doses. However, <a href="https://www.usada.org/spirit-of-sport/selective-androgen-receptor-modulators-sarms-prohibited-class-anabolic-agents/">as USADA has noted</a>, the assumption that SARMs require no PCT is a generalization that does not hold across all compounds, all doses, or all cycle lengths RAD-140 and LGD-4033 at the higher end of their effective dose ranges produce suppression that warrants at minimum a light SERM taper.</p>



<h3 class="wp-block-heading"><strong>Convenience Dosing</strong></h3>



<p class="wp-block-paragraph">RAD-140&#8217;s approximately 60-hour half-life compared to Anavar&#8217;s 9 to 10-hour oral half-life is a practical advantage for users who prefer once-daily dosing without the peaks and troughs that shorter half-life compounds create. </p>



<p class="wp-block-paragraph">Ostarine&#8217;s half-life of 24 hours similarly allows single daily dosing that maintains stable blood concentrations throughout the day. This is a genuine convenience difference rather than a pharmacological superiority, but for users who find split dosing impractical, it is worth noting.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>CrazyBulk SARMs Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Exo+2:wght@600;700;800&#038;family=Inter:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #e0e4e8;
    padding: 28px 16px;
    font-family: 'Inter', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 8px;
    overflow: hidden;
    box-shadow: 0 8px 40px rgba(0,0,0,0.4);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.5);
  }

  /* ── BANNER ── */
  .banner {
    width: 100%;
    background: #080d14;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Top neon bar */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }
  @keyframes barShift {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG texture layers */
  .bg-fx {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background:
      radial-gradient(ellipse 60% 80% at 90% 50%, rgba(0,80,255,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 40% 60% at 15% 50%, rgba(0,200,120,0.07) 0%, transparent 60%),
      repeating-linear-gradient(-52deg, transparent, transparent 16px, rgba(255,255,255,0.014) 16px, rgba(255,255,255,0.014) 17px);
  }

  /* Blue diagonal slash */
  .slash {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background: linear-gradient(108deg,
      transparent 0%,
      transparent 42%,
      rgba(0,100,255,0.09) 42%,
      rgba(0,200,200,0.06) 100%
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    gap: 12px;
    padding: 18px 22px 14px 18px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0;
    width: 118px;
    display: flex;
    align-items: center;
    justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 110px;
    height: auto;
    display: block;
    border-radius: 6px;
    filter:
      drop-shadow(0 0 16px rgba(0,150,255,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
    transform: scale(1.04);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: scale(1.1);
    filter:
      drop-shadow(0 0 22px rgba(0,180,255,0.75))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
  }
  .img-badge {
    position: absolute;
    top: -5px;
    right: -4px;
    background: linear-gradient(135deg, #0055ff, #00c6ff);
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 8px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 7px;
    border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,100,255,0.55);
    white-space: nowrap;
    z-index: 3;
  }

  /* TEXT */
  .text-col {
    flex: 1;
    min-width: 0;
  }
  .eyebrow {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 700;
    letter-spacing: 3px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.9;
    letter-spacing: 1.5px;
    color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,150,255,0.35);
  }
  .headline em {
    color: #00c6ff;
    font-style: normal;
  }
  .sub {
    font-size: 11px;
    color: rgba(255,255,255,0.55);
    line-height: 1.5;
    margin-bottom: 10px;
    max-width: 320px;
  }

  /* Product tags */
  .tags {
    display: flex;
    flex-wrap: wrap;
    gap: 5px;
  }
  .tag {
    display: inline-flex;
    align-items: center;
    gap: 4px;
    background: rgba(0,150,255,0.1);
    border: 1px solid rgba(0,180,255,0.28);
    color: #55ccff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 8px;
    border-radius: 2px;
  }
  .tag::before { content: '▸'; font-size: 8px; }

  /* CTA COLUMN */
  .cta-col {
    flex-shrink: 0;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 9px;
    min-width: 145px;
    padding-left: 6px;
  }

  /* Price */
  .price-wrap { text-align: center; }
  .p-from {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 600;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.3);
    margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px;
    color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 46px;
    line-height: 1;
    color: #fff;
    letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Exo 2', sans-serif;
    font-size: 9.5px;
    font-weight: 800;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: #00ff9d;
    margin-top: 1px;
  }

  /* Button */
  .cta-btn {
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #0044dd 0%, #00aaff 50%, #00ddff 100%);
    background-size: 200% 100%;
    background-position: 0% 50%;
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 12.5px;
    letter-spacing: 1.8px;
    text-transform: uppercase;
    padding: 13px 14px;
    border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,100,255,0.5);
    transition: background-position 0.4s, box-shadow 0.2s, transform 0.2s;
    white-space: nowrap;
    position: relative;
    overflow: hidden;
  }
  .cta-btn::after {
    content: '';
    position: absolute;
    top: 0; left: -100%;
    width: 50%;
    height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,140,255,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow {
    font-size: 14px;
    transition: transform 0.2s;
  }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px;
    color: rgba(255,255,255,0.25);
    text-align: center;
    letter-spacing: 0.8px;
    text-transform: uppercase;
  }

  /* DIVIDER between text and cta */
  .v-divider {
    width: 1px;
    align-self: stretch;
    margin: 10px 0;
    background: linear-gradient(to bottom, transparent, rgba(0,180,255,0.3), transparent);
    flex-shrink: 0;
  }

  /* ── PRODUCT STRIP ── */
  .product-strip {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 0;
    background: rgba(0,100,255,0.08);
    border-top: 1px solid rgba(0,180,255,0.15);
    overflow: hidden;
  }
  .ps-item {
    flex: 1;
    text-align: center;
    padding: 7px 6px;
    border-right: 1px solid rgba(0,180,255,0.12);
    transition: background 0.2s;
  }
  .ps-item:last-child { border-right: none; }
  .banner-link:hover .ps-item { background: rgba(0,120,255,0.1); }
  .ps-name {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 800;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .ps-desc {
    font-size: 8px;
    color: rgba(255,255,255,0.35);
    letter-spacing: 0.5px;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
  }

  /* ── BOTTOM STRIP ── */
  .bottom-strip {
    position: relative;
    z-index: 2;
    background: rgba(0,0,0,0.25);
    border-top: 1px solid rgba(255,255,255,0.05);
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 16px;
    padding: 6px 16px;
    flex-wrap: wrap;
  }
  .bs-item {
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.4px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.32);
    display: flex;
    align-items: center;
    gap: 5px;
  }
  .bs-dot {
    width: 3px; height: 3px;
    border-radius: 50%;
    background: #00c6ff;
    opacity: 0.5;
  }

  /* Bottom bar */
  .bottom-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 90px; }
    .product-col img { width: 80px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 38px; }
    .cta-col { min-width: 120px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .ps-desc { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .cta-col { min-width: 108px; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/49747C/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal SARMs</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Legal SARMs Alternatives — OSTA 2866, LIGAN 4033, TESTOL 140, IBUTA 677">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal &amp; Safe Alternatives</div>
          <div class="headline">
            <em>SARMs</em> Range<br>
            Gym Beast Mode
          </div>
          <p class="sub">Torch fat, skyrocket testosterone &amp; build serious muscle — 100% natural, zero side effects, no prescription needed.</p>
          <div class="tags">
            <span class="tag">Muscle Growth</span>
            <span class="tag">Fat Burning</span>
            <span class="tag">Boost T-Levels</span>
            <span class="tag">60-Day Guarantee</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-from">Singles from</div>
            <div class="p-was">Was $84.99</div>
            <div class="p-now">$69.99</div>
            <div class="p-save">Save $15 · Stacks from $249</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Product name strip -->
      <div class="product-strip">
        <div class="ps-item">
          <div class="ps-name">OSTA 2866</div>
          <div class="ps-desc">Muscle Growth</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">LIGAN 4033</div>
          <div class="ps-desc">Energy &amp; Pumps</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">TESTOL 140</div>
          <div class="ps-desc">Boosts Testosterone</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">IBUTA 677</div>
          <div class="ps-desc">HGH &amp; Strength</div>
        </div>
      </div>

      <!-- Social proof strip -->
      <div class="bottom-strip">
        <div class="bs-item"><span class="bs-dot"></span>509,389 Bottles Sold</div>
        <div class="bs-item"><span class="bs-dot"></span>100% Natural Ingredients</div>
        <div class="bs-item"><span class="bs-dot"></span>Legal In All Countries</div>
        <div class="bs-item"><span class="bs-dot"></span>Free Shipping $100+</div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Side Effects: Where the Comparison Gets More Complex</strong></h2>



<h3 class="wp-block-heading"><strong>Anavar Side Effects</strong></h3>



<p class="wp-block-paragraph">Anavar&#8217;s hepatotoxicity from C17-alpha alkylation is the most commonly cited concern, and in context it is the most manageable in its class. ALT and AST elevation at standard doses is dose-dependent, present but not clinically alarming at 20 to 40mg per day in most users, and normalizes post-cycle with TUDCA support used throughout. </p>



<p class="wp-block-paragraph">HDL suppression of 20 to 30 percent with mild LDL elevation reflects the lipid impact of oral androgenic activity meaningful over multiple cycles but not acutely dangerous at single-cycle doses with adequate lipid monitoring. </p>



<p class="wp-block-paragraph">The pharmaceutical-grade formulation guarantees that the compound causing these predictable effects is exactly what the label states, at exactly the stated dose a quality assurance that is fundamentally absent from black-market SARM products.</p>



<p class="wp-block-paragraph">HPTA suppression is light relative to injectables and testosterone-based compounds. PCT is often minimal Nolvadex at 20mg per day for two to four weeks is frequently sufficient for Anavar-only cycles and recovery is reliable in users without pre-existing endocrine compromise.</p>



<h3 class="wp-block-heading"><strong>SARMs Side Effects</strong></h3>



<p class="wp-block-paragraph">The SARM side effect picture is complicated by the contamination and mislabeling problem that regulatory testing has consistently documented. <a href="https://www.uspharmacist.com/article/recreational-use-of-selective-androgen-receptor-modulators">US Pharmacist research and clinical observation</a> has identified liver enzyme spikes in SARM users that in some cases approach or match what oral anabolic steroids at moderate doses produce a finding that challenges the narrative of SARMs as liver-safe alternatives. </p>



<p class="wp-block-paragraph">Vision disturbances associated with Andarine (S4) a yellow tint and difficulty adjusting to darkness are a specific and documented side effect of that compound. Cardiovascular strain, lipid disruption, and hormonal suppression are present across the class to varying degrees.</p>



<p class="wp-block-paragraph">The contamination issue deserves specific emphasis. Independent laboratory testing of commercially available SARM products has found products that contain no active compound, products with significantly different compounds than labeled, and products with undisclosed anabolic steroid content. </p>



<p class="wp-block-paragraph">The user who believes they are running a research-grade SARM may be running an unidentified oral steroid, a different SARM than labeled, or nothing at all. None of these outcomes are controllable without third-party testing of every product batch.</p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Side Effects Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Side Effect</th><th>Anavar</th><th>SARMs (Ostarine / LGD-4033 / RAD-140)</th></tr></thead><tbody><tr><td><strong>Hepatotoxicity</strong></td><td>Low-Moderate — C17-alpha alkylation</td><td>Low to Moderate — enzyme elevation documented</td></tr><tr><td><strong>Purity Guarantee</strong></td><td>Yes — pharmaceutical-grade</td><td>No — black market contamination common</td></tr><tr><td><strong>HPTA Suppression</strong></td><td>Mild to Moderate</td><td>30–70% testosterone reduction</td></tr><tr><td><strong>HDL Suppression</strong></td><td>Moderate — 20–30%</td><td>Mild to Moderate</td></tr><tr><td><strong>Estrogenic Effects</strong></td><td>None</td><td>None</td></tr><tr><td><strong>Vision Side Effects</strong></td><td>None</td><td>S4 (Andarine) documented yellow tint</td></tr><tr><td><strong>Long-Term Safety Data</strong></td><td>Decades of clinical human data</td><td>Minimal — largely preclinical</td></tr><tr><td><strong>PCT Requirement</strong></td><td>Light SERM taper — 2–4 weeks</td><td>Often optional — RAD-140/LGD warrant consideration</td></tr><tr><td><strong>Regulatory Status</strong></td><td>Schedule III — pharmaceutical standard</td><td>Unscheduled research chemical</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Stacking Protocols: Anavar and SARMs</strong></h2>



<p class="wp-block-paragraph">The rationale for combining Anavar with a SARM is not about compounding anabolic effects Anavar already delivers meaningful anabolic support. The logic is additive from different mechanisms: Anavar through androgen receptor binding with pharmaceutical certainty, and a SARM adding selective tissue anabolism without duplicating Anavar&#8217;s hormonal suppression pattern or liver burden significantly. </p>



<p class="wp-block-paragraph">The combination is not for beginners and requires diligent bloodwork and liver enzyme monitoring given that both compounds are orally active.</p>



<h3 class="wp-block-heading"><strong>Cutting Synergy Stack</strong></h3>



<p class="wp-block-paragraph">Anavar at 30 to 50mg per day combined with Ostarine at 10 to 20mg per day across a 6-week cycle addresses both the lean tissue preservation and the mild additional anabolic stimulus that a moderate cut requires. </p>



<p class="wp-block-paragraph">Ostarine is the appropriate SARM choice for this application because it is the most studied, the most predictable, and the least suppressive of the commonly available options. Dual oral use makes liver support non-negotiable TUDCA at 500mg per day throughout, with a full liver enzyme panel before and midway through the cycle. </p>



<p class="wp-block-paragraph">Fish oil at 3g per day for lipid support and zinc at 50mg per day complete the on-cycle support foundation.</p>



<h3 class="wp-block-heading"><strong>Beginner Recomposition Comparison</strong></h3>



<p class="wp-block-paragraph">For someone genuinely undecided between starting with Anavar solo or Ostarine solo a reasonable position for a first-cycle beginner the honest comparison runs as follows. Anavar at 20mg per day delivers more noticeable strength improvement, more reliable lean tissue preservation, and a more consistent and predictable result backed by pharmaceutical purity. </p>



<p class="wp-block-paragraph">Ostarine at 15mg per day delivers a subtler anabolic effect with less suppression and no liver alkylation burden, but with the contamination uncertainty inherent in black-market research chemical sourcing. </p>



<p class="wp-block-paragraph">The risk profiles are different in kind rather than simply different in magnitude, and the right choice depends on which category of risk the individual is more concerned about managing.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="http://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-1024x683.jpg" alt="man doing gymnastic" class="wp-image-3001" srcset="https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-1024x683.jpg 1024w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-300x200.jpg 300w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-768x512.jpg 768w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq-1536x1024.jpg 1536w, https://gymtrix.net/wp-content/uploads/2026/03/3cce37vgdiq.jpg 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>



<h2 class="wp-block-heading"><strong>Dosages, Cycles, and Results Comparison Table</strong></h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Aspect</th><th>Anavar</th><th>SARMs (Ostarine / RAD-140)</th></tr></thead><tbody><tr><td><strong>Dose Range</strong></td><td>20–60mg/day oral (6–8 weeks)</td><td>10–25mg/day oral (8–12 weeks)</td></tr><tr><td><strong>Anabolic Efficacy</strong></td><td>Superior — pharmaceutical grade</td><td>Moderate — research chemical</td></tr><tr><td><strong>Liver Risk</strong></td><td>Low-Moderate — alkylation documented</td><td>Low to Moderate — enzyme data emerging</td></tr><tr><td><strong>Purity Assurance</strong></td><td>Pharmaceutical standard</td><td>Black market — variable and unverified</td></tr><tr><td><strong>Strength Effect</strong></td><td>Noticeable — sustained through deficit</td><td>Subtle — compound and dose dependent</td></tr><tr><td><strong>Suppression Level</strong></td><td>Mild to Moderate</td><td>30–70% testosterone reduction</td></tr><tr><td><strong>PCT Requirement</strong></td><td>Light SERM taper — Nolvadex 20mg/day</td><td>Often natural recovery — RAD-140 warrants consideration</td></tr><tr><td><strong>Female Appropriate</strong></td><td>Yes at 5–20mg/day</td><td>Ostarine only at very low doses</td></tr><tr><td><strong>Cycle Length Limit</strong></td><td>6–8 weeks — hepatic ceiling</td><td>8–12 weeks — no alkylation ceiling</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Cycle Support and PCT Protocol</strong></h2>



<h3 class="wp-block-heading"><strong>PCT After Anavar</strong></h3>



<p class="wp-block-paragraph">Nolvadex at 20mg per day for two to four weeks is the standard protocol following an Anavar-only cycle at moderate doses. The mild suppression Anavar produces typically responds well to this abbreviated SERM taper without requiring the full Clomid combination that heavier compounds demand. </p>



<p class="wp-block-paragraph">Users who ran the higher end of the dosing range 50 to 60mg per day for 8 weeks or who stacked with a more suppressive SARM like RAD-140 may benefit from adding Clomid at 25mg per day for the first two weeks of the taper to ensure a complete restart.</p>



<h3 class="wp-block-heading"><strong>SARM Recovery</strong></h3>



<p class="wp-block-paragraph">The recovery requirement after SARMs varies significantly by compound. Ostarine at conservative doses (15 to 20mg for 8 weeks) frequently recovers naturally without pharmaceutical PCT in otherwise healthy individuals though bloodwork at four weeks post-cycle confirming testosterone normalization is the only reliable verification of this. </p>



<p class="wp-block-paragraph">RAD-140 and LGD-4033, particularly at higher doses or longer cycle lengths, produce enough suppression that a light Nolvadex taper at 20mg per day for three to four weeks is advisable rather than assuming natural recovery will occur adequately.</p>



<h3 class="wp-block-heading"><strong>Daily Support Protocol Reference</strong></h3>



<figure class="wp-block-table"><table class="has-fixed-layout"><thead><tr><th>Support Element</th><th>Compound</th><th>Dose</th><th>Purpose</th></tr></thead><tbody><tr><td><strong>Liver Support</strong></td><td>TUDCA</td><td>500mg/day</td><td>Hepatoprotection — Anavar phase</td></tr><tr><td><strong>Cardiovascular</strong></td><td>Fish Oil</td><td>3g/day</td><td>Lipid and endothelial support</td></tr><tr><td><strong>Testosterone Synthesis</strong></td><td>Zinc</td><td>50mg/day</td><td>Enzyme cofactor support</td></tr><tr><td><strong>PCT — Anavar</strong></td><td>Nolvadex</td><td>20mg/day for 2–4 weeks</td><td>HPTA restart</td></tr><tr><td><strong>PCT — RAD-140/LGD</strong></td><td>Nolvadex</td><td>20mg/day for 3–4 weeks</td><td>Suppression recovery</td></tr><tr><td><strong>Bloodwork</strong></td><td>Full hormone + liver + lipid panel</td><td>Pre, mid, and post-cycle</td><td>Monitoring and safety</td></tr></tbody></table></figure>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<h2 class="wp-block-heading"><strong>Legal Status of Anavar and SARMs</strong></h2>



<p class="wp-block-paragraph">Anavar is a Schedule III controlled substance under the United States Controlled Substances Act. Possession without a valid prescription is a federal offense. The Schedule III classification reflects both the abuse potential assessment and the recognition that the compound has legitimate medical applications muscle wasting treatment, burn recovery, osteoporosis for which it is occasionally prescribed in clinical practice.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Anvarol Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Barlow+Condensed:wght@600;700;800&#038;family=Barlow:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #d5d8db;
    padding: 28px 16px;
    font-family: 'Barlow', sans-serif;
  }

  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 9px;
    overflow: hidden;
    box-shadow: 0 8px 44px rgba(0,0,0,0.42);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.52);
  }

  /* ── BANNER SHELL ── */
  .banner {
    width: 100%;
    background: #090c10;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Animated top bar — teal/cyan/green for Anvarol cutting theme */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }
  @keyframes sweep {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* Background FX */
  .bg-fx {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background:
      radial-gradient(ellipse 55% 80% at 88% 50%, rgba(0,200,150,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 35% 60% at 10% 50%, rgba(0,180,130,0.07) 0%, transparent 55%),
      repeating-linear-gradient(-53deg, transparent, transparent 17px,
        rgba(255,255,255,0.012) 17px, rgba(255,255,255,0.012) 18px);
  }
  .slash {
    position: absolute; inset: 0; z-index: 0; pointer-events: none;
    background: linear-gradient(110deg,
      transparent 0%, transparent 40%,
      rgba(0,180,130,0.08) 40%, rgba(0,220,160,0.04) 100%
    );
  }

  /* Gold accent line — from bottle cap */
  .gold-line {
    position: absolute;
    top: 4px; left: 0; right: 0;
    height: 1px;
    background: linear-gradient(90deg, transparent, rgba(212,168,0,0.25), transparent);
    z-index: 1;
    pointer-events: none;
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative; z-index: 2;
    display: flex; align-items: center;
    gap: 12px;
    padding: 18px 22px 15px 16px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0; width: 112px;
    display: flex; align-items: center; justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 104px; height: auto; display: block;
    filter:
      drop-shadow(0 0 18px rgba(0,200,140,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
    transform: rotate(-4deg) scale(1.06);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: rotate(-1deg) scale(1.12);
    filter:
      drop-shadow(0 0 26px rgba(0,230,160,0.7))
      drop-shadow(0 5px 12px rgba(0,0,0,0.9));
  }
  .img-badge {
    position: absolute; top: -5px; right: -5px; z-index: 3;
    background: linear-gradient(135deg, #007a5e, #00c896);
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 7px; border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,180,120,0.6);
    white-space: nowrap;
  }
  /* Gold cap glow hint */
  .cap-glow {
    position: absolute;
    top: 0; left: 50%;
    transform: translateX(-50%);
    width: 70px; height: 20px;
    background: radial-gradient(ellipse, rgba(212,168,0,0.25) 0%, transparent 70%);
    pointer-events: none;
  }

  /* TEXT */
  .text-col { flex: 1; min-width: 0; }
  .eyebrow {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9px; font-weight: 700; letter-spacing: 3px;
    text-transform: uppercase; color: #00c896; margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(27px, 5.5vw, 44px);
    line-height: 0.9; letter-spacing: 1.5px; color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,200,140,0.35);
  }
  .headline em { color: #00e0a0; font-style: normal; }
  .sub {
    font-size: 11px; color: rgba(255,255,255,0.53);
    line-height: 1.5; margin-bottom: 10px; max-width: 310px;
  }
  .sub strong { color: rgba(255,255,255,0.75); font-weight: 600; }

  .tags { display: flex; flex-wrap: wrap; gap: 5px; }
  .tag {
    display: inline-flex; align-items: center; gap: 4px;
    background: rgba(0,180,130,0.1);
    border: 1px solid rgba(0,200,140,0.28);
    color: #00d4a0;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8.5px; letter-spacing: 1.2px;
    text-transform: uppercase; padding: 3px 8px; border-radius: 2px;
  }
  .tag::before { content: '✓'; font-size: 8px; color: #00c896; }

  /* DIVIDER */
  .v-divider {
    width: 1px; align-self: stretch; margin: 10px 0; flex-shrink: 0;
    background: linear-gradient(to bottom, transparent, rgba(0,200,140,0.3), transparent);
  }

  /* CTA */
  .cta-col {
    flex-shrink: 0;
    display: flex; flex-direction: column; align-items: center;
    gap: 9px; min-width: 148px; padding-left: 6px;
  }
  .price-wrap { text-align: center; }
  .p-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1.8px;
    text-transform: uppercase; color: rgba(255,255,255,0.28); margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px; color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Barlow Condensed', sans-serif; font-weight: 600;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 48px; line-height: 1; color: #fff; letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 9.5px; font-weight: 800; letter-spacing: 1.4px;
    text-transform: uppercase; color: #4ddf8a; margin-top: 1px;
  }
  .p-bulk {
    font-family: 'Barlow Condensed', sans-serif;
    font-size: 8.5px; font-weight: 700; letter-spacing: 1px;
    color: rgba(0,220,160,0.6); margin-top: 2px;
  }

  .cta-btn {
    display: flex; align-items: center; justify-content: center; gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #006644 0%, #00a873 50%, #00d4a0 100%);
    background-size: 200% 100%; background-position: 0% 50%;
    color: #fff;
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 13px; letter-spacing: 1.8px;
    text-transform: uppercase; padding: 13px 14px; border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,180,120,0.5);
    transition: background-position 0.4s, box-shadow 0.2s;
    white-space: nowrap; position: relative; overflow: hidden;
  }
  .cta-btn::after {
    content: ''; position: absolute; top: 0; left: -100%;
    width: 50%; height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.22), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,200,140,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow { font-size: 14px; transition: transform 0.2s; }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }
  .secure {
    font-size: 8.5px; color: rgba(255,255,255,0.24);
    text-align: center; letter-spacing: 0.8px; text-transform: uppercase;
  }

  /* ── BENEFIT ROW ── */
  .benefit-row {
    position: relative; z-index: 2;
    display: flex; align-items: stretch;
    background: rgba(0,180,130,0.07);
    border-top: 1px solid rgba(0,200,140,0.14);
  }
  .br-item {
    flex: 1; text-align: center;
    padding: 7px 4px;
    border-right: 1px solid rgba(0,200,140,0.1);
    transition: background 0.2s;
  }
  .br-item:last-child { border-right: none; }
  .banner-link:hover .br-item { background: rgba(0,200,140,0.06); }
  .br-icon { font-size: 13px; margin-bottom: 2px; }
  .br-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.1px;
    text-transform: uppercase; color: rgba(255,255,255,0.36);
  }

  /* ── USE FOR STRIP ── */
  .use-strip {
    position: relative; z-index: 2;
    display: flex; align-items: center; justify-content: center;
    background: rgba(0,0,0,0.2);
    border-top: 1px solid rgba(255,255,255,0.04);
    gap: 0;
    overflow: hidden;
  }
  .us-label {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 800; font-size: 8px; letter-spacing: 2px;
    text-transform: uppercase; color: #00c896;
    padding: 6px 12px;
    border-right: 1px solid rgba(0,200,140,0.15);
    white-space: nowrap;
    flex-shrink: 0;
  }
  .us-items {
    display: flex; flex: 1; align-items: center;
    flex-wrap: wrap;
  }
  .us-item {
    font-family: 'Barlow Condensed', sans-serif;
    font-weight: 700; font-size: 8px; letter-spacing: 1.2px;
    text-transform: uppercase; color: rgba(255,255,255,0.32);
    padding: 6px 10px;
    border-right: 1px solid rgba(255,255,255,0.05);
    display: flex; align-items: center; gap: 5px;
  }
  .us-item:last-child { border-right: none; }
  .us-dot { width: 3px; height: 3px; border-radius: 50%; background: #00c896; opacity: 0.5; }

  /* Bottom bar */
  .bottom-bar {
    width: 100%; height: 4px;
    background: linear-gradient(90deg, #007a5e, #00c896, #00f5b4, #00c896, #007a5e);
    background-size: 300% 100%;
    animation: sweep 3.5s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 88px; }
    .product-col img { width: 78px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 40px; }
    .cta-col { min-width: 126px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .us-item { padding: 5px 7px; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .us-items { display: none; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/MND7Z/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>
      <div class="gold-line"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="cap-glow"></div>
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Cutting</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Anvarol — Legal Anavar Alternative">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal Anavar Alternative</div>
          <div class="headline">
            <em>Anvarol</em><br>
            Shred &amp; Define
          </div>
          <p class="sub">Incinerate fat, preserve lean muscle &amp; boost <strong>explosive power</strong> — no water retention, no needles, rapid results in 30 days.</p>
          <div class="tags">
            <span class="tag">Fast Fat Loss</span>
            <span class="tag">Lean Muscle</span>
            <span class="tag">Explosive Power</span>
            <span class="tag">Men &amp; Women</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-label">Single Bottle</div>
            <div class="p-was">Was $79.99</div>
            <div class="p-now">$64.99</div>
            <div class="p-save">Save $15 · Buy 2 Get 1 Free</div>
            <div class="p-bulk">Bulk 3-pack only $129.98</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back Guarantee</div>
        </div>

      </div>

      <!-- Benefit icons -->
      <div class="benefit-row">
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f525.png" alt="🔥" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Burns Visceral Fat</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4aa.png" alt="💪" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Muscle Hardness</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Explosive Energy</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4a7.png" alt="💧" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Zero Water Retention</div></div>
        <div class="br-item"><div class="br-icon"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2705.png" alt="✅" class="wp-smiley" style="height: 1em; max-height: 1em;" /></div><div class="br-label">Safe &amp; Legal</div></div>
      </div>

      <!-- Use for / stack strip -->
      <div class="use-strip">
        <div class="us-label">Use For:</div>
        <div class="us-items">
          <div class="us-item"><span class="us-dot"></span>Cutting Cycles</div>
          <div class="us-item"><span class="us-dot"></span>Enhanced Vascularity</div>
          <div class="us-item"><span class="us-dot"></span>Post-Workout Recovery</div>
          <div class="us-item"><span class="us-dot"></span>509,389 Bottles Sold</div>
        </div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<p class="wp-block-paragraph">SARMs occupy more ambiguous regulatory territory that is frequently misrepresented as straightforwardly legal. They are not scheduled controlled substances in the same category as anabolic steroids in the United States, but they are explicitly not approved for human use by the FDA, and the FDA has issued import alerts against companies selling them with human use implications.</p>



<p class="wp-block-paragraph">The SARMs Control Act, which has been introduced in Congress with the intent of scheduling SARMs alongside anabolic steroids, represents the direction of regulatory travel rather than the current status quo. Both compounds are prohibited in competitive sport by the World Anti-Doping Agency without exception.</p>



<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>CrazyBulk SARMs Banner</title>
<link href="https://fonts.googleapis.com/css2?family=Bebas+Neue&#038;family=Exo+2:wght@600;700;800&#038;family=Inter:wght@400;500&#038;display=swap" rel="stylesheet">
<style>
  * { margin: 0; padding: 0; box-sizing: border-box; }

  body {
    background: #e0e4e8;
    padding: 28px 16px;
    font-family: 'Inter', sans-serif;
  }

  /* ── NARROW WRAPPER ── */
  .wrap {
    max-width: 700px;
    margin: 0 auto;
  }

  .banner-link {
    display: block;
    text-decoration: none;
    border-radius: 8px;
    overflow: hidden;
    box-shadow: 0 8px 40px rgba(0,0,0,0.4);
    transition: transform 0.25s ease, box-shadow 0.25s ease;
  }
  .banner-link:hover {
    transform: translateY(-3px);
    box-shadow: 0 18px 60px rgba(0,0,0,0.5);
  }

  /* ── BANNER ── */
  .banner {
    width: 100%;
    background: #080d14;
    position: relative;
    overflow: hidden;
    display: flex;
    flex-direction: column;
  }

  /* Top neon bar */
  .top-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }
  @keyframes barShift {
    0%   { background-position: 0% 50%; }
    100% { background-position: 300% 50%; }
  }

  /* BG texture layers */
  .bg-fx {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background:
      radial-gradient(ellipse 60% 80% at 90% 50%, rgba(0,80,255,0.13) 0%, transparent 65%),
      radial-gradient(ellipse 40% 60% at 15% 50%, rgba(0,200,120,0.07) 0%, transparent 60%),
      repeating-linear-gradient(-52deg, transparent, transparent 16px, rgba(255,255,255,0.014) 16px, rgba(255,255,255,0.014) 17px);
  }

  /* Blue diagonal slash */
  .slash {
    position: absolute;
    inset: 0;
    z-index: 0;
    pointer-events: none;
    background: linear-gradient(108deg,
      transparent 0%,
      transparent 42%,
      rgba(0,100,255,0.09) 42%,
      rgba(0,200,200,0.06) 100%
    );
  }

  /* ── MAIN ROW ── */
  .main-row {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    gap: 12px;
    padding: 18px 22px 14px 18px;
  }

  /* PRODUCT */
  .product-col {
    flex-shrink: 0;
    width: 118px;
    display: flex;
    align-items: center;
    justify-content: center;
    position: relative;
  }
  .product-col img {
    width: 110px;
    height: auto;
    display: block;
    border-radius: 6px;
    filter:
      drop-shadow(0 0 16px rgba(0,150,255,0.55))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
    transform: scale(1.04);
    transition: transform 0.3s ease, filter 0.3s ease;
  }
  .banner-link:hover .product-col img {
    transform: scale(1.1);
    filter:
      drop-shadow(0 0 22px rgba(0,180,255,0.75))
      drop-shadow(0 5px 12px rgba(0,0,0,0.85));
  }
  .img-badge {
    position: absolute;
    top: -5px;
    right: -4px;
    background: linear-gradient(135deg, #0055ff, #00c6ff);
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 8px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 7px;
    border-radius: 3px;
    box-shadow: 0 2px 10px rgba(0,100,255,0.55);
    white-space: nowrap;
    z-index: 3;
  }

  /* TEXT */
  .text-col {
    flex: 1;
    min-width: 0;
  }
  .eyebrow {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 700;
    letter-spacing: 3px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .headline {
    font-family: 'Bebas Neue', sans-serif;
    font-size: clamp(28px, 5.5vw, 44px);
    line-height: 0.9;
    letter-spacing: 1.5px;
    color: #fff;
    margin-bottom: 7px;
    text-shadow: 0 0 30px rgba(0,150,255,0.35);
  }
  .headline em {
    color: #00c6ff;
    font-style: normal;
  }
  .sub {
    font-size: 11px;
    color: rgba(255,255,255,0.55);
    line-height: 1.5;
    margin-bottom: 10px;
    max-width: 320px;
  }

  /* Product tags */
  .tags {
    display: flex;
    flex-wrap: wrap;
    gap: 5px;
  }
  .tag {
    display: inline-flex;
    align-items: center;
    gap: 4px;
    background: rgba(0,150,255,0.1);
    border: 1px solid rgba(0,180,255,0.28);
    color: #55ccff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    padding: 3px 8px;
    border-radius: 2px;
  }
  .tag::before { content: '▸'; font-size: 8px; }

  /* CTA COLUMN */
  .cta-col {
    flex-shrink: 0;
    display: flex;
    flex-direction: column;
    align-items: center;
    gap: 9px;
    min-width: 145px;
    padding-left: 6px;
  }

  /* Price */
  .price-wrap { text-align: center; }
  .p-from {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 600;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.3);
    margin-bottom: 1px;
  }
  .p-was {
    font-size: 10px;
    color: rgba(255,255,255,0.28);
    text-decoration: line-through;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
    letter-spacing: 0.5px;
  }
  .p-now {
    font-family: 'Bebas Neue', sans-serif;
    font-size: 46px;
    line-height: 1;
    color: #fff;
    letter-spacing: 1px;
  }
  .p-save {
    font-family: 'Exo 2', sans-serif;
    font-size: 9.5px;
    font-weight: 800;
    letter-spacing: 1.5px;
    text-transform: uppercase;
    color: #00ff9d;
    margin-top: 1px;
  }

  /* Button */
  .cta-btn {
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 7px;
    width: 100%;
    background: linear-gradient(135deg, #0044dd 0%, #00aaff 50%, #00ddff 100%);
    background-size: 200% 100%;
    background-position: 0% 50%;
    color: #fff;
    font-family: 'Exo 2', sans-serif;
    font-weight: 800;
    font-size: 12.5px;
    letter-spacing: 1.8px;
    text-transform: uppercase;
    padding: 13px 14px;
    border-radius: 5px;
    box-shadow: 0 4px 20px rgba(0,100,255,0.5);
    transition: background-position 0.4s, box-shadow 0.2s, transform 0.2s;
    white-space: nowrap;
    position: relative;
    overflow: hidden;
  }
  .cta-btn::after {
    content: '';
    position: absolute;
    top: 0; left: -100%;
    width: 50%;
    height: 100%;
    background: linear-gradient(90deg, transparent, rgba(255,255,255,0.2), transparent);
    transition: left 0.5s ease;
  }
  .banner-link:hover .cta-btn {
    background-position: 100% 50%;
    box-shadow: 0 6px 30px rgba(0,140,255,0.7);
  }
  .banner-link:hover .cta-btn::after { left: 160%; }
  .btn-arrow {
    font-size: 14px;
    transition: transform 0.2s;
  }
  .banner-link:hover .btn-arrow { transform: translateX(4px); }

  .secure {
    font-size: 8.5px;
    color: rgba(255,255,255,0.25);
    text-align: center;
    letter-spacing: 0.8px;
    text-transform: uppercase;
  }

  /* DIVIDER between text and cta */
  .v-divider {
    width: 1px;
    align-self: stretch;
    margin: 10px 0;
    background: linear-gradient(to bottom, transparent, rgba(0,180,255,0.3), transparent);
    flex-shrink: 0;
  }

  /* ── PRODUCT STRIP ── */
  .product-strip {
    position: relative;
    z-index: 2;
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 0;
    background: rgba(0,100,255,0.08);
    border-top: 1px solid rgba(0,180,255,0.15);
    overflow: hidden;
  }
  .ps-item {
    flex: 1;
    text-align: center;
    padding: 7px 6px;
    border-right: 1px solid rgba(0,180,255,0.12);
    transition: background 0.2s;
  }
  .ps-item:last-child { border-right: none; }
  .banner-link:hover .ps-item { background: rgba(0,120,255,0.1); }
  .ps-name {
    font-family: 'Exo 2', sans-serif;
    font-size: 9px;
    font-weight: 800;
    letter-spacing: 1.2px;
    text-transform: uppercase;
    color: #00c6ff;
    margin-bottom: 2px;
  }
  .ps-desc {
    font-size: 8px;
    color: rgba(255,255,255,0.35);
    letter-spacing: 0.5px;
    font-family: 'Exo 2', sans-serif;
    font-weight: 600;
  }

  /* ── BOTTOM STRIP ── */
  .bottom-strip {
    position: relative;
    z-index: 2;
    background: rgba(0,0,0,0.25);
    border-top: 1px solid rgba(255,255,255,0.05);
    display: flex;
    align-items: center;
    justify-content: center;
    gap: 16px;
    padding: 6px 16px;
    flex-wrap: wrap;
  }
  .bs-item {
    font-family: 'Exo 2', sans-serif;
    font-weight: 700;
    font-size: 8.5px;
    letter-spacing: 1.4px;
    text-transform: uppercase;
    color: rgba(255,255,255,0.32);
    display: flex;
    align-items: center;
    gap: 5px;
  }
  .bs-dot {
    width: 3px; height: 3px;
    border-radius: 50%;
    background: #00c6ff;
    opacity: 0.5;
  }

  /* Bottom bar */
  .bottom-bar {
    width: 100%;
    height: 4px;
    background: linear-gradient(90deg, #0055ff, #00c6ff, #00ff9d, #00c6ff, #0055ff);
    background-size: 300% 100%;
    animation: barShift 4s linear infinite;
    flex-shrink: 0;
  }

  /* ── RESPONSIVE ── */
  @media (max-width: 560px) {
    .main-row { padding: 14px 14px 12px 12px; gap: 10px; }
    .product-col { width: 90px; }
    .product-col img { width: 80px; }
    .headline { font-size: 26px; }
    .p-now { font-size: 38px; }
    .cta-col { min-width: 120px; }
    .tags { display: none; }
    .v-divider { display: none; }
    .ps-desc { display: none; }
  }
  @media (max-width: 420px) {
    .product-col { display: none; }
    .sub { display: none; }
    .cta-col { min-width: 108px; }
  }
</style>
</head>
<body>

<div class="wrap">
  <a class="banner-link" href="https://www.wb22trk.com/cmp/PWQ5H1/49747C/" target="_blank" rel="noopener sponsored">
    <div class="banner">

      <div class="top-bar"></div>
      <div class="bg-fx"></div>
      <div class="slash"></div>

      <!-- MAIN ROW -->
      <div class="main-row">

        <!-- Product image -->
        <div class="product-col">
          <div class="img-badge"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/26a1.png" alt="⚡" class="wp-smiley" style="height: 1em; max-height: 1em;" /> Legal SARMs</div>
          <img decoding="async" src="data:image/jpeg;base64,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" alt="CrazyBulk Legal SARMs Alternatives — OSTA 2866, LIGAN 4033, TESTOL 140, IBUTA 677">
        </div>

        <!-- Text -->
        <div class="text-col">
          <div class="eyebrow">CrazyBulk · Legal &amp; Safe Alternatives</div>
          <div class="headline">
            <em>SARMs</em> Range<br>
            Gym Beast Mode
          </div>
          <p class="sub">Torch fat, skyrocket testosterone &amp; build serious muscle — 100% natural, zero side effects, no prescription needed.</p>
          <div class="tags">
            <span class="tag">Muscle Growth</span>
            <span class="tag">Fat Burning</span>
            <span class="tag">Boost T-Levels</span>
            <span class="tag">60-Day Guarantee</span>
          </div>
        </div>

        <div class="v-divider"></div>

        <!-- CTA -->
        <div class="cta-col">
          <div class="price-wrap">
            <div class="p-from">Singles from</div>
            <div class="p-was">Was $84.99</div>
            <div class="p-now">$69.99</div>
            <div class="p-save">Save $15 · Stacks from $249</div>
          </div>
          <div class="cta-btn">Get the Deal <span class="btn-arrow">→</span></div>
          <div class="secure"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f512.png" alt="🔒" class="wp-smiley" style="height: 1em; max-height: 1em;" /> 60-Day Money-Back</div>
        </div>

      </div>

      <!-- Product name strip -->
      <div class="product-strip">
        <div class="ps-item">
          <div class="ps-name">OSTA 2866</div>
          <div class="ps-desc">Muscle Growth</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">LIGAN 4033</div>
          <div class="ps-desc">Energy &amp; Pumps</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">TESTOL 140</div>
          <div class="ps-desc">Boosts Testosterone</div>
        </div>
        <div class="ps-item">
          <div class="ps-name">IBUTA 677</div>
          <div class="ps-desc">HGH &amp; Strength</div>
        </div>
      </div>

      <!-- Social proof strip -->
      <div class="bottom-strip">
        <div class="bs-item"><span class="bs-dot"></span>509,389 Bottles Sold</div>
        <div class="bs-item"><span class="bs-dot"></span>100% Natural Ingredients</div>
        <div class="bs-item"><span class="bs-dot"></span>Legal In All Countries</div>
        <div class="bs-item"><span class="bs-dot"></span>Free Shipping $100+</div>
      </div>

      <div class="bottom-bar"></div>

    </div>
  </a>
</div>

</body>
</html>



<h2 class="wp-block-heading"><strong>Conclusion: Reliability vs Experimentation</strong></h2>



<p class="wp-block-paragraph">The verdict of this comparison is not that SARMs are without value or that they are interchangeable with dangerous compounds. It is that the comparison between Anavar and SARMs involves weighing two genuinely different categories of risk rather than simply comparing side effect profiles.</p>



<p class="wp-block-paragraph">Anavar&#8217;s risks are known, documented, dose-dependent, and manageable through standard cycle support and bloodwork monitoring. The compound causing those risks is pharmaceutical grade with guaranteed purity. The clinical literature on Oxandrolone spans decades of human studies and post-market safety data. When you run Anavar, you know what you are running and what it is doing.</p>



<p class="wp-block-paragraph">SARMs&#8217; risks are partially known, partially unknown, subject to contamination that changes the risk profile unpredictably, and backed by a research base that is still primarily preclinical or early-phase human data. When you run a black-market SARM without third-party testing, you do not know with certainty what you are running or what it is doing and that uncertainty is itself a meaningful risk that does not appear in any side effect table.</p>



<p class="wp-block-paragraph">For cutting goals, Anavar delivers superior and more reliable results than any individual SARM with better purity assurance and a more complete safety profile. For users specifically seeking to avoid oral alkylation and willing to accept the contamination uncertainty of the research chemical market, Ostarine at conservative doses represents the most studied and most predictable option in the SARM class. </p>



<p class="wp-block-paragraph">The cautious stack Anavar at a moderate dose alongside low-dose Ostarine provides a dual-mechanism approach for experienced users who want both, with diligent monitoring as the non-negotiable condition of doing so safely.</p>



<p class="wp-block-paragraph">Health monitoring is not optional. Bloodwork is not optional. Purity testing of any black-market compound is not optional. Pharmaceutical grade beats research chemical every time on the certainty dimension and certainty is what informed risk management is built on.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://gymtrix.net/anavar-vs-sarms/">Anavar vs SARMs: Proven Steroid vs Research Cutting Alternatives</a> appeared first on <a href="https://gymtrix.net">Gym Trix</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/?utm_source=w3tc&utm_medium=footer_comment&utm_campaign=free_plugin

Page Caching using Disk: Enhanced 

Served from: gymtrix.net @ 2026-06-05 17:16:08 by W3 Total Cache
-->